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1 SUMMARY
Drosophila melanogaster is a model organism to study innate immunity in invertebrates. Temperate
and tropical D. melanogaster populations, being exposed to different environments, potentially face
distinct  parasites  and  parasite  pressure.  Indeed,  there  is  experimental  evidence  suggesting  that
tropical D. melanogaster populations survive longer than temperate ones to infection by the fungal
parasite  Beauveria bassiana.  In the  present  work we test  the generality  of  this  conclusion and
investigate if host populations differ in their molecular response to infection. 
We first exposed to B. bassiana infection two tropical (from Africa and South-East Asia) and two
temperate  (from  Europe  and  North  America)  D.  melanogaster out-crossed  populations.  We
consistently found a significant effect of B. bassiana on Drosophila mortality, but we were not able
to identify a significant difference in survival to infection among populations. These results indicate
that tropical populations may not always survive better than temperate ones, and suggest that other
environmental factors, such as humidity or local species richness may be more accurate predictors
of immune competence. 
Subsequently,  we  recorded  transcriptional  response  to  B.  bassiana in  all  D.  melanogaster
populations, both by microarray and RNA sequencing. To our knowledge this is the first time that
transcriptional  response  to  fungal  infection  has  been  determined  in  multiple  D.  melanogaster
out-crossed populations. We found few or no genes significantly induced 8 hours after infection. On
the  other  hand,  we  identified  between  200  and  1,300  genes  induced  24  hours  after  infection
depending  on  the  population.  This  means  that  transcriptional  response  to  B.  bassiana begins
between 8 and 24 hours after infection. We reveal here that host populations respond differently at
the molecular level, as shown by the large variation in the number of induced genes. We report that
gene ontology categories related to translation, biosynthesis and reproduction are enriched in genes
down-regulated upon infection, suggesting a metabolic cost of mounting the defence response.
Next, we wanted to assess the selective pressures acting on induced candidate genes. We compared
the  genes  induced  in  all  populations  to  the  ones  induced  specifically  in  each  population  and
computed population genetic statistics for a subset of genes in each category. We noticed higher
conservation  at  non-synonymous  sites  for  commonly  induced  genes  compared  to  population
specific ones. This hints that common genes are under stronger selective constraints. 
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Another  topic  we  addressed  in  the  present  work  is  the  effect  of  endosymbionts  and
trans-generational immune priming on  D. melanogaster survival to  B. bassiana. We tested for a
protective effect of the endosymbiont Wolbachia pipientis in two D. melanogaster inbred lines. We
did  not  find  an  effect  of  Wolbachia on  survival  to  infection  in  two  independent  experimental
replicates. In absence of infection, flies bearing  Wolbachia had a lower fitness than cured ones.
Therefore W. pipientis appears to have a negative effect on Drosophila general vigour, but no effect
on mortality upon infection.
Finally, we tested if flies whose parents were exposed to  B. bassiana were less susceptible when
infected by the same parasite. This would imply a transfer of immune memory from parents to
offspring, which is called trans-generational immune priming. However, no evidence of immune
transfer for two D. melanogaster out-crossed populations could be found. Yet, as trans-generational
immune priming depends on host and parasite genotype, more experiments are needed to determine
its generality in the D. melanogaster – B. bassiana system. 
2
2 INTRODUCTION
2.1 GENERALITY OF HOST-PARASITE INTERACTIONS 
Species interact widely both in antagonistic (predation, parasitism, competition) and in synergistic
ways (cooperation, symbiosis). These interactions define the biotic environment of each species,
exert  selection and promote evolution and co-evolution through time.  Host-parasite  interactions
appear to have the greatest importance in this regard, as most of the species on Earth are parasites
(Windsor 1998). Parasites (or pathogens) depend on their host for growth and reproduction and are
at the same time a source of selection on their  host for reduced damage and/or clearance. This
interplay is far from being static, as both parts change – evolve and sometimes co-evolve – through
time (see the next section for more details). The effect of parasites is manifold, as they have been
claimed to be responsible for the evolution of sex (Hamilton et al. 1990; Morran et al. 2011), the
evolution  of  male  ornaments  and  female  choice  (Hamilton  and  Zuk  1982),  populations
diversification (Brockhurst et al. 2004), the maintenance of genetic variation (Berenos et al. 2011)
especially  at  MHC  genes  (Eizaguirre et  al. 2012a),  the  acceleration  of  molecular  evolution
(Paterson et  al. 2010)  and  the  increase  of  host  recombination  frequency  (Fischer  and
Schmid-Hempel 2005). 
Unfortunately parasites are not only a challenging topic in evolutionary biology but remain one of
the main threats for human health, causing every year around 13 millions deaths (WHO 1999). It
has been recently advocated that an evolutionary perspective can help designing more effective
vaccines  (Gandon et al. 2001)  and antibiotics with a lower potential for resistance development
(Andersson 2006), as well as choosing the appropriate clinical setting and antibiotic treatment to
prevent for example the spread of resistance strains in hospitals (Perron et al. 2007). 
While some parasites rely only on one host to complete their life cycle, others infect in succession
one or more intermediate hosts, where they grow and develop, and a final host where they usually
reproduce sexually (Schmid-Hempel 2011). As parasites rely on infection to survive, hosts defend
themselves  to  minimize  fitness  loss.  The first  defence  strategy is  avoidance.  For  example,  the
bumblebee  Bombus  terrestris, is  able  to  recognize  and  avoid  flowers  contaminated  with  the
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pathogenic  bacteria  Crithidia  bombi and  Escherichia  coli (Fouks  and  Lattorff  2011)  and  the
ladybird  Cocinella  settempuncatata avoids  leaf  surfaces  and soil  inoculated  with  spores  of  the
parasitic fungus Beauveria bassiana as well as sporulating cadavers (Ormond et al. 2011).
When infection occurs, the host can defend itself by mounting an immune response. The first line of
defence is the so-called innate immunity (Ferrandon et al. 2007; Janeway 2011). In innate immunity
host  receptors  recognize  conserved  microbial  patterns,  triggering  a  set  of  non-specific  defence
mechanisms. Innate immunity is present both in plants  (Jones and Dangl 2006)  and in animals,
where it is considered an old evolutionary feature highly conserved at the molecular level (Kimbrell
and Beutler 2001).
In vertebrates  an adaptive  (or  acquired)  immunity is  present  besides  the innate  one.  The main
novelty of adaptive immunity is the ability to build up a specific response against an infectious
agent. This is achieved by selection and clonal expansion of defensive cells (B and T lymphocytes
in jawed vertebrates)  that  recognize a specific  motif,  or  antigen,  of  the infecting pathogen.  An
adaptive response needs more time to unfold compared to an innate one, but, as memory cells are
formed,  a second exposure to  the same pathogen leads to  a faster,  stronger  and more effective
response (Janeway 2011; Schmid-Hempel 2011).
For a long time adaptive immunity was regarded as exclusive to vertebrates, but the last decade saw
the  discovery  of  adaptive  defence  in  bacteria  (Koonin  and  Makarova  2009)  and  increasing
evidences for immune memory in invertebrates (Kurtz and Franz 2003; Luna et al. 2012; Luna and
Ton 2012) and in plants (Conrath et al. 2006). This kind of immune memory, also called priming,
shows varying degrees of specificity: from non-specific, so that a challenge with one pathogen or
even a physical stress, can protect against multiple pathogens, to species – or strains – specific
(Rowley and Powell 2007). The protective effect lasts in general for part or the whole life of a host,
but  can  in  some  cases  extend  to  the  next  generation;  this  case  being  referred  to  as
trans-generational immune priming (Rowley and Powell 2007; Sadd and Schmid-Hempel 2007;
Sadd and Schmid-Hempel 2009; Roth et al. 2010; Luna et al. 2012; Slaughter et al. 2012).
The mechanisms behind priming are not clear in invertebrates, although it has been shown that
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immune  memory  in  Drosophila is  dependent  on  phagocytes  (Pham et  al. 2007)  and
trans-generational protection is mediated through factors inside the egg in bumblebees  (Sadd and
Schmid-Hempel 2007). In plants, epigenetic changes and protein kinases accumulation seem to be
related with immune memory (Conrath 2011) and epigenetic change appears mainly responsible for
trans-generational immune priming (Luna and Ton 2012). More research is needed in order to better
characterise the generality of immune priming and its molecular mechanisms. 
Social  insect  colonies  have  evolved  collective  defences  against  pathogens.  Among  them  are
allogrooming,  the  use  of  antimicrobial  compounds  to  disinfect  the  nest  and  social  fever  in
honeybees (Cremer et al. 2007). The fungal parasite Metarhizium anisopliae, for example, is unable
to  spread  through  a  colony  of  termites  (Coptotermes  formosanus) because  the  nest  mates
cannibalise or bury infected or dead individuals in order to kill fungal spores  (Chouvenc and Su
2012).
On the other hand, parasites are under selective pressure to avoid host defences. They can elude
them  by  modifying  their  antigenic  surface,  e.g.  by  expressing  successively  different  surface
variants, or, in long-lived infections like HIV, by mutation of epitopes. Another possibility is to
actively subvert host immune response by secreting compounds that block or interfere with some of
its  steps  (Schmid-Hempel  2011).  A virulent  strain  of  the  bacteria  Pseudomonas aeruginosa for
example is able to suppress Drosophila defence by limiting antimicrobial peptides gene expression
(Apidianakis et al. 2005). 
 
Some parasites modify host behaviour in order to increase their transmission and/or survival. For
example the ant Camponotus leonardi infected by the fungus Ophiocordyceps unilateralis descends
from its canopy nest in the Thai rainforest to reach a leaf in the low vegetation at around 25 cm
from the soil. At that spot, where the conditions for fungal development are optimal, the ant bites
the leaf veins with its mandibles and dies attached to the leaf. The parasite then develops a spore
dispersal structure from the head of the dead ant (Andersen et al. 2009). 
Parasites transmitted via predation can increase transmission probability by acting on the central
nervous system of the intermediate host to reduce predation fear and escaping behaviour (Kaushik
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et al. 2012). An extreme case is the amphipod  Gammarus pulex infected by the acanthocephalan
parasite  Pomphorhynchus laevis. Hosts bearing the non-infective stage of the parasite hide more
than non-infected animals and are less likely to get caught. When the parasite enters the infective
stage, the behaviour of the host changes: infected individuals hide less than uninfected ones and are
more hunted. In this way the parasite modifies host behaviour to maximize its transmission to the
final fish host species at the correct developmental stage (Dianne et al. 2011).
As we have seen host and parasite interplay ranges from the behavioural to the molecular level with
various degrees of specificity. Its far reaching consequences and the overwhelming prevalence of
the parasitic lifestyle make host-parasite interaction one of the most interesting topics in modern
evolutionary biology.
2.2 ECOLOGY AND EVOLUTION OF HOST-PARASITE INTERACTIONS
We will explore here the different evolutionary and ecological forces influencing the outcome of
given host-parasite interactions, i.e. the success of an infection and the extent of fitness loss for the
host and fitness gain for the parasite. The ability to resist a parasite increases host fitness, because it
lowers the probability of infection, and in case of successful infection reduces damages. However,
in absence of infection other traits, such as survival, fecundity, competitiveness and the ability to
resist different parasites are more important. As each trait is costly, its actual level will be the result
of a trade-off between conflicting needs. Zuk and Stoehr identify three possible costs of defence
(Zuk and Stoehr 2002).
1) A “resource cost” is due to limited physiological and metabolic resources and can be paid upon
evolution  and  maintenance  of  immune  defence.  This  is  the  case  in  Drosophila  melanogaster
selected for increased survival to the endoparasitoid  Asobara tabida. Selected flies show reduced
larval competitive ability in absence of infection (Kraaijeveld and Godfray 1997). Immune system
deployment can also incur a resource cost, as shown in bumblebees (Bombus terrestris) injected
with  LPS,  a  bacterial  outer  membrane  molecule  with  antigenic  activity.  Injected  individuals
exhibited a reduced survival rate in food limited conditions (Moret and Schmid-Hempel 2000).
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2) An “option cost” occurs if a change in a receptor molecule increases the ability to recognize one
pathogen  but  decreases  the  ability  to  recognize  a  different  one,  as  has  been  shown for  MHC
haplotypes (Eizaguirre et al. 2012b).
3) An “immunopathology cost” is the result of an unspecific immune response that either is getting
out of control (such as auto-immune diseases) or that is diverted by the parasite causing damage to
the host (Sorci and Faivre 2009; Belloni et al. 2010).
A trade-off  is  present  between  two  different  components  of  defence:  tolerance  and  resistance.
Resistance is the ability to actively reduce the parasite burden, while tolerance is the ability to limit
the damage caused by a given pathogen load (Raberg et al. 2009). For example a single mutation in
a gene encoding a protease in Drosophila melanogaster affects resistance and tolerance to infection
in  a  microbe-dependent  way  (Ayres  and Schneider  2008).  Resistance  and  tolerance  have  quite
different  effects  on  parasite  evolution.  While  resistance  imposes  a  selection  on  the  parasite  to
overcame host defence, and can lead to antagonistic co-evolution between the host and the parasite,
tolerance is not predicted to exercise any selection on the parasite (Raberg et al. 2009). The ability
to resist a pathogen is always dependent on a trade-off against  other physiological and defence
components, and thus cannot be studied independently from host life-history and ecology (Zuk and
Stoehr 2002; Schulenburg et al. 2009). Also parasites incur in trade-offs. For example there is some
evidence that parasites with a broad host range have lower infection intensity and prevalence on
each host compared with more specialized parasites  (Poulin 2002; Garamszegi 2006). The reason
for this  is the negative genetic correlation between fitness on different hosts. Evidences for the
opposite  trend  are  also  observed  though,  with  generalist  parasites  showing  higher  prevalences
(Cleaveland et al. 2001; Woolhouse et al. 2001). Parasites could also pay an evolutionary cost for
being generalist, as they adapt more slowly to each host compared to specialists  (Whitlock 1996;
Kawecki 1998). 
Host and parasites species and populations are not homogeneous entities, but show at least some
degree of genetic variability. Different host or parasite genotypes can address the same trade-off in
different ways, following distinct evolutionary strategies (van Baalen 1998). The outcome of host
parasite  interactions  depends  on  the  genotypes  of  the  two  partners,  the  so-called  Genotype x
Genotype interaction (G x G). For example when the crustacean Daphnia magna is exposed to its
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bacterial microparasite  Pasteuria ramosa, the percentage of infected individuals depends on the
combination of host and parasite genotypes (Carius et al. 2001). The same is true for the expression
level of immunity genes in  Bombus terrestris infected with the gut trypanosome Crithidia bombi
(Riddell et al. 2009). The molecular basis for such specificity will be explained below in this page.
Another  important  factor  that  determines  the  outcome  of  host-parasite  interactions  is  the
environment.  For  example  D.  melanogaster survival  rate  after  infection  with  the  bacteria
Pseudomonas aeruginosa depends on the time of the day when the infection took place (Yang et al.
2008). Temperature fluctuations influence also the development time of the parasite  Plasmodium
chaubadi, the causing agent of rodent malaria, in the vector host Anopheles stephensi (Paaijmans et
al. 2010). 
The effect  of the environment  can be complex and modify the outcome of  infection for given
combination  of  host  and  parasite  genotypes,  so  that  the  same environmental  change  increases
parasite fitness in some cases and host fitness in others  (Wolinska and King 2009). This is the
so-called Genotype x Genotype x Environment interaction (G x G x E). Caution therefore is needed
in interpreting the results of infection experiments performed in the lab,  as they depend on the
genotypes and the environmental conditions used.
The interaction between host and parasite genotypes and the selection pressure they exert on one
another set up the scene for antagonistic co-evolution: host and parasite continuously evolve in
response to each other. It is thus possible to study co-evolution by observing changes in phenotype
and genotype frequencies in time in both species. 
Frequency-dependent  selection  (FDS)  is  thought  to  be  the  major  force  driving  host-parasite
co-evolution (Haldane 1954; Clarke 1964). Under FDS, rare host alleles are favoured because the
corresponding parasite alleles, able to infect these host types, are also at low frequencies. As the
host alleles become more common, the corresponding parasite  alleles are  selected for and thus
increase  in  frequency,  with  a  slight  time  lag.  This  type  of  selection  is  also  called  negative
frequency-dependent  selection  (nFDS)  because  alleles  at  high  frequencies  are  selected  against
(Frank  1992),  or  negative  indirect  frequency-dependent  selection  (ndFDS),  (Tellier  and Brown
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2007).
Parasites are usually considered to have a shorter generation time and therefore to be ahead in the
co-evolutionary race, although this is not always true. For example parasitoids have to kill their host
in order to reproduce (Godfray 1994), thus generation times are in this case synchronised.
Host-parasite co-evolution generates two types of evolutionary dynamics at loci under selection:
recurrent  fixation  of  new  genetic  variants  or  evolutionary  cycles  with  fluctuation  in  allele
frequencies  (Stahl et al. 1999; Bergelson et al. 2001; Holub 2001).  These two extreme scenarios
based  on  FDS  models  involve  different  outcomes,  namely  positive  directional  and  balancing
selection,  and  are  expected  to  leave  different  footprints  at  the  genetic  and  genomic  levels
(Woolhouse et al. 2002; Brown and Tellier 2011). Besides studying the signatures of co-evolution at
the  genomic  level  (see  below  for  further  details),  empirical  studies  have  mainly  focused  on
monitoring  the  changes  in  phenotype  over  time  in  both  natural  and  experimental  populations
(Jokela et al. 2009; Eizaguirre et al. 2012b).
The advantage of exhibiting rare alleles and of generating more diverse offspring, that would not be
infected by common parasites, increases when parasite prevalence is high  (Koskella and Lively
2009).  The  Red Queen Hypothesis  (Van Valen 1973) postulates that high infection rates should
select for sexual reproduction and meiotic recombination in order to increase offspring variability.
These  predictions  have  been  verified  in  different  systems  such  as  the  snail  Potamopygrus
antipodarum (Jokela et al. 2009), and the nematode Caenorhabditis elegans (Morran et al. 2011).
Antagonistic co-evolution is expected to be stronger between closely associated host and parasite
populations.  Hosts  and  parasites  interact  and  co-evolve  locally  and  one  naively  expects  that
adaptation should be evident at a local scale. Indeed local adaptation has been demonstrated in
several systems, although it is not always easy to detect or may not be present at all, because it can
occur over several geographic scales and is influenced by host and parasite migration rates and
parasite specificity and virulence (Kaltz and Shykoff 1998; Gandon 2002; Kawecki and Ebert 2004;
Vos et al. 2009). 
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Environmental (biotic and abiotic) heterogeneity adds a new level of complexity (Lopez Pascua et
al. 2012). According to the “geographic mosaic theory of co-evolution” (Thompson 2005) and to
some experimental evidence,  host and parasite interact and co-evolve more intensively at  some
locations “hot-spots” than at others “cold-spots” (Thompson 1999; Gomulkiewicz et al. 2000; King
et al. 2009); migration from a hot-spot to a cold-spot intensifies co-evolution at the cold-spot, while
the opposite is true in case of migration from a cold spot to a hot-spot (Vogwill et al. 2009). This
again  indicates  the  importance  of  a  holistic  view  in  studying  host-parasite  interactions  and  of
understanding the environmental and geographic dimension in which they unfold.
Furthermore a general effect of latitude has been claimed to influence host-parasite interactions.
Due to the higher  species  richness  at  low latitudes,  parasite  prevalence and host  investment  in
immune defence should be higher in tropical compared to temperate populations. Evidence for this
hypothesis exists, although some exceptions have also been reported (Schemske 2009).
In the last decade the importance of symbionts in host-parasite interaction has been increasingly
recognized  (Gross et  al. 2009).  More  specifically  some  facultative  maternally  transmitted
endosymbionts  of  insects  have  been  shown  to  help  protecting  their  host  from  pathogens
(Scarborough et  al. 2005;  Hedges et  al. 2008;  Jaenike  and  Brekke  2011).  Host  acquisition  of
endosymbionts can indeed deeply influence the evolution of both host and parasite  (Jaenike et al.
2010;  Dion et  al. 2011;  Jiggins  and  Hurst  2011)  and  a  parallelism  between  endosymbionts
acquisition and the occurrence of a beneficial nuclear mutation has been proposed (Jaenike 2012). A
defensive endosymbiont can be advantageous to the host in presence of a parasite but detrimental if
the parasite is absent, representing therefore another example of trade-off. This has been shown for
the pea aphid Acyrthosiphon pisum and its natural endosymbionts Hamiltonella defensa (Oliver et
al. 2008).  In  this  case  the  protective  phenotype  is  actually  dependent  on  the  presence  of  a
bacteriophage  in  the  symbiont  genome  (Oliver et  al. 2009).  Therefore  symbionts,  and  mobile
genetic  elements  of  symbionts,  add  an  extra  level  of  complexity  to  host-parasite  interactions,
especially in combination with the “geographic mosaic theory of co-evolution”.
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2.3  GENETICS AND GENOMICS OF HOST-PARASITE INTERACTIONS IN  DROSOPHILA
MELANOGASTER
Genes that are important in host-parasite interactions are expected to be under natural selection. It is
possible to determine the selection pressure acting on them by looking at the molecular signature it
leaves  (Nielsen et  al. 2005;  Pavlidis et  al. 2008).  One  classical  example  is  the  major
histocompatibility complex (MHC) genes in vertebrates. The extremely high level of intra- and
trans-species  polymorphisms  at  these  genes  is  maintained  by  balancing  selection  (Hughes  and
Yeager 1998; Bernatchez and Landry 2003; Spurgin and Richardson 2010). 
Several  studies  have  assessed  the  selection  forces  acting  on  defence  genes  in  human  and
vertebrates, mainly on MHC genes and innate immunity receptors (Edwards et al. 1997; Barreiro et
al. 2009; Barreiro and Quintana-Murci 2010) and in plants (Stahl et al. 1999; Holub 2001; Tian et
al. 2002; Horger et al. 2012). On the other hand, only a few have focused on infectivity genes of
parasites (Raffaele et al. 2010; Cadar et al. 2012). 
While the majority of these studies looked for evidence of selection in the coding regions of genes,
the  importance  of  regulatory  evolution  has  being  increasingly  recognized  in  the  last  decade
(Wittkopp et al. 2004; Gibson and Weir 2005; Wray 2007; Fay and Wittkopp 2008). 
Changes  in  the  regulatory  region  of  genes  can  modify  their  expression  pattern  and  prompt
evolutionary adaptation  (Lopez-Maury et al. 2008; Fraser et al. 2010). For example  Drosophila
melanogaster experimentally  evolved  for  increased  survival  to  the  bacteria  Pseudomonas
aeruginosa shows higher infection-induced expression of immunity genes than non-evolved lines
(Ye and McGraw 2011). 
Transcriptional response to infection can be a major determinant of the ability to resist a pathogen
(Polesani et al. 2010; Moscou et al. 2011). For example a Drosophila melanogaster line resistant to
the  bacteria  Listeria  monocytogenes shows  a  stronger  activation  of  immune  genes  early  after
infection compared to a susceptible line (Okado et al. 2009).
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On the other hand, transcriptional response is a target for parasite interference. For example only a
virulent  strain  of  the  bacteria  Pseudomonas  aeruginosa,  suppresses  antimicrobial  peptide  gene
expression in  Drosophila melanogaster (Apidianakis et al.  2005). It appears that more studies are
needed to assess the selective forces acting on the regulatory region of defence and infectivity
genes.
Drosophila melanogaster is the model organism to study immunity in invertebrates. For this reason
I will  briefly introduce  Drosophila immune pathways before focusing on what is known at the
genetic and genomic levels. The immune defence in Drosophila melanogaster is based on two main
components:  the  humoral,  or  systemic,  immunity  and  the  cellular  immunity  (Lemaitre  and
Hoffmann 2007) (figure 1). 
Figure 1 Schematic representation of Drosophila melanogaster immunity (see main text)
In humoral immunity, antimicrobial peptides (AMPs) are produced by a specialized tissue, the fat
body, and subsequently secreted into the body cavity. This response is triggered by the presence of
pathogens in the body cavity and shows some degree of genus specificity, as different genera of
pathogens trigger the expression of different AMPs. 
Microbial  detection relies  on direct  contact  between a host  pattern recognition receptor  protein
(PPR) and a pathogen molecule. Bacteria recognition is achieved through peptidoglycan recognition
proteins (PGRPs) that sense peptidoglycan (PGN), an essential component of bacteria cell wall.
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PGRP-LC  isoforms  and  PGRP-LE  are  specialized  in  recognizing  Gram-negative  PGN,  while
PGRP-SA, PGRP-SD and GNBP1 in sensing Gram-positive PGN. Fungal recognition is thought to
depend on GNBP3 that binds beta(1,3)-glucan, a component of fungal cell wall, and on Persephone
that is activated by fungal proteases.
Fungi and Gram-positive bacteria recognition triggers a serine protease cascade that activates the
Toll  signalling pathway  (Lemaitre and Hoffmann 2007).  This results  in the expression of some
AMPs, like defensin, active against  Gram-positive bacteria,  and drosomycin and metchnikowin,
active  against  fungi.  On  the  other  hand  Gram-negative  bacteria  recognition  triggers  the  Imd
signalling pathway with the consequent expression of AMPs like diptericin, attacin and drosocin.
Other signalling cascades that activate immune genes in Drosophila fat body have been recognized,
as the JAK/STAT and the JNK pathways, although their precise contribution to immune defence is
not clear. 
The cellular response relies on blood cells (hemocytes) present in the body cavity. Plasmatocytes
represent  90-95% of  all  hemocytes  in  Drosophila and  are  responsible  for  the  phagocytosis  of
microorganisms  and  apoptotic  cells.  Several  receptors  have  been  shown  to  be  involved  in
phagocytosis, the most studied are Eater and Dscam. A group of six thioester-containing proteins
(TEPs) has an important role in this defence mechanism. TEPs are secreted proteins and three of
them are up-regulated upon infection. There is evidence that they bind to pathogens and promote
phagocytosis in a similar fashion as the complement proteins in vertebrates  (Blandin et al. 2004;
Stroschein-Stevenson et al. 2006). 
Plasmotocyte also promote coagulation (or clotting) consisting in the production of fibers at injury
site  that  trap  bacteria  and promote  their  killing  (Lemaitre  and Hoffmann 2007).  Hemolectin, a
plasmotocyte specific gene, codes for the main component of the clotting fibres and is required for
coagulation in D. melanogaster. Other genes required for proper coagulation response are fondue,
that codes for a protein involved in the cross-linked of the clotting fibres, and transglitaminase that
is involved in the first stage of clotting formation (Lindgren et al. 2008).
Lamellocytes, another category of hemocytes, are specialized in encapsulating and killing parasitoid
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wasp  eggs  in  Drosophila larvae,  possibly  by  local  cytotoxic  products.  While  the  molecular
mechanism of encapsulation are virtually unknown, recent evidence suggests that N-glycosilation of
lamellocyte membrane components has a key role in the encapsulation response  (Mortimer et al.
2012).
Crystal cells, the last group of hemocytes, are responsible for melanization, a defence mechanism
consisting in melanin production at cuticular injury sites and on the surface of parasites invading the
body  cavity.  Many  genes  have  been  implicated  in  the  melanization  cascade,  like  MP1,  with
antibacterial and antifungal activity and MP2, shown to be specific against fungi.
A third and more recently discovered component of Drosophila innate immunity is antiviral RNA
interference  (Wang et  al. 2006;  Obbard et  al. 2009a;  Saleh et  al. 2009).  In  this  pathway
double-strand RNA from viruses is recognized by Dicer that cuts it into short fragments of 21-24
nucleotides. These fragments activate an Argonaute-containing complex that slices viral RNA with
complementary sequence, stopping the virus infection.
Many studies have looked for signature of selection at Drosophila immunity genes (Clark and Wang
1997; Jiggins and Hurst 2003; Schlenke and Begun 2005; Jiggins and Kim 2006; Jiggins and Kim
2007;  Sackton et  al. 2007;  Lazzaro 2008; Obbard et al. 2011).  A first  remarkable point is  that
immunity genes have a significantly higher rate of adaptive substitution compared to control genes
in Drosophila species (Sackton et al. 2007; Obbard et al. 2009a). This means that parasites indeed
exercise a strong selection pressure on Drosophila.
Going  down to  single  defence  genes  categories,  Obbard  and  colleagues  found  higher  rates  of
adaptive substitution for genes in the antiviral RNA interference pathway and in the Imd signalling
pathway (Obbard et al. 2009b) (figure 2). Evidence of positive selection has also been reported for
the TEP proteins, especially TEP1 (Jiggins and Kim 2006; Sackton et al. 2007). However, AMP and
recognition genes of humoral immunity do not show evidence of positive selection. The most likely
explanation is that both are constrained as they bind to highly conserved targets.
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Figure 2 Evidence of positive selection at Drosophila melanogaster immunity genes. Genes are coloured according to the estimated rate of adaptive
substitution as indicated in the legend. Reprinted from (Obbard et al. 2009b). 
Sackton and colleagues reported high levels of gene duplication and turnover for AMP genes in
Drosophila species  (Sackton et al. 2007). On the other hand, signalling genes show strong copy
number and function conservation.  This  could make them a more suitable  target  for  pathogens
interference and explain the higher rate of adaptive substitution they experienced (Lazzaro 2008).
Evidence of recent fixation of positively selected variants has been observed at some Drosophila
melanogaster immune genes. For example, Argonaute-2, a member of the antiviral RNAi pathway,
has experienced recurrent spreads of selected alleles in three  Drosophila  species  (Obbard et al.
2011). Similarly, at the CHKov1 locus of Drosophila melanogaster an allele conferring resistance to
the  sigma  virus  (Rhabdoviridae) has  recently  spread  to  become  the  common  form  in  natural
populations (Magwire et al. 2011). 
Interestingly,  no  evidence  of  balancing  selection  has  been  reported  to  date  for  Drosophila
melanogaster immunity genes. This is a clear difference with vertebrates immune system receptors
of adaptive immunity like MHC (see above) or plant resistance genes  (Barreiro et al. 2009) that
have  been  shown  to  evolve  under  balancing  selection.  Indeed  it  has  been  proposed  that  the
unspecific  nature  of  Drosophila immunity  could  explain  the  absence  of  genes  evolving  under
balancing  selection  (Schlenke and Begun  2003).  The observation  that  genes  of  the  vertebrates
innate immunity evolve under positive or negative, but not balancing, selection corroborates this
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hypothesis (Barreiro et al. 2009).
All the studies cited above focus on coding sequence evolution and look for past selection that acted
at the species level. Therefore research on regulatory evolution and recent selection acting at the
population level is required.
Several studies have assessed Drosophila transcriptional response to different pathogens (Lemaitre
et  al. 1997;  De  Gregorio et  al. 2001;  Roxstrom-Lindquist et  al. 2004;  Wertheim et  al. 2005;
Wertheim et al. 2011). For example De Gregorio and colleagues (De Gregorio et al. 2001) surveyed
transcriptional response to  Beauveria bassiana in  Drosophila melanogaster at  four time points,
from 12 to 96 hours after infection. Among the genes that displayed a significant change in gene
expression 32 were already known as immune genes, while 368 had previously not been associated
with immunity. Therefore transcriptome analysis  can help us to identify new candidate immune
genes and get a better understanding of how immune response unfolds.
Roxström-Lindquist and collaborators assessed gene expression in D. melanogaster 24 hours after
infection by B. bassiana, the protozoan parasite Octosporea muscaedomesticae, the Gram-negative
bacterium Serratia marcensens and Drosophila C virus (Edwards et al. 1997; Roxstrom-Lindquist
et al. 2004). They found a high degree of microbe specificity, with the fungal infection generating
the strongest response with 298 genes induced. 
Wertheim and co-workers investigated transcriptional response following parasitoid wasp attack in
D. melanogaster larvae (Wertheim et al. 2005). Most genes found in this study differ from the ones
induced by antimicrobial  immune response and were not previously reported as immune genes.
Their results improved our knowledge of the encapsulation defence mechanism.
A common characteristic of the studies cited above is that in all of them only one inbred line of D.
melanogaster  was  used.  A problem  with  this  approach  is  that  the  outcome  of  host-parasite
interaction and host transcriptional response are dependent on the interacting genotypes (G x G, see
previous section). For example different genes are found to be induced after B. bassiana infection in
De Gregorio et al. (2001) and Roxstrom-Lindquist et al. (2004). A likely explanation is that they
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used two different D. melanogaster strains, although discrepancies in the infection procedure and in
data analysis could also play a role. 
Another drawback of using inbred lines is that inbreeding reduces fitness and resistance to parasite
in D. melanogaster (Luong et al. 2007). Therefore the use of out-cross populations would be closer
to the natural situation. In addition, because differences in the set-up can make two experiments
difficult to compare, having multiple populations in the same experiment allows to assess between
populations variability. This could also help to identify genes facing contrasting selective pressure
for gene regulation among populations. The present work tries to address some of these issues.
In comparison to what we know on the genomics of Drosophila immune response, our knowledge
of what happens at the protein level is still in its infancy. As infection affects gene expression, it
also changes proteins concentration (Engstrom et al. 2004; Levy et al. 2004). More studies and new
technologies are needed to achieve a better comprehension of immune response at the proteomic
level and of how this correlates with changes in gene expression.
2.4 BEAUVERIA BASSIANA: A MODEL FUNGAL ENTOMOPATHOGEN
Fungal parasites of insects (fungal entomoptahogens) gain access to the host via cuticle penetration
(Vega and Kaya 2012). As a first step, spores need to adhere to host surface through mucilage and
enzymes production. Penetration is then achieved both by enzymes secretion and the development
of specialized structures called appresoria that exert mechanical pressure. When the fungus reaches
the body cavity of the host it produces hydrolytic enzymes to assimilate nutrients and toxins with
immunosuppressive activity (Gillespie et al. 2000). If the host fails to clear the infection the fungus
eventually kills the insect and transmission is achieved by sporulation from the cadaver (figure 3).
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Figure  3 Grasshoppers killed  by  the  entomopathogenic  fungus  Beauveria  bassiana.  The  sporulating  fungus  has  a  white  colour  (Wikimedia
Commons).
Beauveria  bassiana (Clavipitaceae  family,  Hypocreales)  is  an  entomopathogenic  fungus  with  a
global geographic distribution  (Rehner and Buckley 2005; Devi et al. 2006). Its extremely broad
host range (> 700 insect hosts) makes it a natural candidate as pest control  (Samish et al. 2004;
Akbar et  al. 2005;  Dara  2008).  Together  with  Metarhizium  anisopliae,  another  related
entomopathogenic  fungus,  it  has  also  been proposed as  bio-control  against  malaria  mosquitoes
(Bukhari et al. 2011; Fang et al. 2011).
To further improve B. bassiana insecticidal activity and bio-control potential, several studies have
assessed the effect of growth medium and spores suspension on fungal virulence,  viability  and
thermotolerance (Daoust et al. 1983; Ying and Feng 2004; Ying and Feng 2006; Safavi et al. 2007).
Other studies have focused on isolating secreted compounds with toxic activity that could be used
as active principles in bio-insecticides (Vey et al. 1993; Quesada-Moraga 2003; Ortiz-Urquiza et al.
2010).  A consequent research effort  has been done to isolate and characterise toxic compounds
produced by B. bassiana and other entomopathogenic fungi (Fuguet et al. 2004; Kaur and Padmaja
2009; Xu et al. 2009; Valencia et al. 2011). Destruxins play a specific role in this context, as they
are able to suppress AMP gene expression (Pal et al. 2007). 
In spite of their prevalent parasitic way of life, B. bassiana and other entomopathogenic fungi could
live in association with plants and grow in plant tissues as endophytes (Ownley et al. 2008; Vega
2008).  Interestingly  this  association  results  in  plant  feeding  deterrence,  as  the  fungus  inhibits
phytopathogenic fungi mycelial growth and kills herbivorous insects. 
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The phylogeny of the genus Beauveria has been deeply revised with the appearance of molecular
markers as taxonomical informative morphological traits are scarce  (St Leger 1992; Rehner and
Buckley 2005; Devi et al. 2006; Rehner et al. 2011). B. bassiana represents a species-complex and
it is not clear if genetic structure is associated with geographic distance, host range or neither of
them  (Maurer 1997; Gaitan 2002; Wang et al. 2003; Rehner et al. 2006; Fernandes et al. 2009;
Meyling et al. 2009). At the same time there is contrasting evidence on the association between
thermal growth preference and climatic origin of isolates  (Fargues 1997; Bidochka et al. 2002).
Overall, studies are so far inconclusive on whether local adaptation to some host or environment
occurs  in  B.  bassiana.  More  research  is  therefore  needed  to  better  characterize  B.  bassiana
phylogeny and factors determining genetic structure in this species. 
The genome of one B. bassiana strain has been recently sequenced, together with its transcriptome
in different  environmental  conditions  (Xiao et  al.  2012).  This  study has  shed new light  on the
physiology and evolution of B. bassiana by comparing its genome with the ones of the fungal insect
pathogens Metarhizium robertsii, M. acridum and Cordyceps militaris. 
B. bassiana contains more bacterial-like toxins than other fungal entomoptahogens, suggesting a
possible  oral  toxicity.  The four  species  have  more  proteases  than  plant  pathogenic  fungi.  This
expansion is dramatic in B. bassiana and M. robertsii that have a broad host range and less marked
in M. acridum and C. militaris that are more specialized pathogens. Therefore the increased number
of proteases may reflect an adaptation to infect insects and is possibly influenced by host range.
Another common feature of insect pathogenic fungi is the abundance of chitinases compared with
plants pathogens. This is likely an adaptation to the amount of chitin in the insect cuticle. 
The transcriptome analysis identifies transcription factors, G protein coupled receptors and kinases
involved in signal transduction that are differently expressed on root exudates, insect cuticle and
insect body cavity. Furthermore genes involved in metabolism show an induction pattern that is
environment specific.
The genome and transcriptome analysis therefore suggests that  B. bassiana  is well adapted to its
prevalent parasitic way of life. A deeper understanding of the genes and molecular mechanisms
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involved  in  infection  is  required  also  in  order  to  better  characterise  the  targets  for  parasite
interference inside the host.
Many studies have used B. bassiana as a model fungal pathogen to gain insight in different aspects
of  insect  immunity  (Lemaitre et  al. 1997;  De  Gregorio et  al. 2001;  Levy et  al. 2004;
Roxstrom-Lindquist et al. 2004; Tinsley et al. 2006; Pham et al. 2007; Kraaijeveld and Godfray
2008; Le Bourg et al. 2009; Reber and Chapuisat 2012). Tinsley and co-workers found variation in
survival to B. bassiana infection both within and between D. melanogaster populations (Tinsley et
al. 2006) and reported higher survival in tropical host populations compared to temperate ones. This
last  finding supports  the theory of higher  immune investment  at  tropics (see above).  Given  B.
bassiana broad host range, it seems unlikely that it is engaging a strict co-evolutionary arms-race
with a particular host species or population (Kawecki 1998). Therefore B. bassiana use in infection
experiments gives us the possibility to study how the host responds to a generalist fungal pathogen
and to assess if variability among host populations is present, possibly due to different life history
strategies. 
2.5 OBJECTIVES OF THIS THESIS
The general aim of this work is to determine the extent of variation in survival and transcriptional
response to  a  generalist  pathogen among host  populations.  We further  investigate  the effect  of
endosymbionts and trans-generational immune priming on host survival. We use the  Drosophila
melanogaster – Beauveria bassiana model system to address these questions. 
In  the  first  part  of  the  present  study we test if susceptibility  to  B.  bassiana  varies  among  D.
melanogaster  populations. The  presence  of  variability  can  provide  information  on  how  host
populations adjust their immune investment and defence strategy depending on the environment in
which  they  live  and/or  evolved.  Tinsley  and  co-workers  (Tinsley et  al. 2006) found  lower
susceptibility to B. bassiana in tropical D. melanogaster populations. We assessed two tropical and
two temperate host populations in order to test the generality of such geographical trend. To avoid
the  immune depressive  effect  of  inbreeding we created  out-cross  populations starting  from lab
inbred lines. We also investigated if parasite genotype can affect the outcome of infection, possibly
20
due to G x G interactions. To this purpose we used in separate experiments two distinct B. bassiana
strains: strain 547 isolated from Coleptera (Malaysia, 1986) and strain 1630 isolated from Diptera
(France, 1984). 
In the second part of this work we assess D. melanogaster transcriptional response to B. bassiana
and  its  variability  among  host  populations. At  least  two studies  have  already  surveyed  gene
expression change in a D. melanogaster inbred line upon B. bassiana infection (De Gregorio et al.
2001; Roxstrom-Lindquist et  al. 2004). However,  inbred lines could differ in the response they
mount  from natural  populations  that  are  genetic  variable.  We used  the  same  D.  melanogaster
out-cross populations as for the survival experiment and infected them with B. bassiana strain 1630.
As  we  tested  multiple  populations  in  the  same  experiment,  we  were  able  to  compare  their
transcriptional response directly. 
Early response to infection has been identified as an important predictor of survival ability in  D.
melanogaster (Okado et  al. 2009).  Evidences  indicate  that  D.  melanogaster  changes  in gene
expression occur already few hours after B. bassiana infection (Lemaitre et al. 1997; De Gregorio et
al. 2001). On this basis we choose two time points for our analysis: 8 and 24 hours post infection.
We performed two independent experiments. In the first one we used a full genome microarray
approach at 8 hours post infection, while in the second RNA sequencing (RNAseq) both at 8 and 24
hours following infection. Combining these data with the ones from the survival analysis allows us
to have a better picture of the defence mechanisms that different host populations unfold and of
their efficacy.
Finally, in the last part of our study we look for the effect of endosymbionts and trans-generational
immune  priming on  D. melanogaster susceptibility  to  B.  bassiana.  In  the  first  sub-section  we
focused  on  the  role  of  the  endosymbiont  Wolbachia  pipientis. As  we  have  seen  above  an
endosymbiont can protect its host from parasites. W. pipientis is a natural intracellular symbiont of
many arthropods  (Werren et al. 2008) and nematodes  (Taylor et  al.  2012) and exhibits  varying
prevalence  in  D.  melanogaster populations  (Riegler  et  al.  2005;  Ilinskii  and  Zakharov  2007;
Verspoor  and Haddrill  2011).  W. pipientis  increases  survival  of  D.  melanogaster against  RNA
viruses  (Hedges et  al. 2008;  Teixeira et  al. 2008) and a  previous  study has  hinted  a  potential
protective effect against  B. bassiana  in one  D. melanogaster inbred line  (Panteleev et al. 2007).
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However, the outcome of such triple complex interactions may depend on the genotype of the host,
the parasite and the endosymbiont. 
We  cured  one  European  and  one  African  D.  melanogaster inbred  lines  from  W.  pipientis  by
tetracycline treatment and exposed them together with the original lines to B. bassiana 1630 strain.
We  controlled  for  the  effect  of  the  antibiotic  by  treating  a  Wolbachia-free  African  line  with
tetracycline. Flies from this line, both tetracycline treated and not, were infected together with the
other two lines described above. We repeated the infection experiment twice in order to gain a
clearer picture.
In the second sub-section we wanted to verify if trans-generational immune priming plays a role in
the  study system.  As we have  seen  above there  is  increasing  evidence  of  immune memory in
invertebrates. This could be limited to one generation or extend to the offspring. In this last case it is
called "trans-generational immune priming" (see above). There is evidence that  D. melanogaster
injected  with  heat-killed  B.  bassiana spores  survives  longer  when  later  exposed  to  the  living
parasite (Pham et al. 2007). However, no study to our knowledge has tested if immune memory to
B. bassiana extends to the next generation in D. melanogaster.
No evidence of trans-generational immune priming was found in D. melanogaster infected with the
bacteria Lactococcus lactis and Pseudomonas aeruginosa (Riegler et al. 2005). However, a possible
drawback of this study is that the flies used for the experiment were not virgin and this could leave
few place for priming if it happens at the eggs level (Sadd and Schmid-Hempel 2007; Zanchi et al.
2012). 
We used the fungal strain 1630 and the European and the American out-cross populations described
above in two separate experiments. Male and virgin female flies were exposed separately for 2-3
days to the parasite or to a control treatment. After exposure male and female flies were pooled and
allowed to reproduce. The offspring were collected and infected with the same fungal strain as the
parents. We tested if flies whose parents were exposed to the parasite exhibit a lower susceptibility
than  flies  whose  parents  were  exposed  to  the  control  treatment,  indicating  the  presence  of
trans-generational immune priming. 
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3 MATERIALS AND METHODS
3.1 ASSESSMENT OF SURVIVAL TO B. BASSIANA IN D. MELANOGASTER POPULATIONS
3.1.1 Drosophila melanogaster out-crossed populations 
In order to build out-cross populations we crossed inbred lines that have been kept in the lab since
several  years.  We  used  10  inbred  lines  derived  from  an  African  population  (Lake  Kariba,
Zimbabwe),  12  from  an  European  population  (Leiden,  the  Netherlands),  12  from  an  Asian
population (Kuala Lumpur, Malaysia) and 12 from a North American population (Raleigh, North
Carolina)  (Glinka et al. 2003; Laurent et al. 2011;  Mackay et al, 2012). These populations were
chosen to represent major geographic regions in the worldwide distribution of  D. melanogaster
(Stephan and Li 2007). Flies were reared at 23°C on standard fly media (see Appendix, 6.1), with a
14 hours light and 10 hours dark cycle. The lines used are reported in Appendix (6.2).
Initial  differences  in  fecundity  among  the  lines  could  bias  the  genetic  composition  of  the
out-crossed populations. In order to reduce this effect we followed a two steps approach. In the first
step  the inbred  lines  from the same population  were crossed in  pairs.  Reciprocal  crosses  were
performed so that the Y chromosome of each line was represented (figure 4). For example if there
were 12 lines, it was necessary to perform 12 crosses: males from line 1 with females from line 2
produced the F1 1.2; females from line 1 with males from line 2 produced the F1 2.1; males from
line 3 with females from line 4 produced the F1 3.4 ; males from line 4 with females from line
produced the F1 4.3 and so on to get 12 F1s: 1.2, 2.1, 3.4, 4.3, 5.6, 6.5, 7.8, 8.7, 9.10, 10.9, 11.12,
12.11. In the second step F1 flies from each population were pooled for out-crossing.
In the first step 20 males and 20 virgin females were used for each cross. D. melanogaster females
need 12-14 hours to be sexually mature (Ashburner 1989). Therefore the adult flies were removed
every day in the morning from the bottles where they were reared and virgin females were collected
6 hours later. In the second step 50 male and 50 female flies from each F1 were pooled. In total this
represents 1,000 to 1,200 flies for each population. The offspring from these crosses are regarded as
the first out-crossed generation in the following.
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Figure 4 Schematic representation of the approach used to generate the out-crossed populations. In the first step, lines are crossed in pairs in both
directions to obtain F1 lines. In the second step the F1s are pooled for out-crossing.
In  order  to  maintain  the  out-crossed  populations  at  a  constant  size  of  around  1,000  flies,  the
appropriate  number  of  eggs  was collected  every  two weeks  and a  new generation  was  started
following  Clancy and Kennington (2001). At the second out-crossed generation each population,
except for the African one, was split in two sub-populations with the same size of about 1,000 flies.
For the African population, it was necessary to wait until the fourth generation to get enough eggs
for building two sub-populations. At the 34th out-crossed generation each sub-population pair was
merged and the resulting populations have been maintained at the same census size of 1,000 flies
since (figure 5).
Figure 5 Schematic representation of the out-crossed populations' maintenance through generations. Generation 1 is the first out-crossed generation
(see main text); generations increase from top to bottom (left arrow).
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STEP 1: CROSSING
3.1.2 Beauveria bassiana strains
B.  bassiana strains  547  and  1630  were  ordered  from  USDA  ARSEF  Collection  Center
(http://www.ars.usda.gov/Main/docs.htm?docid=12125&page=2) (table 1). Both strains have been
collected several years ago and since then have been maintained in the lab.
STRAIN ORIGIN HOST YEAR
547 Malaysia Coleoptera: Chrysomelidae 1986
1630 France Diptera: Calliphoridae 1984
Table 1 Strains used for the infection experiments; strains number, place and date of collection and host from which they have been isolated are
reported.
During this time the strains'  virulence may have attenuated. In any case, to select for increased
virulence against Drosophila, both strains were passed through a Drosophila yacuba inbreed line as
in Tinsley et al. (2006). This allows us to increase the virulence of the strain, while avoiding fungal
adaptation to a specific D. melanogaster line. We proceeded as in Tinsley et al. (2006) with minor
modifications. Flies were sprayed in a mesh cage with a fungal/oil suspension (see below), Petri
dishes with agar-molasses medium were changed every day and cadavers were collected for the
following 10 days. Dead flies were incubated two weeks at 25°C at 24 hours dark. Sporulating
cadavers  were  homogenised  in  Shellsol  T oil  and  plated  onto  potato  dextrose  agar  containing
chloramphenicol antibiotic (5 x 10 -5 g/ml).
Plates were incubated 2 weeks at 25 °C at 24 hours dark and then dried at room temperature for 1
week. Sporulating material was collected from each plate, dried in silica gel and stored in the fridge
suspended in oil (87.5% Shellsol T, 12.5% Ondina El). The spore concentration was adjusted to 10 -8
spores/ml by mixing approximately one volume of spores with four volumes of oil. The suspension
was agitated using a probe sonicator at medium power for 30-45 seconds to avoid spore clustering.
In order to determine spore concentration an aliquot of the suspension was diluted 100 times in
Shellsol T oil. The spores were counted using a haemocytometer and 10 independent measurements
were performed. 
An airbrush was used to spray the spores/oil suspension on transparency film. After 2 weeks each
transparency film was cut into stripes (approximately 5 cm wide and 7.5 cm long). Each stripe was
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then rolled and inserted into a standard Drosophila vial in order to cover its walls from below the
food surface up to the stopper. Mean spore density was determined by washing 10 stripes with 5 ml
Shellsol T oil in a centrifuge tube. Tubes were inverted several times and then centrifuged for 5
minutes at maximum speed. Spore concentration was assessed using a haemocytometer and spore
density on the paper was thus determined. 
3.1.3 Infection procedures
Three  to  five  days  old  male  flies  coming  from  the  same  cohort  were  collected  using  CO 2
anaesthesia and placed in vials with standard Drosophila food (see Appendix, table 1). Fifteen flies
were placed in each vial. Flies for the infection treatment were transferred 1-3 days after collection
to vials containing the transparency film sprayed with the oil/spores suspension, while flies for the
control treatment to vials containing transparency film sprayed with oil. A number was assigned
randomly to each vial. Flies were exposed 3 days to infection/control before being moved to fresh
vials free of any transparency film.
For the whole duration of the experiment, the standard  Drosophila food was amended to exclude
the anti-fungal agent Nipagin and the anti-fungal/anti-bacterial compound propanoic acid. In order
to assure homogeneity in the experimental procedure, similar food was used both for infection and
control treatments. Every 3 days flies were changed to fresh vials and the number of dead flies was
recorded. A possible cause of loss of flies independent of infection and natural mortality was also
recorded, namely escaped flies from the vial. 
As no preservatives were present in the food, contamination from unrecognised bacteria and molds
was observed in around 2% - 5% of the vials every day. In such cases flies were immediately
changed to fresh vials, and when severe contamination occurred, the entire vials were discarded.
The experiment ended on the 21st day after treatment, although it was possible that some infection
treatment flies were still alive. Vials were kept in an incubator at 25°C, 14 hours light – 10 hours
dark for the whole duration of the experiment. 
Several  infection  experiments  were  conducted  with  the  out-crossed  populations.  In  the  first
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experiment,  flies  from  the  5th generation  of  the  out-cross  populations  were  infected  with  B.
bassiana strain 547. As both out-crossed populations from each continent were used, there were 8
populations in total. For each population 20 infection and 5 control vials were started, for a total of
200 vials.
In the second experiment flies from the 8th generation of the out-crossed populations described
above were  infected  with  B.  bassiana strain  1630.  As both  out-crossed  populations  from each
continent were used, there were 8 populations in total. For each population 25 infection and 10
control vials  were started,  for a total  of 280 vials.  For practical reasons,  flies were exposed to
infection/control treatment in two randomised groups with one day difference. 
In the third experiment, flies from the 17th generation of the out-crossed populations were infected
with B. bassiana strain 1630. As both out-crossed populations from each continent were used, there
were 8 populations in total. For each population 25 infection and 10 control vials were started, for a
total of 280 vials. 
3.1.4 Statistical analyses
All statistical analyses were performed twice: considering the pairs of replicate populations together
as continents “Continent analysis” or each population independently “Population analysis”. This
allows  us  to  compare  the  outcome  of  the  two  sub-populations  (i.e.  the  replicates  of  each
population). In all experiments we observed a high proportion of flies dying in the first 3 days
following  exposure  to  infection/control  (29%,  12%  and  27%  in  the  1st to  3rd  experiment,
respectively).
Interestingly this percentage was constantly higher in controls than in infected flies (see Results). A
likely explanation is that the flies died because of the oil and not because the infection. The reason
for the higher mortality in controls is probably that in the absence of spores the oil takes longer to
dry and more flies could soak or stick to the vial walls (M. C. Tinsley, personal communication). To
assess the effect of treatment and continent/population of origin three days after infection, the data
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were both graphically summarised and a generalized linear mixed model was fitted (see below). In
order to avoid the confounding effect due to the oil, the early mortality rate was excluded from all
subsequent analyses
3.1.4.1 Generalized linear mixed models
The data were analysed using generalised linear mixed models (GLLM) (Bolker et al. 2009). These
models are able to deal with random factors and are especially good for data from ecology and
evolution that usually do not follow a normal distribution. The number of flies dead and alive in
each vial at each time interval was chosen as dependent variable and the effect of covariates on
mortality was assessed. A binomial distribution was used to fit the data. Flies that escaped and vials
that were lost due to contamination were discarded from the analysis.
The following covariates were used: “Time”, “Logarithm of time”, “Time squared”, “Treatment”,
“Continents”  (or  “Populations”)  and  the  interaction  between  “Treatment”  and  “Continents”  (or
“Treatment” and “Populations”). In addition the random factor “Vial” was used to account for the
repeated measurements from the same vial.  For  the second experiment  the additional  covariate
“Group” was introduced to account for the fact that flies were infected in two separate groups (see
above). 
The time covariates have six levels. For example “Time” has the following levels: “6”, “9”, “12”,
“15”, “18” and “21”, that represent days after infection. The covariate “Treatment” has two levels:
“infected” and “controls”. The covariate “Continents” has four levels: “Africa”, “Asia”, “America”
and “Europe”. The covariate “Populations” has eight levels: “Africa 1”, “Africa 2”, “America 1”,
“America 2”, “Asia 1”, “Asia 2”, “Europe 1” and “Europe 2”. “Vial” has a number of levels equal
to the number of vials used in the analysis. “Group” has two levels, “Group 1” and “Group 2”.
“Continents” and “Populations” are categorical covariates. In these cases one level was chosen as
reference and all  the others were compared to it.  For example in the “Continents” analysis the
difference  between  “Africa”  and  the  other  three  continents  was  assessed;  in  the  “Populations”
analysis the difference between “Africa 1” and the other seven populations was assessed. In the case
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of the random factor “Vial” we were not  interested in its  effect on mortality,  as for the others
covariates, and the experimental variance explained by this factor was determined and removed
from the analysis. 
We specified multiple time covariates because we did not make do any assumption on how time
affects mortality. To determine which time covariate or combination of time covariates described
better the data,  a likelihood ratio  test  was performed  (Steiger  et  al.  1985).  In a first  step three
models were fitted each with a different time covariate and the model with the higher likelihood (L)
was selected. In the next step a new time covariate was added to this model and the likelihood of the
new model (L’) was assessed. The likelihoods of the more general model (L’) and of the nested one
(L) were then compared. For large samples the following relation holds:
W =(−2log( L))−(−2log(L ' ))∼ χ2 ,
meaning that the statistic W follows a chi squared distribution with a number of degrees of freedom
equal to the difference in covariates number between the two models (one in this case). If the test
was significant, then the model with two time covariates was selected and the same approach was
repeated for the third time covariate. Otherwise the simpler model was retained. The same approach
was used in the second infection experiment for the covariate “Group”. 
To  analyse  the  mortality  data  three  days  after  treatment  the  following  covariates  were  used:
“Treatment”, “Continents” or “Populations” and, in the case of the second experiment, “Group”. A
generalised linear model (GLM) was used instead of a generalised linear mixed model (GLMM)
because no random factor was present. The data were fitted using a pseudo-binomial distribution
that allows for over-dispersion. Both the GLMM and GLM were fitted using the R library “lme4”. 
3.1.4.2 Survival analysis
We additionally used survival analysis methods to examine our data. In survival analysis the time to
death of each individual (in this case of each single fly) is used as dependent variable and the effect
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of  covariates  on  survival  time is  assessed  (Klein  and Moeschberger  2005).  A characteristic  of
survival  data  is  that  some subjects  could escape or be removed from the experiment  for  some
reason,  here  for  example  due  to  vial  contamination.  Another  common situation  is  that  not  all
subjects die by the end of the experiment. Survival analysis does not discard this information but
takes it into account in the following way. 
The time from the beginning of the experiment (t) at which each individual dies is recorded. If a
subject is lost at time t = k than it is considered to have died during the time interval t  [k, ∞).∈
Similarly the subjects still alive at the end of the experiment (e.g. t = z) are considered to have died
during  the time interval  t   [z,  ∈ ∞).  There are  several  ways to  analyse survival  data.  Here we
graphically visualise the Kaplan-Meier estimator of the survivor function and used Cox proportional
hazard models to assess the effect of covariates on survival (see below).
3.1.4.2.1 Graphical representation of the data
Data  were  graphically  represented  using  the  Kaplan-Meier  estimator  (Goel  et  al.  2010).  The
Kaplan-Meier  survival  curve  gives  the  probability  of  surviving  to  a  given time  point.  Time  is
divided in observation (or counting) intervals and survival probability is computed for each interval.
The probability (St) of surviving to a given time interval is given by:
St= (Number of individuals surviving to that time interval -
 Number of individuals at risk)/ Number of individuals at risk.
In this case the number of individuals at risk is equal to the number of flies that are still alive before
the beginning of that time interval minus the number of flies that are lost in that time interval. The
total probability of surviving to a given time interval is the product of the survival probabilities at
all preceding time intervals. To obtain the Kaplan-Meier survival curve, the R package “survival”
was used.
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3.1.4.2.2 Cox proportion hazard models
Proportional hazards models (Bollen 1989) estimate the effect of covariates and of their interaction
on survival. In these models a baseline hazard function h0(t) defining the instantaneous rate of
death is first fitted. The hazard function hi (t)  for an individual i with specific covariates values
(for example:  infected and American) is  given by the baseline hazard function multiplied by a
constant Φ i that depends on the covariates values. If x i1 is the value of the first covariate for
the individual i, x i2 the value of the second covariate for the individual i (and so on) and there are
p covariates, then the relationship between hazard function and covariates is:
hi (t)=Φ i∗h0(t )
Φ i=exp(hi)
ηi=β1∗x i1+ β2∗x i2+ β3∗xi3+ β p∗x ip .
The additive form means that each covariate affects  the hazard independently. Using maximum
likelihood is it possible to estimate the coefficients β. A covariate k has a significant effect on the
hazard if βk is significantly different from 0. A drawback of proportional hazard models is that
the distribution of the baseline hazard function has to be specified.
Cox models  (Cox 1972) are a special kind of proportional hazard models that do not make any
assumption on the baseline hazard distribution. The significance of the covariates is assessed using
a partial  likelihood maximisation.  This feature makes Cox proportional  hazard model  the most
widespread model in survival analysis. The Cox proportional hazard model was fitted using the R
library  “coxme”.  For  the  “Continent”  analysis,  the  following  fixed  effects  were  specified:
“Treatment”,  “Continent”  and  their  interaction  “Treatment  x  Continent”.  For  the  “Population
analysis” the following fixed effects were specified: “Treatment”, “Population” and their interaction
“Treatment x Population”. In the case of the second experiment, where flies were infected in two
independent groups, the extra fixed effect “Group” was specified. The random factor “Vial” was
introduced to account for the vial to which each fly belonged.
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3.2 D. MELANOGASTER TRANSCRIPTIONAL RESPONSE TO B. BASSIANA
3.2.1 Micro-array analysis
3.2.1.1 Infection experiment
Flies  for  the  microarray  experiment  originated  from  the  17 th generation  of  the  out-crossed
populations described above. Flies were collected and exposed to infection or control treatment in
the  same time  as  the  ones  used  for  the  third  infection  experiment  described  in  3.1.3.  The  B.
bassiana strain 1630 was used (see above). For each out-crossed population 15 infection treatment
and 15 control treatment vials were used, each one containing around 15 male flies. Vials were
placed at 25° C under a 14 hours light and 10 hours dark cycle. 24 hours after infection flies from
each vial were anaesthetised using  CO2, transferred to an Eppendorf tube previously labelled and
frozen in liquid nitrogen. Frozen tubes were stored at -80° C for 3-7 months before proceeding to
RNA extraction.
 
3.2.1.2 RNA extraction, sample preparation and array hybridisation
RNA was extracted from groups of 65 - 75 flies (pooling of 5 vials) from the same out-crossed
population and treatment. RNA was retro-transcribed to cDNA and labelled with a green or a red
fluorescent dye. Labelled cDNAs from two different samples were competitively hybridised on the
array. Full genome D. melanogaster microarrays D14k3 (UHN Microarray Centre) were used. For
more details and protocols see Appendix (6.3).
3.2.1.3 Hybridisation scheme 
Competitive hybridisations were performed following a ring design (figure 6, Appendix table 2).
For each comparison two hybridisations were done. In the first one, one sample was labelled with
the red dye and the second with the green one,  while  in  the respective dye-swap the opposite
sample-dye combination was used. This was done in order to avoid a bias in the case a dye gives a
stronger signal than the other. The full ring design was repeated twice, once for each out-crossed
population replication (figure 6, Appendix table 2). In total 24 comparisons and 48 hybridisations
were performed. 
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Figure 6 Experimental design scheme. Each pair of coloured arrows pointing in opposite direction represents the two dye swaps for each comparison.
The following hybridisation scheme was repeated twice, once for each out-crossed population replication. "AF" stands for Africa,"AM" for America,
"AS" for "Asia" and "EU" for Europe. "t" stands for treatment, while "c" stands for control.  
3.2.1.4 Array scanning 
Signal intensity on the hybridised arrays was assessed using the scanner Aquire (Genetix). This
machine uses one channel to detect the signal of the red dye and another one to detect the signal of
the green dye. For each spot on the array the signal intensity of one dye is proportional to the RNA
quantity of the corresponding transcript in the sample marked with that given dye.
3.2.1.5 Spot annotation and editing
Scanned  arrays  were  analysed  using  the  program  Qscan  (Genetix).  The  annotation  file
“CMDCoD14Kv3.gal”, provided by the UHN Microarray Centre, was used in order to assign each
spot to a gene. Spot position was manually edited to better fit the spot signal on the array. Finally,
red and green foreground and background signal intensities were computed for each spot on the
array and exported together with the annotation information as a text file. 
3.2.1.6 Normalisation 
Row data were normalised using the CARMAweb 1.5 online service  (https://carmaweb.Genome.
tugraz.at/carma/). Text files were converted to the “.gpr” format (the input format for CARMAweb)
using the Munich Microarray Analysis  Tool (http://10.153.163.103/MuMAT/index.html).  Several
normalisation steps were followed for each slide. First, background correction was carried out: the
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intensity of each spot was normalised against the unspecific background intensity around the spot.
The  “minimum”  correction  mode  was  chosen  (for  details  see  CARMAweb  users  guide:
https://carmaweb.genome.tugraz.at/carma/UsersGuide.pdf).  Then,  within-array  normalisation  was
performed in order to correct for spatial trends in signal intensity on the array. The “print tip loess”
normalisation  mode  was  selected  (Smyth  and  Speed  2003).  The  next  step  was  normalization
between the two dye-swaps for each comparison. The “quantile” normalisation mode was chosen
(Yang and Thorne 2003). 
Finally, for each array, spots whose signal intensity in at least one channel was higher than the 95%
of the distribution of the negative (blank) control spots were retained for statistical analysis. 
3.2.1.7 Statistical analysis
Two analyses were performed: one to compare all possible population – treatment combinations (in
the  following “Eight  nodes  analysis”)  and the  other  one  to  compare  infected  and control  flies
independently on a per population basis (in the following “Two nodes analysis”).
 
In the “Eight nodes analysis” each population – treatment  combination was a node in  the ring
design shown in figure 6. All nodes are connected directly or through one or more intermediate
nodes. Using the program BAGEL (Townsend and Hartl 2002) it was possible to estimate genes
differently expressed for each pair of nodes. 
BAGEL accepts as input the normalised red/green ratios of the retained spots for each array and the
description of the experimental design (figure 6). As output the software returns for each pair of
nodes the p-value of each gene to exhibit a higher expression in one or in the other node. When data
are lacking for one gene, for example if the corresponding spot has been discarded for many arrays,
then BAGEL excludes this gene from the analysis. 
In order to correct for multiple testing, the association among red/green ratios and the description of
the samples hybridised on the array was randomised. BAGEL was run a second time with the
randomised data set and new p-values were computed for each pair of nodes. We calculated the
false discovery rate (FDR) as the number of genes in the randomised data set whose p-value was
lower than an arbitrary threshold, divided by the number of genes in the real data-set whose p-value
was lower than the same threshold. By choosing the p-value threshold we got the significant genes
34
at  the  desired  FDR.  In  the  second analysis  the  same procedure  described above was followed
assuming only two possible nodes: control and infected flies. 
3.2.1.8 Gene ontology analysis
Gene  ontology  analysis  was  carried  out  using  the  online  tool  GOrilla
(http://cbl-gorilla.cs.technion.ac.il/)  (Eden et al. 2009). GOrilla compares a set of target genes,  in
this case the genes up- or down-regulated after infection, to a background list of genes, in this case
all the genes retained in the BAGEL analysis. The program performs an enrichment analysis to
identify gene ontology categories more commonly associated with the target genes than expected by
chance, if genes were randomly drawn from the background set.
As all the categories associated with at least one gene in the target set are tested, the Benjaminin and
Hochberg correction for multiple test (Benjamin and Hochberg 1995) is used to produce a FDR
corrected q-value for each significant category. GOrilla allows to choose ontology categories related
to molecular function, biological process or cellular component (cellular, tissue or organ location).
All types of categories were used in our analyses.
3.2.1.9 Comparison among populations and with previous studies
For the “Eight nodes analysis”,  genes differently expressed in infected vs control flies for each
within  population  comparison  were  compared  among  populations  and  with  the  results  of  De
Gregorio et al. (2001) and Roxstrom-Lindquist et al. (2004). For the “Two nodes analysis” genes
differently expressed in infected vs control flies were compared with the results of (De Gregorio et
al. 2001; Roxstrom-Lindquist et al. 2004). To obtain functional and molecular information for the
genes shared among two or more populations and also among this study and those of De Gregorio
et  al.  (2001)  and  Roxstrom-Lindquist  et  al.  (2004),  Flybase  was  used  (http://flybase.org/)
(Bettencourt et al. 2004).
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3.2.2 RNA sequencing analysis
3.2.2.1 Infection experiment
Flies were reared at 23°C on standard fly media (see Appendix, table 1) with a 14 hours light and 10
hours dark cycle. Flies from the 36th generation of the out-crossed populations described above were
employed. Four populations were used in the experiment, as the pairs of replicate populations were
pooled at the 31th generation after out-crossing (see 3.1.1). Flies were infected with the fungal
strain 1630 (see 3.1.2). 
The experimental procedure was the same as outlined above (see 3.1.3) with the major difference
that there were three treatments: control, 8 hours infection and 24 hours infection. Control flies
were exposed 8 hours to mock treatment (i.e. oil), while infected flies were exposed 8 and 24 hours
to the spores. During the experiment flies were kept at 25°C under a 14 hours light and 10 hours
dark cycle. For each population 6 vials, with 15 male flies in each, were exposed to each treatment,
for a total of 72 vials (see Appendix, table 3). All treatments were started simultaneously.
Eight hours after the beginning of the experiment control flies and infected ones were anaesthetised
using CO2. Flies from the same vial were transferred to an Eppendorf tube previously labelled, and
frozen  in  liquid  nitrogen.  Frozen  tubes  were  then  stored  at  -80°  C.  The  same  procedure  was
followed for 24 hours infected flies. Flies were kept at -80° C for 5-7 days before proceeding to
RNA extraction.
3.2.2.2 RNA extraction
For each population – treatment combination, three independent RNA extractions were performed,
each from two vials (around 30 male flies) and treated as biological replicates. Therefore RNA was
extracted from a total of 36 samples. The Master Pure RNA Purification kit from Epicentre was
used for extraction of total RNA according to the manufacturer's instructions.
 
3.2.2.3 RNA Sequencing
RNA from the 36 samples was sent on dry ice to GATC Biotech AG for sequencing. Each sample
had an approximate amount of 3.5 - 5  μg prepared in RNAse free water with a concentration of
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around 200 ng/μl. For each sample GATC Biotech AG performed a quality control to assess if RNA
was not degraded. The mRNA of samples that passed the quality control was isolated from total
RNA, fragmented, retro-transcribed to cDNA and sequenced via Illumina technology to generate
50-base pairs single end sequences. 
3.2.2.4 Reads mapping
Sequencing reads  were assigned to  D. melanogaster genes  using the  program Stampy (version
1.0.20) (Lunter and Goodson 2011). Reads were mapped against  D. melanogaster  transcriptome
(version 5.48). In case of a gene with multiple transcripts, the reads assigned to each transcript were
summed up. A count table with the number of reads for each sample assigned to D. melanogaster
genes was produced. Around 15,000,000 - 27,000,000 reads were mapped to D. melanogaster genes
for sample. 
3.2.2.5 Statistical analysis
Genes differently expressed among control and 8 hours infected flies and among control and 24
hours infected flies were identified. Row count data were normalised, bringing reads number to a
common scale among samples, and analysed in R using the "DESeq" package (Anders and Huber
2010). For each time point both a "population analysis" and a "treatment analysis" were performed.
In  the  "population  analysis"  control  and  infected  flies  were  compared  independently  for  each
population.  In  the  "treatment  analysis"  two  models  were  fitted,  a  full  model  containing  both
"population" and "treatment" as factors and a reduced one containing only the factor "population".
For each gene the two models were compared and the genes for which the specification of treatment
significantly increased the fit of the model, i.e. "treatment" had a significant effect, were identified.
3.2.2.6 Gene ontology analysis and comparison with previous studies
Gene ontology (GOs) analysis was performed using the online tool GOrilla (Eden et  al.  2009).
Results were compared with previous studies (De Gregorio et al. 2001, Roxstrom-Lindquist et al.
2004) and with the micro-array analysis described above. If not differently stated, molecular and
functional  information  for  interesting  genes  were  obtained  from the  internet  database  Flybase
(Bettencourt et al. 2004).
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3.2.2.7 Immunity related induced genes
In order to find immune related genes whose change in gene expression had a biological meaning,
an approach similar to the one proposed in Mortazavi et al. (2008) was followed. Normalised genes
count data (see above) were divided by the length of their longest transcript (in thousand of base
pairs) and averaged among all treatments and populations. In this way a value proportional to the
average gene expression level was obtained. This value is called thereafter "estimated average gene
expression level" (EAGEL). Only immune related genes with an EAGEL value in the 60% higher
quantile  of  the  distribution  were  considered  for  this  analysis.  The  rationale  is  that  for  genes
expressed on average at low levels, a change in gene expression, although significant, is not likely
to be biologically meaningful. 
3.2.3 Genetic analysis of candidate genes
3.2.3.1 Subset of interesting genes
A subset of candidate genes is shown in table 2. “Shared” genes are induced in at least two different
analyses  and  can  be  divided  in  three  groups.  The  first  group  comprises  genes  induced  in  all
populations  at  24  hours  after  infection  and  in  at  least  one  of  De  Gregorio  et  al.  (2001)  and
Roxstrom-Lindquist et al. (2004). The second group comprises 2 genes induced in one ore more
populations both at 8 and 24 hours after infection in the RNA sequencing. These genes are CG2064,
that is induced at 8 hours in the American population and at 24 hours in the African, American and
European ones, and Cyp6d2 (CG4373) that is induced in the Asian and European population at 8
hours and in all populations at 24 hours. The last group is constituted of only one gene: CG10247,
that is induced both in the European, African, and American populations 24 hours after infection
and in the African population in the microarray study. In addition the three private genes showing
the highest up-regulation and the two-three private genes showing the highest down-regulation at 24
hours post-infection were examined for each population. 
 SHARED SHARED AFRICA AMERICA ASIA EUROPE
CG14516 CG2064 CG16772 CG8346 CG32356 CG6653 
CG10118 CG4373 CG13840 CG14585 CG16879 CG15589 
CG10247 CG6667 CG3047 CG14356 CG17226 CG15253
CG11073 CG6816 CG15919 CG4178 CG4739 CG6578 
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CG11951 CG7171 CG31954 CG12763 CG31922 CG17820
CG12766 CG7592 CG34305 CG13026
CG17560 CG8453
CG9649
Table 2 Analysed genes are reported. “SHARED” stands for “SHARED” genes, “AFRICA” stands for African privately induced genes, “AMERICA”
for American privately induced genes, “ASIA” for Asian privately induced genes and “EUROPE” for European privately induced genes. 
3.2.3.2 Genetic sequences
Fully  sequenced  D.  melanogaster lines  from  France,  Netherlands,  North  American,  Malaysia,
Rwanda, and Zambia-Zimbabwe populations were analysed. Note that some of these Netherlands
and North American lines were used to build our out-crossed populations (see 3.1.1). Along with
each  gene  (exons  +  introns),  2,000  base  pairs  up-stream and  down-stream,  or  less  in  case  of
flanking genes nearer than 2,000 base pairs, were assessed. 
3.2.3.3 Coding sequence evolution
In order to determine the level of coding sequence evolution, the ratio of non-synonymous over
synonymous substitutions and the ratio of synonymous over non-synonymous polymorphisms were
computed in DnaSP (v 5.10) (Librado and Rozas 2009) using D. simulans as out-group. In the case
of  privately  induced  genes,  the  sequences  of  the  population  (or  populations)  from  the  same
continent were used. In the case of “shared” genes, the sequences from all populations were pooled
and analysed together.
3.3  EFFECT  OF  WOLBACHIA AND  PARENTAL  PARASITE  EXPOSURE  ON  D.
MELANOGASTER SURVIVAL TO B. BASSIANA 
3.3.1 Effect of the endosymbiont Wolbachia pipientis
3.3.1.1 Drosophila melanogaster inbred lines
Flies were reared at 23°C on standard fly media (see Appendix, table 1), with a 14 hours light and 
10 hours dark cycle. The Drosophila melanogaster European line E20 (Leiden, the Netherlands) 
and the Egyptians lines Eg25 and Eg57 (Cairo, Egypt) were used. The lines E20 and Eg25 were 
already identified as bearing Wolbachia pipientis, while the line Eg57 was found free from the 
endosymbiont (Jancke 2011).
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The lines Eg25 and E20 were cured from Wolbachia by exposure to the antibiotic tetracycline: flies
were reared on standard fly media supplemented with 0.5 mg/ml of tetracycline for 4 generations.
The line Eg57 was exposed to tetracycline to test for a general effect of the antibiotic on fly fitness
and survival to infection. Absence or presence of  W. pipientis was assessed by PCR (see below).
Flies treated with tetracycline were exposed for two days to media coming from bottles of the
respective not exposed line to allow them to recover the normal fly gut microbiome (Sharon et al.
2011; Charroux and Royet 2012). Antibiotic exposed flies were subsequently reared on standard fly
media without the antibiotic for at least two generation before being exposed to fungal infection. 
3.3.1.2 PCR assessment of Wolbachia pipientis
To determine if flies were bearing W. pipientis, the Wolbachia gene Wsp coding for a surface protein
was amplified by PCR. Primers commonly used in similar studies were chosen (Zhou et al. 1998;
Teixeira et al. 2008; Rottschaefer and Lazzaro 2012) and visible in Appendix table 4. The PCR
protocol  is  given  in  Appendix  tables  5  and  6.  The  D.  melanogaster ribosomal  gene  28S was
amplified  as  a  control  using  the  primers  indicated  in  Appendix  table  4  and the  PCR protocol
reported in Appendix tables 5 and 6. Two repetitions of the PCR were performed, the first one just
after the tetracycline exposure and the second one 10 generation after exposure.
DNA was extracted from samples of 10 male and 10 female flies for each line, both for antibiotic
exposed  and  not  exposed  flies.  DNA extraction  was  performed  using  the  MasterPure  DNA
Purification kit from Epicentre according to the manufacturer's instructions. PCR products were run
on 1.5% agarose gel at 100 V for 40 minutes.
3.3.1.3 Infection experiment
Flies from lines E20, Eg25 and Eg57, both exposed and not exposed to tetracycline, were infected
with the B. bassiana strain 1630 (see above). Two replicates of the infection were performed, the
first one using flies from the third generation after the tetracycline exposure and the second one
using flies from the sixth generation after the antibiotic treatment. The infection procedure was the
same as outlined above with the major difference that flies were reared at the temperature of 21° C
instead of 25° C during the experiment. 
The first  experiment  was performed only  with male flies.  As there were both  flies  exposed to
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tetracycline and not exposed flies and 3 different D. melanogaster inbred lines, in total 6 groups of
flies were present. For each fly group 25 vials, with approximately 15 flies per vial, were exposed to
infection, while 10 vials, again with approximately 15 flies per vial, were exposed to control. In
total 210 vials were started. Mortality was assessed every third day after treatment for 21 days.
The second experiment was performed with both male and female flies. As both cured flies and flies
bearing W. pipientis were used for each D. melanogaster inbred line, 6 fly groups were present, 12
considering flies' sex. For each fly group 26 vials (13 vials for each sex), containing approximately
15 males or females, were exposed to infection, while 10 vials (5 vials for each sex) were exposed
to control treatment.  In total  of 210 vials  were started.  Mortality  was assessed every day after
treatment for 21 days.
3.3.1.4 Statistical analysis
Statistical analysis was performed using the same methods outlined above. As the aim was not to
detect differences among D. melanogaster lines but to determine the effect of W. pipientis and of its
interaction with the experimental treatment on mortality, in all analyses a separate model was fitted
for each fly line (E20, Eg25, Eg57).
3.3.1.4.1 Generalized linear mixed models 
The following covariates were used: “Time”, “Logarithm of time”, “Time squared”, “Treatment”,
“Wolbachia”  (or  “Antibiotic”  for  the  Drosophila  line  Eg57)  and  the  interaction  between
“Treatment” and “Wolbachia” (or “Treatment” and “Antibiotic” for the Drosophila line Eg57). The
covariate “Wolbachia” has two levels: “Wolbachia” and “Cured”, the covariate “Antibiotic” has two
levels: “Antibiotic” and “Not Antibiotic”, the other covariates have already been described in the
previous  section.  The  random  factor  “Vial”  was  introduced  to  account  for  the  repeated
measurements  from  the  same  vial.  For  the  second  experiment  the  extra  covariate  “Sex”  was
introduced.  To analyse the mortality data three days after treatment the following covariates were
used: “Treatment” and “Wolbachia” and, in the case of the second experiment, “Sex”. Analysis was
performed as outlined in the previous section.
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3.3.1.4.2 Cox proportional hazards models
The same covariates specified for the other proportional hazard models (see above) were used  and
additionally the random factor “Vial” to account for the vial to which each fly belonged. Analysis
was performed as outlined in the previous section
3.3.2 Effect of trans-generational immune priming
3.3.2.1 Drosophila out-crossed populations 
Flies were reared at 21°C on standard fly media with a 14 hours light and 10 hours dark cycle. Two
experiments were performed. In the first experiment flies from the 27 th  out-crossed generation  of
one of the two replicate European populations described above (see 3.1.1) were used. In the second
experiment  flies  from  the  30th  out-crossed  generation  of  one  of  the  two  replicate  American
populations described above (see 3.1.1) were used. In both experiments flies were infected with the
fungal strain 1630 (see 3.1.2). 
3.3.2.2 Parents priming
400 male and 400 virgin female flies were collected from the out-crossed population in the first
experiment, 600 males and 600 females in the second experiment. In order to collect female virgin
flies  the  same approach  outlined  above  was  followed  (see  3.1.1).  Male  and  female  flies  were
exposed separately to infection and to control treatment. Half of the flies of each sex were exposed
to  each  treatment.  Flies  exposed  to  infection  treatment  were  divided  into  two  groups  of
approximately the same size. Each group was transferred to a mating cage with walls covered with
ink-jet paper sprayed with fungal spores (see above). The same approach was followed for control
treatment, with the only difference that the ink-jet paper was sprayed with oil. Flies were kept on
agar molasses media at 25°C with a 14 hours light and 10 hours dark cycle for 48 hours. 
After 48 hours all male and female flies exposed to the same treatment were moved to a new mating
cage free from sprayed ink-jet paper, placed at 21°C with a 14 hours light and 10 hours dark cycle
and supplemented with agar molasses plates. Molasses plates were changed every day and eggs
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were collected from infected and control flies for the next two days and placed in bottles (see
above) on standard fly media at 21°C with a 14 hours light and 10 hours dark cycle.
3.3.2.3 Offspring infection
Male and female offspring of the infected and control parents were exposed to infection or control
treatment (see above). For each parental group and offspring sex, 25 vials, with around 15 flies
each, were exposed to infection and 10 vials to control treatment (see table 3). For each category 3
extra  vials,  with  approximately  15  flies  per  vial,  were  exposed  to  infection  and  3  to  control
treatment (see below). These extra-vials were used to replenish vials if needed due to the mortality
of flies (see below). In total  140 vials  were used plus the 24 extra ones. Infection and control
treatment were carried out as outlined in the previous section with the main difference that flies
were  exposed to  treatment  for  48  hours.  During  treatment  flies  were  kept  at  25°C in  the  first
experiment and at 21°C in the second experiment with a 14 hours light and 10 hours dark cycle. 
After treatment, the flies were moved to vials free from ink-jet paper and kept at 21°C with a 14
hours light and 10 hours dark cycle for the rest of the experiment. As a few flies died during the 48
hours treatment, they were replaced by flies from the corresponding extra vials in order to keep
approximately 15 flies in each vial. One day later, the flies were changed again to new vials and
dead flies were recorded. The flies were changed to new vials and mortality was recorded every
third day until the 21st day after the beginning of the experiment. 
PARENTS TREATMENT OFFSPRING SEX OFFSPRING TREATMENT NUMBER OF VIALS
Infection Male Infected 25 +3
Control 10 +3
Female Infected 25 +3
Control 10 +3
Control Male Infected 25 +3 
Control 10 +3 
Female Infected 25 +3
Control 10 +3
Table 3 The table shows parents treatment, offspring treatment and offspring sex combinations with the number of vials used in the experiment for
each combination. “+ 3” indicate the three extra vials for each category. 
3.3.2.4 Statistical analysis
The Statistical analysis of mortality data was performed using the same methods outlined above.
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Note that dead flies were not recorded during the first two days. In the first experiment there was no
significant difference among control and infected flies at this time point, while in the second one
control flies suffered a significantly higher mortality than infected ones.
3.3.2.4.1 Generalized linear mixed models 
The  following  covariates  were  used:  “Time”,  “Logarithm  of  time”,  “Time  squared”,  "Sex",
“Treatment”,  “Parents"  and  the  interaction  between  “Treatment”  and  “Parents”.  The  covariate
“Parents”  has  two  levels:  “Infected”  and  “Control”,  the  other  covariates  have  been  already
described in  the previous  section.  The random factor  “Vial”  was introduced to account  for the
repeated measurements from the same vial. To analyse the mortality data three days after treatment
the following covariates were used: “Treatment”, “Parents” and "Sex". The statistical analysis was
performed in R as outlined in the previous section.
3.3.2.4.2 Cox proportional hazards models
The same covariates specified for the other proportional hazard models (see above) were used with
additionally  the  random factor  “Vial”  to  account  for  the vial  to  which each fly  belonged.  The
statistical analysis was performed in R as outlined in the previous section.
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4 RESULTS
4.1 ASSESSMENT OF SURVIVAL TO B. BASSIANA IN D. MELANOGASTER POPULATIONS
4.1.1 First infection experiment
The mean spore concentration in the oil/spores suspension was 1.7 x 108 spores/ml with a standard
deviation of 0.95 x 108 spores/ml (10 independent measurements were performed). The mean spore
density on the ink-jet transparency film was 2,520 spores/mm2  with a standard deviation of 1,120
spores/mm2 (10 independent measurements were performed). Twenty one vials were discarded due
to  contamination.  As  the  exact  date  was  not  recorded,  these  vials  were  removed  from all  the
statistical analyses. 
4.1.1.1 Mortality at three days after treatment
Control  flies  suffered  a  higher  mortality  than  infected  ones  (figure  7).  Mortality  was  not
homogeneous among continents and populations (figure 8). “Treatment” was significant both in the
“Continent”  (p-value  =  0.00325) and  in  the  “Population”  analysis  (p-value  =  0.00348).  In  the
“Continent” analysis “America” was significantly different from “Africa” (p-value = 0.02844). In
the “Population” analysis “Asia 1” was significantly different from “Africa 1” (p-value = 0.03925). 
Figure 7 Box plot representing the number of dead flies per vial during the first three days after treatment. 
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The higher mortality of control flies was due to the effect of the oil: more flies got stuck to the vial
walls or soaked in the oil (see Materials and Methods). Also the variability in mortality among
continents and populations is of interest and reflects a difference in general vigour, highlighting the
higher  fitness  of  the  American  populations  (see  figure  8);  conversely  the  “Asia  1”  population
exhibits an extremely pronounced mortality (see figure 8).
Figure 8 (a) Box plot representing the number of dead flies per vial during the first three days after treatment for each continent . (b) Box plot
representing the number of dead flies per vial during the first three days after treatment for each population. (“AF1” = Africa 1, “AF2” = Africa 2,
“AM1” = America 1, “AM2” = America 2, “AS1” = Asia 1, “AS2” = Asia 2, “EU1” = Europe 1, “EU2” = Europe 2). 
4.1.1.2 Mortality at six days after treatment and later
4.1.1.2.1 Generalized linear model
All  time  covariates  were  retained  and  were  significant  both  in  the  “Continent”  and  in  the
“Population” analysis (table 4, 5). In the “Continent” analysis “Treatment” was significant. In the
“Population” analysis only “America 2” was significantly different from “Africa 1”. 
Time Log Time Time squared Treatment
p-value 0.002833 0.048800 0.000684 0.002198
Table 4 P-values of the significant covariates in the “Continent” analysis.
These results do not support any difference in susceptibility to fungal infection among continents or
populations.  In  the  “Population”  analysis  “Treatment”  was not  significant,  probably  due to  the
relatively small increase in mortality in infected compared to control flies and to the big variability
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among populations (figure 9, 10). The flies from the “America 2” population died less then the ones
from  the  other  populations  (table  5,  figure  10)  reflecting  higher  vigour  independently  of  the
treatment.
Time Log Time Time squared America 2
p-value 0.002804 0.048280 0.000678 0.036002
Table 5 P-values of the significant covariates in the “Population” analysis.
4.1.1.2.2 Kaplan-Meier estimator
The Kaplan-Meier survival curve for each continent is shown in figure 9. As expected infected flies
suffered higher mortality than control ones; we also observed that temperate populations performed
better  than  tropical  ones  both  for  infected  and  the  control  flies.  This  plot  again  suggests  no
difference in susceptibility to fungal infection and a difference in general vigour among continents. 
Figure 9 Kaplan-Meier plot representing survival curves from six days after treatment for all continents. Full lines represent infected flies (“I” in the
legend), while dashed lines represent control flies (“C” in the legend). Colours are as follow: African flies in blue, American in red, Asian in black and
European in pink. 
The Kaplan-Meier survival curve for each pair of replicate populations is reported in figure 10.
There is  some variability  among replicate  populations,  especially  for the treatments  of  the two
African populations. The American and European populations are the ones with the lowest mortality
after infection.
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Figure 10 Kaplan-Meier plots for pairs of replicate populations. (a) represents the African replicates, (b) represents the American replicates, (c)
represents the Asian populations and (d) represents the European populations. 
 
4.1.1.2.3 Cox hazard model
In the “Continent” analysis “Treatment” was significant (p-value = 0.0035). In the “Population”
analysis “America 2” was significantly different from “Africa 1” (p-value = 0.0340). These results
once more reject the hypothesis of different susceptibility to fungal infection among continents and
populations and suggest that the “America 2” population is more fit independently of the treatment.
4.1.2 Second infection experiment
The mean spore concentration in the oil/spore suspension was 2.2 x 108 spores/ml with a standard
deviation of 0.7 x 108 spores/ml (10 independent measurements were performed). The mean spore
density  on  the  ink-jet  transparency  was  not  measured  because  a  similar  value  as  in  the  first
experiment was expected. Eighty one vials were discarded due to contamination. 
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4.1.2.1 Mortality at three days after treatment
Control flies suffered higher mortality than infected ones (figure 11). 
Figure 11 Box plot representing the number of dead flies per vial during the first three days after treatment. 
Mortality was not homogeneous among continents and populations (figure 11, figure 12). 
Figure 12 (a) Box plot representing the number of dead flies per vial during the first three days after treatment for each continent. (b) Box plot
representing the number of dead flies per vial during the first three days after treatment for each population. There are initially approximately 15 flies
per vial. (AF1 = Africa 1, AF2 = Africa 2, AM1 = America 1, AM2 = America 2, AS1 = Asia 1, AS2 = Asia 2, EU1 = Europe 1, EU2 = Europe 2). 
“Group”  was  not  significantly  increasing  the  likelihood  neither  in  the  “Continent”  nor  in  the
“Population” analysis and therefore was dropped from the models. “Treatment” was significant both
in the “Continent” and in the “Population” analysis. In the “Continent” analysis “America” and
“Europe” were significantly different from “Africa” (table 6). 
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Treatment America Europe
p-value 0.000478 0.001218 0.024138
Table 6 P-values of the significant covariates in the “Continent” analysis.
In the “Population” analysis the “Africa 2”, “America 1”, “America 2”, “Asia 2”, “Europe 1” and
“Europe 2” were significantly different from “Africa 1” (table 7).  Mortality was higher in control
than in infected flies, most likely due to the negative effects of the oil (see above). “America” and
“Europe”  show  the  highest  vigour  and  “America  1”,  “America  2”  and  “Europe  2”  are  the
populations with the lowest mortality (see figure 12).
Treatment Africa 2 America 1 America 2
p-value 0.000263 0.003636 0.00089 8.47E-05
Asia 2 Europe 1 Europe 2
p-value 0.020273 0.040411 9.72E-05
Table 7 P-values of the significant covariates (p-value < 0.05) in the “Population” analysis.
4.1.2.2 Mortality from six days after treatment
4.1.2.2.1 Generalized linear model
All  time  covariates  were  retained.  The  covariate  “Group”  was  not  significantly  increasing  the
likelihood neither in the “Continent” nor in the “Population” analysis and therefore was dropped
from the models. All time covariates and “Treatment” were significant both in the “Continent” and
in the “Population” analysis (table 8, 9). 
Time Log Time Time squared Treatment
p-value 1.80e-12 0.000274 < 2e-16 2.64e-16
Table 8 P-values of the significant covariates in the “Continent” analysis.
Also in this case there is no evidence for a difference in susceptibility to fungal infection among
continents and populations. “Europe 2” shows significantly higher vigour than “Africa 1” (see table
9). 
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Time Log Time Time squared Treatment Europe 2
p-value 1.82e-12 0.000273 < 2e-16 3.69e-09 0.035993
Table 9 P-values of the significant covariates in the “Population” analysis.
4.1.2.2.2 Kaplan-Meier estimator
The Kaplan-Meier survival curve for each continent is shown in figure 13. Infected flies suffered a
higher mortality rate than control ones. This plot does not suggest any difference in susceptibility
among continents.
Figure 13 Kaplan-Meier plot representing survival curves from six days after infection for all continents. 
The Kaplan-Meier survival curve for each pair of replicate populations is reported in figure 14.
There is  some variability  among replicate  populations,  especially  for the treatments  of  the two
American and of the two Asian populations. However, note that the mortality is higher than for
experiment 1 above (figure 9 ).
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Figure 14 Kaplan-Meier plots for pairs of replicate populations. (a) represents the African replicates, (b) represents the American replicates, (c)
represents the Asian populations and (d) represents the European populations.
4.1.2.2.3 Cox hazard model
“Group”  did  not  significantly  increase  the  likelihood  neither  in  the  “Continent”  nor  in  the
“Population” analysis and therefore was dropped from the models. “Treatment” was significant both
in the “Continent” (p-value = 9.4e-14) and in the “Population” analysis (p-value = 2.2e-06). In the
“Continent”  analysis  “America”  was  significantly  different  from  “Africa”  (2.3e-02).  In  the
“Population” analysis “America 2” and “Europe 2” were significantly different from “Africa 1”
(p-value  =  3.6e-02  and  p-value=2.8e-02,  respectively).  There  is  no  evidence  of  different
susceptibility to infection among continents and populations. “America” has a higher vigour than
the  other  continents  and “America  2” and “Europe 2” are  more  fit  than  the  other  populations
independently of treatment. 
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4.1.3 Third experiment
The mean spores concentration in the oil/spore suspension was 1.7 x 108 spores/ml with a standard
deviation of 0.95 x 108 spores/ml (10 independent measurements were performed). The mean spore
density on the ink-jet transparency film was 13,693 spores/mm2 with a standard deviation of 6,791
spores/mm2 (10 independent measurements were performed). Note that 12 vials were discarded due
to contamination. 
4.1.3.1 Mortality three days after treatment
 
As  expected  control  flies  suffered  higher  mortality  than  infected  ones  (figure  15),  but  not
significantly higher. 
Figure 15 Box plot representing the number of dead flies per vial during the first three days after treatment. 
Mortality was not homogeneous among continents and populations (figure 16). In the “Continent”
analysis  “America”  was  significantly  different  from  “Africa”  (p-value  =  9.04e-09).  In  the
“Population” analysis “Africa 2”, “America 1”, “America 2”, “Asia 2”, “Europe 1” and “Europe 2”
were significantly different from “Africa 1” (table 10). 
Africa 2 America 1 America 2 Asia 2 Europe 1 Europe 2
p-value 5.63e-05 2.94e-10 2.50e-08 0.000151 0.042967 5.12e-06
Table 10 P-values of the significant covariates in the “Population” analysis.
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Once again the higher mortality of the control flies has likely to do with the negative effects of the
oil. Flies from “America” have higher vigour than the ones from other continents and the American
populations are more fit than the others (see figure 16). 
Figure 16 (a) Box plot representing the number of dead flies per vial during the first three days after treatment for each continent. (b) Box plot
representing the number of dead flies per vial during the first three days for each population (AF1 = Africa 1, AF2 = Africa 2, AM1 = America 1,
AM2 = America 2, AS1 = Asia 1, AS2 = Asia 2, EU1 = Europe 1, EU2 = Europe 2). 
4.1.3.2 Mortality from six days after treatment
 
4.1.3.2.1 Generalized linear model
For the “Continent” and “Population” analyses two best models were found: one with “Log time”
and “Time” as time covariates (model 1) and the other with “Log time” and “Time squared” as time
covariates  (model  2).  The  use  of  all  three  time  covariates  did  not  increase  the  likelihood
significantly.  “Treatment”  and  the  time  covariates  were  significant  in  each  model  both  in  the
“Continent” and in the “Population” analysis (table 11, 12, 13, 14). In the “Continent” analysis
“America” was significantly different from “Africa” (table 11, 12).
Log time Time Treatment America
p-value 1.56e-06 0.0358 1.43e-07 0.0465
Table 11 P-values of the significant covariates in the “Continent” analysis (model 1).
Log time Time squared Treatment America
p-value 4.63e-12 0.0416 1.43e-07 0.0465
Table 12 P-values of the significant covariates in the “Continent” analysis (model 2).
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In the “Population” analysis “America 1” was significantly different from “Africa 1” (table 13, 14). 
Log time Time Treatment America 1
p-value 1.58e-06 0.035930 0.000189 0.049468
Table 13 P-values of the significant covariates in the “Population” analysis (model 1).
Log time Time squared Treatment America 1
p-value 4.71e-12 0.041706 0.000189 0.049475 
Table 14 P-values of the significant covariates in the “Population” analysis (model 2).
Based on these results  there is  no significant  difference in susceptibility  among continents  and
populations. “America” has a significantly higher vigour than the other continents, and “America 1”
is significantly more fit than the other populations independently of treatment (see figures 17,18). 
4.1.3.2.2 Kaplan-Meier estimator
The Kaplan-Meier survival curve for each continent is reported in figure 17. Infected flies suffered
a  higher  mortality  than  control  ones;  the  American  population  performed better  than  the  other
populations both for infected and control flies. The plot suggests no difference in susceptibility
among continents and a reduced mortality in control and infected American flies compared to the
ones from other continents. The Kaplan-Meier survival curve for each pair of replicate populations
is reported in figure 18. There is some variability among replicate populations, especially for the
infected flies of the two European populations.
Figure 17 Kaplan-Meier plot representing survival curves from six days after infection for all continents. 
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Figure 18 Kaplan-Meier plots for pairs of replicate populations. (a) represents the African replicates, (b) represents the American replicates, (c)
represents the Asian populations and (d) represents the European populations.
4.1.3.2.3 Cox hazards model
 
“Treatment” was significant both in the “Continent” (p-value = 2.4e-07) and in the “Population”
analysis  (p-value = 0.00015).  In the “Continent” analysis  “America” was significantly different
from “Africa” (p-value = 4.3e-02).  In the “Population” analysis  “America 1” was significantly
different from “Africa 1” (p-value = 0.04800).
These results do not support any difference in susceptibility to fungal infection among continents
and populations, but support the higher vigour of the flies from “America” and especially from the
“America 1” population.
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4.2 D. MELANOGASTER TRANSCRIPTIONAL RESPONSE TO B. BASSIANA
4.2.1 Micro-array analysis
4.2.1.1 Eight-nodes analysis
4.2.1.1.1 Induced genes 
14,229 genes (from a total of 14,338) were retained in the BAGEL analysis. With a false discovery
rate of 6.7 % we found between 18 and 30 genes induced in each population (table 15).
AFRICA UP AFRICA DOWN AMERICA UP AMERICA DOWN ASIA UP ASIA DOWN EUROPE UP  EUROPE DOWN
CG10637 CG12028 CG9094 CG1314 CG6342 CG14454 CG40339 CG14674
CG10247 CG9919 CG6342 CG30496 CG8833 CG4136 CG31415 CG10533
CG10174 CG3221 CG31422 CG7638 CG11373 CG11720 CG16848 CG2160
CG32450 CG5258 CG40002 CG7735 CG3000 CG10245 CG3301 CG10501
CG11373 CG1539 CG30361 CG11951 CG11354 CG12001 CG15313 CG12042
CG12758 CG9490 CG14095 CG6759 CG9108 CG8615 CG1244 CG6506
CG11663 CG15368 CG3600 CG12798 CG13361 CG12736 CG7321 CG18358
CG3878 CG40339 CG30273 CG15539 CG12699 CG40270 CG15414 CG15736
CG5475 CG12224 CG12278 CG31868 CG18478 CG12559 CG8884
CG1221 CG7833 CG5902 CG11329 CG15454
CG7535 CG15118 CG13195 CG17035
CG30154 CG30061 CG14095
CG3608 CG15381 CG11598
CG11425 CG4019 CG30496
CG12092 CG17136 CG17707
CG3245 CG12913
CG7654 CG12050
CG32476 CG5537
CG32476
Table 15 Genes induced upon infection in each population (FDR: 6.7%). "UP" stays for genes up-regulated and "DOWN" for genes down-regulated
following infection. For each gene the annotation symbol is reported. 
4.2.1.1.2 Gene ontology enrichment
Genes  down-regulated  in  the  African  population  upon  infection  show  enrichment  for  the  GO
category "ecdysteroid 22-hydroxylase activity"  (p-value:  0.000579),  but  this  was not significant
after multiple tests  correction (FDR q-value: 1).  We did not find enrichment for any other GO
category in genes over-expressed in infected or control flies for any other population.
4.2.1.1.3 Genes shared among populations
Genes up-regulated after infection in two or more populations are reported in table 16. Functional
and biological  information  is  available  for  the  gene CG6342  (iron-responsive element  binding;
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aconitate hydratase activity; regulation of translational initiation by iron). The gene CG30496 is
down-regulated upon infection in the American and European populations.
POPULATIONS GENE
AFRICA_ASIA CG11373
AMERICA_ASIA CG6342
Table 16 Genes up-regulated after infection (FDR 6.7%) in two or more populations; for each gene the annotation number is reported. 
4.2.1.1.4 Genes shared with other studies
We refer to  Roxstrom-Lindquist  et  al.  (2004) as “Roxs04” and to  De Gregorio et  al.  (2001) as
“DeGreg01” in the rest of the Results section. 
The gene CG11425 is up-regulated both in the African population and in Roxs04 and is known to
have  phosphatidate  phosphatase  activity  and  to  be  involved  in  dephosphorylation.  The  gene
CG3301 is  up-regulated both in the European population and in DeGreg01 and is known to have
oxidoreductase activity and to be involved in metabolic process.
No gene was down-regulated both in one or more populations of the present study and in Roxs04.
The gene  CG4019 is  down-regulated both in the American population and in DeGreg01 and is
known to have water channel activity and to be involved in renal system process.
4.2.1.1.5 Conclusions about the population analysis
Few genes are significantly induced in this study, less than in Roxs04 and in DeGreg01. The gene
ontology analysis did not reveal enrichment for any meaningful GO category and no GO category
was significant after multiple tests correction. Only few genes show the same expression pattern
among populations or are shared with the two other studies cited above.
These results indicate that transcriptional response to infection is absent or just starting 8 hours after
infection and no clear pattern appears from the data. These findings differ to a large extent from
what we observed in the RNA sequencing analysis (see below). Also in the RNAseq analysis we
found few genes induced 8 hours after infection but they have a more coherent function and are
mainly involved in detoxification (see below). The difference among the two studies possibly relies
on the higher power of the RNA sequencing technology and on the intrinsic noise of the micro-array
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experiments (Wang et al. 2009) that may not be able to detect the low signal produced by infection
on gene expression at an early time point. 
4.2.1.2 Two-nodes analysis
4.2.1.2.1 Induced genes
14,229 genes (from a total of 14,338) were retained in the BAGEL analysis. There were 27 genes
induced with a FDR of 7.4 % (see table 17).
UP DOWN
CG40002 CG11430
CG8833 CG15690
CG6342 CG32297
CG2746 CG1555
CG40040 CG31200
CG8038 CG11951
CG11373 CG3221
CG18135 CG6283
CG31422 CG11502
CG10605 CG12249
CG10637 CG4841
CG1362 CG7735
CG12602 CG11893
CG10174
Table 17 Induced genes (FDR 7.4 %). "UP" denotes genes up-regulated and "DOWN" genes down-regulated following infection.
4.2.1.2.2 Gene ontology enrichment
We did not find enrichment for any GO category in genes over-expressed in infected or control
flies, or for any population and at any false discovery rate.
4.2.1.2.3 Genes shared with other studies
No gene  was  up-regulated  following  infection  both  in  the  present  study  and  in  Roxs04  or  in
DeGreg01. The gene  CG6283 is down-regulated after infection both in the present study and in
Roxs04 and is  known to have triglyceride lipase activity and to be involved in lipid metabolic
process. No gene was down-regulated upon infection both in the present study and in DeGreg01. 
4.2.1.2.4 Conclusions about the two-nodes analysis
 
As for the “Eight-nodes analysis” few genes were found to be induced upon infection in comparison
to DeGreg01  and Roxs04.  The  gene  ontology  analysis  did  not  reveal  enrichment  for  any  GO
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category, and no clear picture emerges from the analysis. Again the reason could be the inadequacy
of the micro-array technology to detect the low signal present at the early time point after infection
that was chosen (see above). 
4.2.2 RNA sequencing analysis
4.2.2.1 Sample quality control
All  samples,  with the exception of one American control  biological  replicate,  passed the RNA
quality  control.  Therefore  only  two  American  control  biological  replicates  were  used  in  the
following analyses.
4.2.2.2 Principal Components Analysis (PCA)
Principal  component  analysis  of  expression  profile  was performed and results  are  presented  in
figure 19. Control flies and 8 hours infected flies cluster together and are almost undistinguishable
(figure 19a). This is in agreement with the micro-array results. On the other hand, 24 hours infected
flies show a different pattern, meaning that infection has a significant effect on gene expression at
this time point. Difference among populations is also present, with the American flies clustering
apart from the others (figure 19b).
Figure 19 PCA plots. (a) colours define different treatments,"C" stands for control, "I08" for 8 hours infected and "I24" for 24 hours infected flies. (b)
colours define different populations, "Af" stands for Africa, "Am" for America, "As" for Asia and "Eu" for Europe. 
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4.2.2.3 Control and eight hours infected flies
In the following sections transcriptional response eight hours after infection is described and the
corresponding induced genes are discussed. First we start by describing the result of the expression
analysis considering each population independently.
4.2.2.3.1 Volcano plots 
Volcano plots, reporting FDR corrected p-values as a function of fold change for all genes, are
presented in figure 20 for each population. The first notable observation is that few genes show a
significant change in expression. This is in agreement with the PCA and the micro-array results (see
above). Not all the populations show the same pattern of transcriptional response: the American
flies have more genes significantly induced than all the other populations. On the other hand only
one gene is significantly induced in the African population. These results suggest that the American
population is the fastest to mount a transcriptional response to infection. 
Figure 20 Volcano plots for genes induced 8 hours after infection in each population. The x axis represents gene expression in terms of log2 fold
change: a positive value on this axis means that a gene is up-regulated upon infection, while a negative value indicates that is down-regulated. The y
axis represents significance level in terms of -log10 of the Benjamin-Hochberg corrected p-value: a high value on this axis means that the difference
in gene expression is highly significant; genes with significant p-value (FDR 5%) are indicated in red. (a) is for the African population, (b) is for the
American population, (c) is for the Asian population and (d) is for the European population. 
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4.2.2.3.1 Induced genes
Significantly induced genes (FDR 5%) are reported in table 18. The first notable result is that in
each population there is at least one up-regulated gene member of the cytochrome P450 family:
Cyp6a8 (CG10248) in Africa,  Cyp6a2 (CG9438) and  Cyp4e2 (CG2060) in America and  Cyp6d2
(CG4373) in Asia and Europe. The cytochrome P450s family consists of 83 functional genes in D.
melanogaster  (Tijet et al. 2001).  These genes code for enzymes that catalyze chemical reactions
important in development, detoxification of foreign substances and insecticide resistance (Tijet et
al. 2001, Thomas 2007, Chung et al. 2009, Giraudo et al. 2010, Kleinhesselink et al. 2011, Thomas
et al. 2013). Cyp6a8 is known to be expressed in D. melanogaster malpighian tubules, Cyp6a2 and
Cyp4e2 both in larvae midgut and malpighian tubules and Cyp6d2 in the tracheal system (Chung et
al. 2009). 
Malpighian  tubules  is  an  excretory  organ  (Beyenbach  et  al.  2010)  important  for  hemolymph
detoxification and has recently been proposed to play a role in insect immunity (Davies et al. 2012).
On the other side the tracheal system serves in insects for the transport  of oxygen through the
cuticle and throughout the body (Cabernard et al. 2004) and is a hot spot for fungal penetration of
host cuticle (Pekrul and Grula 1979, Gillespie et al. 2000, Sahayaraj et al. 2013).
The  up-regulation  of  several  cytochrome  P450  genes  early  after  infection  suggests  that
detoxification of toxic compounds produced by the fungus is of primary importance during the first
phase of defence response. Indeed entomopathogenic fungi are known to produce toxic compounds
during infection (see Introduction). The prevalence of Cyp450s among the induced genes early after
infection also prompts the intriguing hypothesis of their involvement in sensing the infection and
triggering the defence response.
The metabolism of drugs and toxic compounds usually happens in three steps (Parvez and Reiss
2001). The first one is modification, meaning the insertion of a polar group in the target compound,
and could happen by oxidation, reduction or hydrolisis. Cyp450s can catalyze both oxidative and
reductive reactions. The second step is conjugation. In this step the modified toxic compounds are
conjugated with negatively charged species as glutathione (GSH), sulfate, glycine, or glucuronic
acid. In the third step conjugated compounds are eventually further metabolised and finally actively
excreted.
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Looking from this perspective CG2064 and CG9360 that have oxidoreductase activity could be
involved in the first phase of toxic compounds metabolism. On the other hand CG5724 that has a
glucuronosyltransferase activity is clearly involved in phase two metabolism, as could be the case
for  CG10182 that has an acyl group transfer activity. In conclusion it emerges the importance of
detoxification in early response to infection.
AFRICA I08 AFRICA C AMERICA I08 AMERICA C ASIA I08 ASIA C EUROPE I08 EUROPE C
CG10248 CG9438 CG34387 CG4373 CG15263 CG4373 CG6484
CG2060 CG42795 CG10182 CG6385
CG9360 CG14446
CG2064 CG9907
CG5724
CG31104
Table  18 Significant  induced  genes  in  each  population."I08"  stays  for  genes  over-expressed  in  8  hours  infected  flies,  "C"  stays  for  gene
over-expressed in control files. 
4.2.2.3.1 Gene ontology analysis
In Appendix table 7 gene ontology categories showing enrichment in genes up- or down-regulated
upon infection in each population are presented.  The American population has more significant
GOs, as is to be expected given the higher number of induced genes in this population. No GO
category is  significant after multiple tests correction, possibly due to the low number of induced
genes at this time point.
4.2.2.3.1 Comparison among populations
Only one gene is up-regulated upon infection in two populations: Cyp6d2 (CG4373). This gene is
seen both in Asia and Europe and is up-regulated in the African and American populations, although
not significantly after multiple tests correction. As already discussed above, Cyp6d2 is known to be
expressed  in  the  tracheal  system and  could  therefore  be  involved  in  early  response  to  fungal
infection.
4.2.2.3.1 Comparison with other studies
We could not find any gene induced both in this study and in Roxs04. Three genes are induced both
in the present  analysis  and in  DeGreg01:  CG9360 that  has  an oxido-reducatase activity  and is
involved in metabolic process,  Cyp4e2 (CG2060) and CG15263, whose molecular and biological
function are unknown. Interestingly we could not find any gene induced both in the present and in
63
the microarray analysis. This is quite surprising given that in both cases the same time point after
infection was chosen (see Discussion). 
4.2.2.3.2 Treatment analysis 
In this  section we show the results  of the expression analysis considering the general effect of
treatment.
4.2.2.3.2 Volcano plot
The volcano plot is presented in figure 21. As already observed in the "populations" analysis, the
number of induced genes is low. Interestingly all induced genes are up-regulated upon infection.
Figure 21 Volcano plot for treatment analysis. 
4.2.2.3.2 Induced genes
Significantly induced genes (FDR 5%) are reported in table 19. In this analysis only one gene from
the cytochrome P450 family was found: Cyp6d2 (CG4373) (see above). The other Cyp450s found
in the "population analysis" could be involved in population specific responses to early stage fungal
infection. CG2064 has an oxido-reductase and CG5371 a reductase activity and could possibly be
involved in the first step of toxic compounds metabolism. 
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Three genes likely involved in the second phase of toxic compounds metabolism are CG4371 that
has  a  glutathione  transferase  activity,  CG13270  with  a  glucuronosyltransferase  activity,  and
possibly CG10182 that has an acyltransferase activity.
Smvt (CG2192) and CG30272 are important in transmembrane transport and could be involved in
the excretion of metabolised xenobiotics.
Finally CG13160, CG33012 and Jonah 65Aii (CG6580) code for proteolytic enzymes and possibly
take part in a not yet characterised defence mechanism.
I08 C
CG10182
CG4371
CG4373
CG13160
CG13270
CG30272
CG33012
CG5371
CG6580
CG2064
CG2069
CG2191
Table 19 Significantly induced genes in each population.                   
4.2.2.3.2 Gene ontology analysis
No gene ontology category was enriched in the induced gene set. This could be due to the low
number of induced genes.
4.2.2.3.2 Comparison with other studies
We could not find any gene induced both in  this  analysis  and in Roxs04, DeGreg01 or in the
micro-array analysis (see above). Once again the difference could be due to the lower power of the
micro-array analysis (see above).
4.2.2.4 Control and twenty-four hours infected flies
In the following part, we show the transcriptional response 24 hours after infection. First, the results
of the expression analysis considering each population independently are shown.
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4.2.2.4.1 Volcano plots
Volcano plots  are  presented  in  figure  22.  The first  evident  result  is  that  many more genes  are
induced at 24 than at 8 hours after infection. This indicates that strong transcriptional response to
infection begins between these two time points. Interestingly there is quite a big variability in the
number of induced genes among populations, from more than 1,000 in the African population to
only 200 in the Asian one. The expression fold change of up- and down-regulated genes also varies
and is especially high in the Asian population and low in the European one. These peculiarities may
reflect different strategies of sensing and responding to fungal infection between D. melanogaster
populations. 
Figure 22 Volcano plots for genes induced 24 hours after infection in each population. 
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4.2.2.4.1 Induced genes
In table 20 the number of genes up- or down-regulated upon infection in each population is shown. 
AFRICA I24 AFRICA C AMERICA I24 AMERICA C ASIA I24 ASIA C EUROPE I24 EUROPE C
861 459 189 103 104 95 249 195
Table 20 Number of significantly induced genes in each population.
4.2.2.4.1 Gene ontology analysis
In the following sections gene ontology categories enriched in genes up- and -down regulated upon
infection are reported for each population. Due to the high number of significant categories only the
ones related to biological process (see 3.2.1.8) are reported here. 
4.2.2.4.1 African population
274 GOs are significantly enriched in genes up-regulated upon infection.  The ones involved in
response to stimulus, immunity,  circadian rhythm and tracheal system are reported in Appendix
table 8. Several GOs enriched in up-regulated genes are involved in response to stimulus. These
processes  are  possibly  connected  with  sensing  the  infection.  Some  categories  are  involved  in
immunity and the tracheal system. This last group is of interest as fungi penetrate through the host
cuticle and the trachea openings are an ideal spots for penetration (see above). Finally it is worth
noting that gene ontology categories involved in circadian rhythm are also enriched. This is most
likely due to the time when flies were sampled: control flies were sampled in the evening, while 24
hours infected flies in the morning. 
Given their hign number, GOs significantly enriched in genes down-regulated upon infection are
visible in Appendix  table 9. The majority of these categories is involved in energy production,
reproduction and biosynthesis. This suggests that infected flies may reduce non-essential metabolic
and biological processes to mount a response to infection.
While  we  touch  upon  only  a  portion  of  all  significant  GOs,  the  high  number  of  significant
categories and the different biological processes in which they are involved suggest that fungal
infections trigger a complex transcriptional response in  D. melanogaster.  The higher number of
induced genes and enriched GOs in the African population is  of particular interest  and will  be
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addressed in the discussion. 
4.2.2.4.1 American population
The GOs enriched in genes up-regulated after infection are reported in table 21. Among them there
are: "Toll signalling pathway" that is known to be involved in humoral immunity (Lemaitre 1996),
"response to organic substance", "response to abiotic stimulus" and "response to insecticide" that
have likely to do with sensing the infection, and "circadian rhythm" that probably reflects the time
at which flies were sampled (see above). None of these categories, however, is significant after
multiple-testing correction (see table 21).
GO Term Description p-value FDR q-value
GO:0055114 oxidation-reduction process 3.22E-06 1.71E-02
GO:0009072 aromatic amino acid family metabolic process 7.13E-06 1.89E-02
GO:0044710 single-organism metabolic process 7.43E-06 1.31E-02
GO:0008063 Toll signaling pathway 1.88E-04 2.49E-01
GO:0019752 carboxylic acid metabolic process 4.62E-04 4.90E-01
GO:0010033 response to organic substance 5.57E-04 4.92E-01
GO:0009628 response to abiotic stimulus 5.97E-04 4.52E-01
GO:0006573 valine metabolic process 6.69E-04 4.43E-01
GO:0006572 tyrosine catabolic process 6.69E-04 3.94E-01
GO:0043436 oxoacid metabolic process 6.76E-04 3.58E-01
GO:0006082 organic acid metabolic process 6.76E-04 3.26E-01
GO:0017085 response to insecticide 8.57E-04 3.79E-01
GO:0007623 circadian rhythm 9.07E-04 3.70E-01
Table 21 Gene ontology categories enriched in genes up-regulated after infection in the American population. 
The GOs enriched in genes down-regulated after infection are reported in table 22. The significance
of most categories, with the exception of "organic cation transport" and "transmembrane transport",
is due to two circadian genes:  timeless and  period (data not shown). These categories may be a
consequence  of  the  sampling  approach (morning sampling).  The two other  categories  may not
appear  to  be  clearly  connected  with  the  infection  process.  No  GO  is  significant  after
multiple-testing correction (see table 22).
GO Term Description p-value FDR q-value
GO:0001659 temperature homeostasis 6.99E-05 3.70E-01
GO:0060086 circadian temperature homeostasis 6.99E-05 1.85E-01
GO:2000678 negative regulation of transcription regulatory region DNA binding 2.08E-04 3.68E-01
GO:2000677 regulation of transcription regulatory region DNA binding 2.08E-04 2.76E-01
GO:0043392 negative regulation of DNA binding 4.15E-04 4.40E-01
GO:0015695 organic cation transport 4.15E-04 3.66E-01
GO:0051100 negative regulation of binding 4.15E-04 3.14E-01
GO:0048871 multicellular organismal homeostasis 6.87E-04 4.56E-01
GO:0055085 transmembrane transport 7.01E-04 4.13E-01
Table 22 Gene ontology categories enriched in genes down-regulated after infection in the American population. 
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4.2.2.4.1 Asian population
The GOs enriched in genes up-regulated after infection are reported in table 23. Among them there
are:  "response  to  organic  cyclic  compound",  "response  to  organic  substance"  and "response  to
alkaloid" that are possibly involved in sensing the fungal infection. Nevertheless only "response to
organic compounds" is significant after multiple-tests correction (see table 23). 
GO Term Description p-value FDR q-value
GO:0014070 response to organic cyclic compound 7.90E-06 4.19E-02
GO:0050962 detection of light stimulus involved in sensory perception 6.82E-05 1.81E-01
GO:0010033 response to organic substance 3.53E-04 6.24E-01
GO:0055114 oxidation-reduction process 7.61E-04 1.00E+00
GO:0043279 response to alkaloid 9.29E-04 9.86E-01
Table 23 Gene ontology categories enriched in genes up-regulated after infection in the Asian population. 
The GOs enriched in genes down-regulated upon infection are reported in table 24. We expect that
most of them, with the exception of "mating", "multicellular organism reproduction, "reproduction",
"multi-organism reproductive process"  and "response to  DDT",  are  due to  the  circadian  genes:
timeless and period (data not shown). These categories may appear due to the sampling approach
(see  above).  The  categories  involved  in  reproduction  may  reflect  the  decrease  of  biological
functions not essential for response to fungal infection (see above).
GO Term Description p-value FDR q-value
GO:0032504 multicellular organism reproduction 1.70E-05 9.00E-02
GO:0000003 reproduction 2.34E-05 6.20E-02
GO:0007618 mating 3.55E-05 6.28E-02
GO:0001659 temperature homeostasis 4.61E-05 6.11E-02
GO:0060086 circadian temperature homeostasis 4.61E-05 4.89E-02
GO:0044703 multi-organism reproductive process 8.34E-05 7.37E-02
GO:2000678 negative regulation of transcription regulatory region DNA binding 1.38E-04 1.04E-01
GO:2000677 regulation of transcription regulatory region DNA binding 1.38E-04 9.12E-02
GO:0043392 negative regulation of DNA binding 2.74E-04 1.61E-01
GO:0051100 negative regulation of binding 2.74E-04 1.45E-01
GO:0046680 response to DDT 2.74E-04 1.32E-01
GO:0048871 multicellular organismal homeostasis 4.55E-04 2.01E-01
GO:0007620 copulation 9.46E-04 3.86E-01
GO:0009648 photoperiodism 9.46E-04 3.58E-01
Table 24 Gene ontology categories enriched in genes down-regulated after infection in the Asian population. 
4.2.2.4.1 European population
The GOs enriched in genes up-regulated after infection are reported in table 25. Among them there
are  several  categories  involved  in  response  to  stimulus  or  chemical  substance,  although  only
"response to organic cyclic compounds" and "response to organic substance" are significant after
multiple-testing correction.  Several  categories  are  related to  immunity and some of  them quite
specifically against fungi. Nevertheless none of these categories is significant after multiple-testing
69
correction. 
GO Term Description p-value FDR q-value
GO:0014070 response to organic cyclic compound 7.34E-06 3.89E-02
GO:0010033 response to organic substance 1.63E-05 4.32E-02
GO:0051239 regulation of multicellular organismal process 1.07E-04 1.89E-01
GO:0048935 peripheral nervous system neuron development 1.48E-04 1.96E-01
GO:0045087 innate immune response 2.53E-04 2.69E-01
GO:0097305 response to alcohol 3.77E-04 3.33E-01
GO:0006967 positive regulation of antifungal peptide biosynthetic process 4.02E-04 3.04E-01
GO:0002810 regulation of antifungal peptide biosynthetic process 4.02E-04 2.66E-01
GO:0042221 response to chemical stimulus 4.20E-04 2.47E-01
GO:2000026 regulation of multicellular organismal development 4.36E-04 2.31E-01
GO:0050896 response to stimulus 5.62E-04 2.71E-01
GO:1900150 regulation of defense response to fungus 5.94E-04 2.62E-01
GO:0002788 regulation of antifungal peptide production 5.94E-04 2.42E-01
GO:0009605 response to external stimulus 6.58E-04 2.49E-01
GO:0008063 Toll signaling pathway 6.73E-04 2.38E-01
GO:0009636 response to toxic substance 6.94E-04 2.30E-01
GO:0050817 coagulation 8.36E-04 2.61E-01
GO:0050962 detection of light stimulus involved in sensory perception 8.36E-04 2.46E-01
GO:0042381 hemolymph coagulation 8.36E-04 2.33E-01
GO:0007599 hemostasis 8.36E-04 2.22E-01
GO:0006955 immune response 9.63E-04 2.43E-01
GO:0048731 system development 9.79E-04 2.36E-01
GO:0050793 regulation of developmental process 9.80E-04 2.26E-01
GO:0043279 response to alkaloid 9.95E-04 2.20E-01
Table 25 Gene ontology categories enriched in genes up-regulated after infection in the European population.
Given their high number, the GOs enriched in genes down-regulated upon infection are reported in
Appendix  table  10  Several  of  them  are  involved  in  biosynthetic/metabolic  processes  and  in
reproduction.  This  possibly  reflects  the  decrease  of  non  essential  biological  processes  upon
infection. 
4.2.2.4.1 Comparison among populations 
The number  of  genes  induced privately  in  each population  or  jointly  in  two,  three  or  all  four
populations is visible in figure 23. We note that the majority of genes is privately expressed in the
African population, based on the higher number of induced genes in this population (see table 20).
Interestingly 65 genes are induced in all populations, of them 47 are up- and 18 down-regulated
upon infection. These genes are natural candidates to understand the D. melanogaster response to
fungal infection. 
Gene ontology categories which are enriched in genes up-regulated in all populations are shown in
table  26.  Interestingly  these  GOs  do  not  seem  directly  involved  in  immunity.  The  only  two
categories  significant  after  multiple-testing  correction  are  "oxidoreducatese  activity"  and
"fatty-acyl-CoA reductase (alcohol-forming activity)". 
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Figure 23 The Venn diagram represents the number of induced genes (both up- and down-regulated) privately in each population or jointly in two or
more populations. The diagram was generated using the R library "Vennerable".
The GOs enriched in genes down-regulated upon infection do not appear interesting. Most of them
are due to circadian genes time, period and vrille (see above).
BIOLOGICAL PROCESS
GO Term Description p-value FDR q-value
GO:0014070 response to organic cyclic compound 3.61E-04 1.00E+00
GO:0055114 oxidation-reduction process 5.40E-04 1.00E+00
GO:0050962 detection of light stimulus involved in sensory perception 6.79E-04 1.00E+00
MOLECULAR FUNCTION
GO Term Description p-value FDR q-value
GO:0016491 oxidoreductase activity 0.0000194 0.0471
GO:0080019 fatty-acyl-CoA reductase (alcohol-forming) activity 0.0000382 0.0463
GO:0003824 catalytic activity 0.000101 0.0821
GO:0016616 oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor 0.000261 0.158
GO:0016620 oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor 0.00032 0.156
GO:0016903 oxidoreductase activity, acting on the aldehyde or oxo group of donors 0.000645 0.261
Table 26  Gene ontology categories enriched in genes up-regulated after infection in all population. Both GOs involved in biological process and
molecular function are reported. 
A clearer  pattern  emerges,  however,  if,  instead  of  looking at  GOs,  we focus  on some specific
induced genes. A subset of genes up-regulated upon infection in all populations is presented in table
27. A first  category of interesting genes is  composed of two Cyp450 genes.  Cyp450 genes  are
known to be involved, among other things, in detoxification (see above). Interestingly Cyp6d2 was
already found to be induced 8 hours after infection and is known to be expressed in the tracheal
system,  a  potential  hotspot  for  fungal  penetration.  On  the  other  side  Cyp6g1 is  known  to  be
involved in detoxification processes and is expressed specifically in  D. melanogaster  malpighian
tubules  (Chung  et  al.  2009).  The  importance  of  detoxification  is  also  highlighted  by  the
up-regulation of three genes that are involved in the phase II metabolism of toxic xenobiotics (see
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above): CG6649, CG9363, CG18578.
The induction of several genes involved in transmembrane transport  could be explained in this
context by the transport processes necessary to excrete metabolised toxic substances (see above).
The  up-regulation  of  genes  involved  in  oxidation-reduction  processes  could  reflect  reactions
involved in the modification of toxic compounds (see above) or possibly the energetic needs of
excretion (Davies et al. 2012). 
CYTOCROMES P450
GENE BIOLOGICAL PROCESS MOLECULAR FUNCTION
CG4373 (Cyp6d2) response to camptothecin electron carrier activity 
CG8453 (Cyp6g1) response to insecticide ... electron carrier activity 
PHASE 2 DETOXIFICATION
GENE BIOLOGICAL PROCESS MOLECULAR FUNCTION
CG6649 glucuronosyltransferase activity metabolic process 
CG9363 glutathione transferase activity glutathione metabolic process
CG18578 glucuronosyltransferase activity. metabolic process 
TRANSPORT
GENE BIOLOGICAL PROCESS MOLECULAR FUNCTION
CG2191 sodium-dependent multivitamin transmembrane transporter activity
CG12787 transporter activity
CG1213 glucose transmembrane transporter activity. transmembrane transport
CG3380 sodium-independent organic anion transmembrane transporter activity response to methotrexate
CG4607 substrate-specific transmembrane transporter activity transmembrane transport
CG31321 transmembrane transport. 
OXID-REDUCTION PROCESSES
GENE BIOLOGICAL PROCESS MOLECULAR FUNCTION
CG17560 nucleotide binding; fatty-acyl-CoA reductase (alcohol-forming) activity
CG17562 nucleotide binding; fatty-acyl-CoA reductase (alcohol-forming) activity
CG12766 alditol:NADP+ 1-oxidoreductase activity. oxidation-reduction process
CG7171 urate oxidase activity allantoin biosynthetic process
CG13091 nucleotide binding; fatty-acyl-CoA reductase (alcohol-forming) activity
CG7724 oxidoreductase activity, acting on CH-OH group of donors oxidation-reduction process
CUTICLE
GENE BIOLOGICAL PROCESS MOLECULAR FUNCTION
CG4784 structural constituent of chitin-based cuticle
CG14534 structural constituent of chitin-based cuticle chitin-based cuticle development
IMMUNITY
GENE BIOLOGICAL PROCESS MOLECULAR FUNCTION
CG9377 serine-type endopeptidase activity
CG10118 (pale) pigmentation ... tyrosine 3-monooxygenase activity 
CG7356 (transglutaminase) hemolymph coagulation; innate immune response 
protein-glutamine gamma-glutamyltransferase
activity 
CG6667 (dorsal) immune response ...
RNA polymerase II regulatory region 
sequence-specific DNA binding ...
Table 27 Subset of genes up-regulated upon infection in all populations. Biological process and molecular function information was obtained in
Flybase. "..." means that only some term reported in Flybase are shown in the table.
A further interesting category is constituted by two genes that code for structural constituents of
cuticle: CG4784 and CG14534, given the importance of cuticle to prevent parasite penetration (see
above). 
Finally  four  immunity  genes  are  found.  Among  them  pale  (CG10118)  and  transglutaminase
(CG7356) are involved in the melanization and coagulation process, respectively (see Introduction).
The other two genes are dorsal (CG6667) that is part of the Toll signalling pathway and CG9377
that is possibly involved in the serine protease cascade up-stream of Toll signalling pathway (see
72
above). 
Conversely no clear pattern appears when looking at genes down-regulated in all populations. Three
genes:  timeless,  period and  vrille are  involved  in  circadian  rhythm and  could  reflect  the  flies
sampling approach (see above). One gene, Cyp18a1 (CG6816) is a member of the Cyp450 family
(see above) and is reported to have a "steroid hydroxylase activity", but could also be involved in
phase one of toxic compounds metabolism. The other two genes, CG13309 and Spds (CG8327), are
related to "multicellular organism reproduction" and to "spermidine biosynthetic process", possibly
reflecting the decrease of biological processes, such as reproduction, which are not necessary for
responding the infection (see above).  The detoxification process appears to be the constituent of
early transcriptional response to B. bassiana infections in D. melanogaster. 
An interesting question is thus weather genes that are induced in all populations have on average a
different expression fold change than genes induced privately in each population. In figure 24 the
absolute fold change value of private and common induced genes is compared for each population.
Figure 24 Box plots of the log2 fold change absolute value of privately and commonly induced genes for each population. (a) African population, (b)
American population, (c) Asian population and (d) European population. The significance of the difference among the two categories of genes for
each population was assessed by performing a Wilcoxon test and the resulting p-value is reported on the top of each graph.
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In all populations common induced genes have on average a significantly higher fold change than
private induced ones.  This pattern is  stronger in the African population,  where many genes are
induced with a low fold change, and weaker in the Asian population, where fewer genes are induced
but with a comparably higher fold change (see figure 24).
One one hand, this is not completely unexpected, as genes with a higher fold change are more likely
to be significant.  On the other hand, it  means that looking at  genes commonly induced among
populations allows us to identify the highly responsive ones (see Discussion).
4.2.2.4.1 Comparison with genes induced eight hours after infection
In table 28, genes induced in one or more populations both at 8 and 24 hours after infection are
shown. In table 29 genes induced both in the treatment analysis 8 hours after infection and in one or
more populations 24 hours after infection are reported.
AFRICA 8 AMERICA 8 ASIA 8 EUROPE 8
AFRICA 24
CG9438 
CG2064 
CG9907 CG4373 CG4373 
AMERICA 24
CG2064 
CG5724 
CG31104 CG4373 CG4373 
ASIA 24
CG15263 
CG4373 CG4373 
EUROPE 24
CG9438 
CG2064 
CG15263 
CG4373
CG6484 
CG6385 
CG4373
Table 28 The table reports genes induced in one or more populations both at 8 and 24 hours after infection; table rows correspond to populations 24
hours after infection, table columns correspond to population 8 hours after infection. Genes induced in all populations 24 hours after infection are
indicated in italic; genes privately induced in the same population both at 8 and at 24 hours are indicated in bold.
We first note that  Cyp6d2 (CG4373) is expressed both in the African and Asian population at 8
hours after infection and in all populations at 24 hours after infection. This is of interest, given its
possible role in detoxification and the reported expression in the tracheal system (see above). 
Paralytic (CG9907) is expressed both at 8 and at 24 hours only in the African population, while
CG6484 and CG6385 in the European. Paralytic has as molecular function "voltage-gated sodium
channel activity" and is involved in several biological processes, among which we find "response to
hypoxia", "response to mechanical stimulus" and "response to pyrethroid" (Flybase). CG6484 has
as  molecular  function  "glucose  transmembrane  transporter  activity"  and  is  involved  in
"transmembrae transport". CG6385 has as molecular function "sarcosine dehydrogenase activity"
and is involved in "oxidation-reduction process". We suggest that that these genes are involved in
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population specific responses to infection and may deserve further investigation.
Cyp6d2 (CG4373) and Smvt (CG2191) are induced both in the treatment analysis at 8 hours and in
all  populations  at  24  hours  after  infection  (table  29).  Smvt  has  as  biological  function
"sodium-dependent  multivitamin transmembrane"  and is  involved in  "transmembrane transport"
(Flybase). It is possible that this gene is important in the transport processes related to excretion
(see above).
AFRICA AMERICA ASIA EUROPE
CG5371 CG2064 CG5371 CG5371
CG2064 CG4373 CG13160 CG2064 
CG13160 CG2191 CG4373 CG13160
CG4373 CG13270 CG6580 CG4373
CG6580 CG30272 CG2191 CG6580
CG2191 CG2191
CG13270
Table 29 The table reports genes induced both in the treatment analysis at 8 hours and in one or more populations at 24 hours after infection; table
columns correspond to population 24 hours after infection. Genes induced in all populations 24 hours after infection are indicated in italic.
4.2.2.4.1 Comparison with genes induced in the micro-array
Genes that are induced both in this analysis and in the micro-array are reported in tables 30 and 31.
In  table  30  genes  induced both  in  one  or  more  populations  in  the  present  analysis  and in  the
micro-array are shown. CG11951 is induced in the American population in the micro-array and in
all populations in the present analysis. Few genes, in bold in table 30, are privately induced in the
same population in the two studies.
AFRICA M AMERICA M ASIA M EUROPE M
AFRICA 24
CG7535
CG10247
CG12758
CG3608
CG11373
CG1539
CG6342
CG11951
CG6342
CG11373
CG8884
CG1244
CG31415
AMERICA 24
CG10247
CG12092
CG12224
CG11951
CG10245
ASIA 24
CG3608
CG12092 CG11951
EUROPE 24 CG10247 CG11951
Table 30 The table reports genes induced in one or more populations both in the microarray and at 24 hours after infection in the RNA sequencing
analysis; table rows correspond to populations 24 hours after infection in the RNA sequencing, table columns correspond to populations in the
microarray study ("M" stands for microarray). Genes induced in all populations in the RNA sequencing are indicated in italic; genes privately induced
in the same population in the two analyses are indicated in bold.
In table 31, we show genes induced both in one or more populations in the RNA sequencing and in
the  micro-array  two-nodes  analysis.  Again  CG11951 is  induced in  all  populations  in  the  RNA
sequencing  and  in  the  micro-array  two-nodes  analysis  and  therefore  may  deserve  further
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investigation.
The African population in the present analysis has more genes in common with the micro-array
study compared to the other populations. This may be due to the extremely high number of induced
genes in the African population in the RNA sequencing analysis.
AFRICA AMERICA ASIA EUROPE
CG11502 CG11893 CG11502 CG11502
CG6342 CG11951 CG11951 CG18135
CG18135 CG31200 CG11951
CG11951
CG11373
CG31200
Table 31 Genes induced both in the micro-array treatment analysis and in one or more populations at 24 hours after infection in the RNA sequencing
are reported; table columns correspond to populations in the RNA sequencing. Genes induced in all populations are indicated in italic.
4.2.2.4.1 Comparison with other studies
In table 32, the number of genes induced both in Roxs04 and in each population in the present
analysis is reported. In table 33, we show genes induced both in DeGreg01 and in all populations in
the  present  analysis.  Looking  at  table  33  the  only  gene  directly  involved in  immunity  is  pale
(CG10118). It has a role in the melanization defence response (see above). CG14516 and CG11951
have a proteolitic activity and may be part of a not yet characterised general defence response to
fungal  infection.  Interestingly  CG11951  was  already  found  to  be  induced  in  the  two-nodes
micro-array analysis (see above).
AFRICA AMERICA ASIA EUROPE
62 39 17 25
Table 32 Number of genes induced both in Roxs04 and in each population in the present analysis.
Urate oxidase (CG7171) is specifically expressed in malpighian tubules where it converts uric acid
into the more soluble compound allantoin (Wu et al. 1989, Wu et al. 1992). Interestingly this gene is
also strongly up-regulated in  D. melanogaster infected by the bacteria Listeria monocytogenes,
although  the  biological  meaning  of  its  induction  is  not  clear  (Chambers  et  al.  2012).  Obp99b
(CG7592) is related to autophagic cell death, possibly suggesting a role for apoptosis in fungal
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immunity.
GENE BIOLOGICAL PROCESS MOLECULAR FUNCTION
CG14516 proteolysis aminopeptidase activity 
CG7171 (Urate oxidase) allantoin biosynthetic process urate oxidase activity
CG9400
CG10118 (pale) melanization
CG11951 proteolysis aminopeptidase activity 
CG11073
CG7592 (Obp99b) autophagic cell death odorant binding 
Table 33 Genes induced both in Roxs04 and in all populations in the present analysis; biological process and molecular function of each gene is
reported as in Flybase when available.
In table 34, the number of genes induced both in DeGreg01 and in each population in the present
analysis is indicated. 
AFRICA AMERICA ASIA EUROPE
88 50 21 54
Table 34 Number of genes induced both in DeGreg01 and in each population in the present analysis
In table 35, genes induced both in DeGreg01 and in all populations in the present analysis are
reported.  The  only  two  genes  directly  involved  in  immunity  are  pale (CG10118) and  dorsal
(CG6667)  (see above). Cyp18a1 (CG6816) and  Cyp6g1 (CG8453) are  members of the Cyp450
family and are likely important in detoxification. Urate oxidase (CG7171), Obp99b (CG7592) and
pale (CG10118) are found in all populations in the present analysis and in Roxs04 and DeGreg01
and are therefore likely to be of key importance in response to fungal infection.
GENE BIOLOGICAL PROCESS MOLECULAR FUNCTION
CG11407 metabolic process long-chain fatty acid transporter activity
CG8453 (Cyp6g1 ) response to DDT ... electron carrier activity 
CG6667 (dorsal ) Toll signalling pathway
CG17560 nucleotide binding; fatty-acyl-CoA reductase (alcohol-forming) activity 
CG7171 (Urate oxidase) allantoin biosynthetic process urate oxidase activity
CG12766 oxidation-reduction process alditol:NADP+ 1-oxidoreductase activity 
CG10118 (pale) pigmentation
CG9649 neurogenesis endopeptidase activity 
CG7592 (Obp99b) autophagic cell death odorant binding 
CG6816 (Cyp18a1) pupation; metamorphosis steroid hydroxylase activity 
Table 35 Genes induced both in DeGreg01 and in all populations in the present analysis; biological process and molecular function of each gene is
reported as in Flybase when available.
4.2.2.4.2 Treatment analysis
In this section we show the expression analysis considering the general effect of treatment.
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4.2.2.4.2 Volcano plot
The volcano plot is shown in figure 25. We note that 3,262 are significantly induced (FDR = 5%),
more than in the population analysis. This is due to the higher power of this analysis (see Materials
and Methods). 
Figure 25 Volcano plots for genes induced 24 hours after infection in the treatment analysis. Genes with significant p-value (FDR 5%) are indicated
in red. 
4.2.2.4.2 Induced genes
Of the 3,262 induced genes, 1,837 are up- and 1,425 down-regulated upon infection. 
4.2.2.4.2 Gene ontology analysis
Due to the high number of significant categories only the ones related to biological process (see
3.2.1.8) are reported here. After multiple testing correction 456 GOs are significantly enriched in
genes up-regulated after infection. Among them 41 are involved in response to stimulus (table 36). 
The importance of sensing and responding to fungal infection is shown as the category "response to
stimulus" has  an extremely low corrected p-value (see table  36).  We find two categories  quite
specific  against  fungal  infection:  "regulation  of  antifungal  peptide  biosynthetic  process"  and
"positive regulation of antifungal peptide biosynthetic process". Nine categories are related to the
tracheal system, supporting the idea that the trachea may be important for the infection and defence
mechanisms. Finally some GOs relate to circadian rhythm, as expected due to the flies sampling
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approach (see above). A subset of the GOs involved in response to stimulus or substance, immunity,
tracheal system and circadian rhythm, are visible in table 36. 
RESPONSE TO STIMULUS OR STRESS
GO Gene ontology category (Flybase) p-value FDR
GO:0050896 response to stimulus 1.97E-47 3.48E-44
GO:0048585 negative regulation of response to stimulus 1.07E-15 9.62E-14
GO:0048584 positive regulation of response to stimulus 7.74E-7 1.96E-5
GO:0006950 response to stress 4.58E-4 5.76E-3
GO:0032101 regulation of response to external stimulus 8.32E-4 9.83E-3
IMMUNITY
GO Gene ontology category (Flybase) p-value FDR
GO:0002810 regulation of antifungal peptide biosynthetic process 2.04E-4 2.92E-3
GO:0006967 positive regulation of antifungal peptide biosynthetic process 2.04E-004 2.93E- 3
GO:0045087 innate immune response 2.63E-4 3.67E-3
GO:0006952 defense response 3.43E-4 4.49E-3
GO:0006959 humoral immune response 6.89E-4 8.26E-3
TRACHEAL SYSTEM
GO Gene ontology category (Flybase) p-value FDR
GO:0007424 open tracheal system development 4.15E-9 1.56E-7
GO:0007427 epithelial cell migration, open tracheal system 1.92E-7 5.39E-6
GO:0035152 regulation of tube architecture, open tracheal system 2.44E-7 6.7E-6
CIRCADIAN RHYTHM
GO Gene ontology category (Flybase) p-value FDR
GO:0007623 circadian rhythm 1.46E-8 4.95E-7
GO:0048512 circadian behavior 1.5E-7 4.4E-6
GO:0042752 regulation of circadian rhythm 1.27E-5 2.59E-4
Table 36 Subset of gene ontology categories significantly enriched in genes up-regulated after infection; for each category p-value and FDR corrected
q-value are reported.
On the other side 82 categories are significantly enriched in genes down-regulated upon infection
after multiple testing correction. Interestingly 25 of them relate to biosynthesis, possibly reflecting
the decrease of non-necessary metabolic processes in the presence of infection (see above). A subset
of GOs involved in biosynthesis and reproduction are shown in table 37. 
GO Gene ontology category (Flybase) p-value FDR
GO:0044710 single-organism metabolic process 1.76E-20 9.32E-17
GO:0006412 translation 2.23E-17 5.92E-14
GO:0032504 multicellular organism reproduction 2.63E-17 4.66E-14
GO:0000003 reproduction 6.64E-17 8.81E-14
GO:0008152 metabolic process 6.54E-14 4.33E-11
GO:0009058 biosynthetic process 6.56E-12 2.90E-09
GO:0006091 generation of precursor metabolites and energy 1.42E-10 5.79E-08
GO:0009059 macromolecule biosynthetic process 1.33E-07 3.70E-05
GO:0006754 ATP biosynthetic process 2.83E-07 7.14E-05
GO:0044283 small molecule biosynthetic process 2.47E-05 3.12E-03
GO:0046390 ribose phosphate biosynthetic process 4.49E-05 4.96E-03
GO:0009260 ribonucleotide biosynthetic process 4.49E-05 4.86E-03
GO:0009152 purine ribonucleotide biosynthetic process 5.18E-05 5.50E-03
GO:0006164 purine nucleotide biosynthetic process 8.24E-05 7.28E-03
Table 37 Subset of gene ontology categories significantly enriched in genes down-regulated after infection.
4.2.2.4.2 Comparison with genes induced eight hours after infection
Genes found to be induced both 8 and 24 hours after infection are reported in table 38. Interestingly
Cyp6d2 (CG4373) is induced both in the 24 hours treatment analysis and in the Asian and European
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populations and treatment analysis 8 hours after infection (see table 38).
AFRICA AMERICA ASIA EUROPE TREATMENT
CG9438 CG4373 CG6385 CG30272
CG2064 CG4373 CG4371
CG31104 CG5371
CG34387 CG2064
CG14446 CG13160
CG9907 CG4373
CG6580
CG2191
CG13270
CG33012
Table  38  Genes  induced  both  in  the  present  analysis  and  in  the  population  and  treatment  analysis  8  hours  after  infection  are  reported.
"TREATMENT" stands for treatment analysis.
4.2.2.4.2 Comparison with genes induced in the micro-array analysis
In  table  39,  we report  the  genes  induced  both  in  the  present  analysis  and  in  the  micro-array.
Interestingly CG11951 is found to be induced both in the present analysis and in the American
population and treatment analysis in the micro-array. 
AFRICA AMERICA ASIA EUROPE TREATMENT
CG5258 CG5345 CG8288 CG15414 CG5345
CG3557 CG2050 CG11373 CG14966 CG4205
CG12602 CG9378 CG12699 CG11876 CG15429
CG3608 CG7380 CG4710 CG14048 CG12602
CG7654 CG5497 CG9108 CG11502 CG18135
CG11373 CG3803 CG6342 CG8884 CG11373
CG32450 CG5582 CG10245 CG1244 CG40002
CG12092 CG15539 CG15088 CG11502
CG10637 CG40002 CG7458 CG10637
CG7535 CG10605 CG5931 CG10605
CG1221 CG6342 CG6342
CG10247 CG6950 CG12758
CG12758 CG12224 CG11893
CG1090 CG7390 CG11951
CG11893 CG11951 CG31200
CG1539
Table 39 Genes induced both in the present analysis and in the population and treatment analysis in the micro-array are reported. 
4.2.2.4.2 Comparison with other studies
The number of genes induced in the present analysis, in Roxs04 and in DeGreg01 are shown in
figure 26. We show that, due to the higher statistical power, more genes are found to be induced in
our analysis than in the two other studies.
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Figure 26 Venn diagram showing the number of genes induced privately in one or jointly in two or all studies; PRESENT stands for the present
analysis, DeGreg01 for (De Gregorio et al. 2001) and Roxs04 for (Roxstrom-Lindquist et al. 2004).
Interestingly the majority of the 67 biological process GOs that are after multiple-testing correction
significantly enriched in genes induced in all studies relates to immunity. The categories with lower
corrected q-values are shown in table 40. Immunity GOs arise in our analysis, but not with major
preponderance and significance than when studying genes induced in all studies. This is probably
due to the fact that immunity GOs are the most significant and preponderant genes found both in
Roxs04 and in De Greg01 (data not shown). The fact that less genes directly involved in immunity
are  found  in  our  study  than  previously  reported  is  of  interest  and  will  be  addressed  in  the
Discussion.
GO Term Description P-value FDR q-value
GO:0006952 defense response 1.65E-17 8.78E-14
GO:0051707 response to other organism 4.87E-16 1.29E-12
GO:0009607 response to biotic stimulus 6.03E-16 1.07E-12
GO:0051704 multi-organism process 7.54E-15 1E-11
GO:0008063 Toll signaling pathway 2.1E-14 2.23E-11
GO:0019730
antimicrobial humoral 
response 2.8E-13 2.48E-10
GO:0006950 response to stress 3.4E-13 2.58E-10
GO:0031347 regulation of defense response 3.6E-13 2.39E-10
GO:0006955 immune response 4.43E-13 2.61E-10
GO:0009617 response to bacterium 9.41E-13 4.99E-10
Table 40 The 10 gene ontology categories with lower FDR corrected q-values are listed; for each GO the p-value and the FDR corrected q-value are
reported. 
4.2.2.4.3 Immunity related induced genes
In the present section, we discuss immunity or defence related genes found to be induced in the
population and/or in the treatment analysis. We limit our survey to genes with an EAGEL value in
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the 60% higher quantile (see Materials and Methods). This is done in order to focus on genes whose
expression change is more likely to be biologically meaningful.
Starting with humoral immunity, induced genes coding for members of the Toll signalling pathway
are shown in table 41. The first notable point is that, due to the higher statistical power, more genes
are found in the treatment analysis than privately in each population. The population which exhibits
the most genes is the African, as could be expected given the higher number of overall induced
genes in this population. Conversely, in the Asian population only one gene is significantly induced,
pointing  to  a  low  induction  of  the  Toll  pathway  in  this  population  at  the  time  point  under
investigation. The only gene that is found in all populations is dorsal (CG6667). This gene is quite
down-stream in the Toll signalling pathway. The up-regulation of  dorsal is of key importance for
the activation of humoral immunity (Lemaitre 1995).
 
Almost all genes reported in table 41 are induced also in Roxs04 and/or in DeGreg01 confirming
the importance of the Toll pathway in anti-fungal immunity.
TOLL SIGNALLING PATHWAY (GO:0008063)       
GENE SYMBOL NAME T AF AM AS EU ALSO IN
CG15066 IM23 Immune induced molecule 23 1.7 1.73 1.81 DeGreg01 & Roxs04
CG16844 IM3 Immune induced molecule 3 0.8 0.93 1.01 Roxs04
CG18279 IM10 Immune induced molecule 10 0.76 1.05 1.16 DeGreg01 & Roxs04
CG6667 dl dorsal 0.44 0.47 0.4 0.52 0.37 DeGreg01
CG6794 Dif Dorsal-related immunity factor 0.39 0.47 0.35 0.33 DeGreg01
CG6134 spz spatzle 0.38 0.4 0.36 DeGreg01 & Roxs04
CG11992 Rel Relish 0.32 0.29 0.3 DeGreg01
CG1857 nec necrotic 0.3 0.33 0.37 DeGreg01 & Roxs04
CG5848 cact cactus 0.21 0.23 DeGreg01 & Roxs04
CG4261 Hel89B Helicase 89B 0.16
CG11709 PGRP-SA Peptidoglycan recognition protein SA -0.2 DeGreg01 & Roxs04
CG5212 Pli Pellino -0.21 -0.27
CG5974 pll pelle -0.29 -0.43 DeGreg01 & Roxs04
Table 41 Genes of the Toll signalling pathway induced in one or more populations and/or in the treatment analysis are shown in the table. When a
gene is significant the log2 fold change in expression is shown. “T” stands for Treatment, “AF” for Africa, “AM” for America, “AS” for Asia and
“EU” for Europe. For each gene is also reported if is found to be induced also in Roxs04 and/or in DeGreg01. All genes are member of the gene
ontology "Toll signalling pathway" (GO:0008063) as reported in Flybase.
Serine proteases and their inhibitors, Serpins, play an important role in immunity: a serine protease
cascade is known to be involved in the activation of the Toll ligand Spätzle (Krem 2002) and could
possibly be important in triggering the melanization and coagulation defense response (Tang 2009). 
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Given their high number, induced genes coding for serine proteases and Serpins are reported. in
Appendix table 11 and table 12 Particularly one serine protease gene, CG9372, deserves further
investigation, as it is up-regulated in the treatment analysis and in all populations and was observed
also in DeGreg01.
In table 42 we show the induced genes coding for members of the Imd signalling pathway. As
expected, fewer genes are found in comparison with the Toll pathway (see above). As discussed in
the Imd pathway is responsive mainly to Gram negative bacteria. Nevertheless, and in agreement
with Roxs04 and DeGreg01, some genes, among which the transcription factor Relish, are found to
be induced in the treatment analysis and in the African and European populations. This indicates
that cross-talks among the two pathways exist. 
IMD SIGNALING PATHWAY (GO:0061057) 
GENE SYMBOL NAME T AF AM AS EU ALSO IN
CG11992 Rel Relish 0.32 0.29 0.3 Roxs04 & DeGreg01
CG9080 Listericin Listericin 0.26 0.54 Roxs04 & DeGreg01
CG7417 Tab2 TAK1-associated binding protein 2 0.15
CG15917 Gbp Growth-blocking peptide -0.26 -0.33
Table 42 Genes coding for members of the Imd pathway induced in one or more populations and/or in the “Treatment” analysis are shown in the
table. When a gene is significant the log2 fold change in expression is shown. All genes are member of the gene ontology "Imd signalling pathway"
(GO:0061057) as reported in Flybase.
To conclude  the  survey of  humoral  immunity  we report  induced genes  coding  for  recognition
proteins and antimicrobial  peptides (table 43). Recognition proteins do not seem to be strongly
induced and are detected almost only in the “Treatment” analysis.
Regarding the genes coding for antimicrobial peptides, we show the induction of Drosomycin-like 5
(CG10812) in the “Treatment” analysis and at low levels. This protein is known to have anti-fungal
activity (Yang 2006). The strong down-regulation of the Drosocin gene in the “Treatment” analysis
and in the African and European populations and of the Diptericin gene in the “Treatment” and in
the American population are also of interest.  Drosocin and  Diptericin are specific against Gram
negative bacteria  (Lemaitre and Hoffmann 2007) and their down-regulation in presence of fungal
infection could indicate that resources may be saved to produce AMPs specific to fungi.
Regarding cellular immunity, we report induced genes coding for complement like proteins (table
44).  These  proteins  recognize the pathogen and trigger  the  phagocytosis  defence response (see
Introduction).
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CATEGORIES AND GENES T AF AM AS EU ALSO IN
RECOGNITION PROTEINS (PGRP)
CG11709 (PGRP-SA) -0.2 DeGreg01 & Roxs04
CG9681 (PGRP-SB1) -0.24 -0.76 DeGreg01
CG32042 (PGRP-LA) 0.16
RECOGNITION PROTEINS (GNBP)
CG13422 (GNBP-like) 0.97 1.12 DeGreg01 & Roxs04
CG12780 (GNBP-like) -0.37 -0.39 DeGreg01 & Roxs04
AMPs
CG10812 (Drosomycin-like 5 ) 0.24 DeGreg01 & Roxs04
CG10816 (Drosocin) -1.29 -1.19 -2.44 DeGreg01
CG12763 (Diptericin) -1.3 -1.76 DeGreg01
CG1365 (Cecropin A1) -0.34 DeGreg01 & Roxs04
Table 43 Genes coding for recognition proteins and antimicrobial peptides (AMP) that are induced in one or more populations and/or in the treatment
analysis are shown in the table. When a gene is significant the log2 fold change in expression is shown. 
These genes do not show a strong induction and are especially absent in the Asian and European
populations,  pointing  possibly  to  a  low  activation  of  phagocytosis  at  the  time  point  under
investigation. 
COMPLEMENT LIKE PROTEINS
GENE T AF AM AS EU ALSO IN
CG7052 (Tep2) 0.18 DeGreg01 & Roxs04
CG7068 (Tep3) 0.25 0.37
CG10363 (Tep4) 0.3 0.35 0.32 DeGreg01 & Roxs04
CG7586 (Mcr,Tep VI) 0.2 0.28
Table 44 Genes coding for complement like proteins that are induced in one or more populations and/or in the treatment analysis are shown in the
table. When a gene is significant the log2 fold change in expression is shown.
Given  their  high  number,  the  induced  genes  coding  for  proteins  involved  in  the  phagocytosis
defence response are shown in Appendix table 13. Once again almost no gene is induced in the
Asian  and  European  populations,  with  the  interesting  exception  of  Pdh  (CG4899)  and  inaC
(CG6518). These two genes are over-expressed in all populations and could therefore be up-stream
in the phagocytosis defence response. Interestingly they are not induced either in DeGreg01 or in
Roxs04.
The induced genes coding for proteins involved in the melanization defence response are shown in
table  45.  The  gene  pale (CG10118)  is  the  most  highly  up-regulated  in  all  populations  and  is
up-stream in the melanin production pathway. This gene is  up-regulated also in  DeGreg01 and
Roxs04 and therefore its  induction  is  a  hallmark  of  the activation of  the  melanization  defence
response. Dorsal, which is part of the Toll signaling pathway, is also involved in the activation of
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the melanization defense pathway (Bettencourt et al. 2004) (table 45). 
MELANIN METABOLIC PROCESS (GO:0006582) and MELANIZATION DEFENSE RESPONSE (GO:0035006) 
GENE SYMBOL NAME T AF AM AS EU ALSO IN
CG10118 ple pale 0.58 0.61 0.59 0.6 0.51 DeGreg01&Roxs04
CG6667 dl dorsal 0.44 0.47 0.4 0.52 0.37 DeGreg01
CG12120 t tan 0.28 0.35
CG1634 Nrg Neuroglian 0.27 0.36
CG3066 Sp7 Serine protease 7 0.27 DeGreg01&Roxs04
CG1768 dia diaphanous 0.25 0.31
CG1511 Eph Eph receptor tyrosine kinase 0.18
CG10697 Ddc Dopa decarboxylase 0.17 DeGreg01&Roxs04
CG42783 aPKC atypical protein kinase C 0.15
CG9366 RhoL Rho-like -0.14
CG8063 yellow-f2 yellow-f2 -0.2 -0.28
CG9792 yellow-e yellow-e -0.21 -0.45
CG9441 Pu Punch -0.26 DeGreg01
CG9889 yellow-d yellow-d -0.3 -0.33
Table 45 Genes coding for proteins involved in the melanization defence response that are induced in one or more populations and/or in the treatment
analysis are shown in the table. When a gene is significant the log2 fold change in expression is shown. All genes are member of the gene ontology
"melanin metabolic process" (GO:0006582) and "melanization defense response" (GO:0035006) as reported in Flybase.
The genes coding for proteins playing a role in the coagulation defence response are shown in table
46. The gene transglutaminase (CG7356) is over-expressed in all populations, pointing to a key role
of its induction in the coagulation process.
COAGULATION (GO:0050817) 
GENE SYMBOL NAME T AF AM AS EU ALSO IN
CG7356 Tg Transglutaminase 0.55 0.59 0.57 0.65 0.4
CG15825 fon fondue 0.41 0.55 0.47 DeGreg01
Table 46 Genes coding for proteins involved in the coagulation defence response that are induced in one or more populations and/or in the treatment
analysis are shown in the table. When a gene is significant the log2 fold change in expression is shown. (De Gregorio et al. 2001, Roxstrom-Lindquist
et al. 2004). All genes are member of the gene ontology "coagulation" (GO:0050817) as reported in Flybase.
We assess two categories of genes which role in immunity has not been well defined. The first
group is the iron binding proteins, mainly belonging to the Cyp450 family (see above) which are
involved among other activities in detoxification of toxic compounds and possibly immunity. Due
to their high number, induced genes coding for iron binding proteins are reported in Appendix table
14. Two Cyp450 genes are up-regulated in all populations: Cyp6d2, that is expressed in the tracheal
system and  Cyp6g1,  that is specific of the malpighian tubules and also observed in DeGreg01.
These two genes possibly play an important role in the detoxification of toxic compounds from the
fungus. The gene pale (CG10118) that is part of the melanization defence response is also present in
Appendix table 14 as it is an iron binding protein. 
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Finally  several  genes  coding  for  proteins  exhibiting  lipase  activity  have  been  proposed  to  be
involved in a not yet characterized defense mechanism DeGreg01. We find them to be induced in
one or more populations (Appendix table 15). Of special interest is CG6675, that is up-regulated in
the treatment analysis and in all populations except the European one and that shows up also in
Roxs04 and DeGreg01. Additionally CG42237 is down-regulated in all populations. 
4.2.3 Genetic analysis of candidate genes
4.2.3.1 Coding region conservation
The distribution of Ka/Ks and Pi(a)/Pi(s) ratios is shown in figure 27 both for shared and private
induced genes. The Ka/Ks ratio is lower for shared genes than for private induced ones, with the
exception of the American population. These results suggest that genes induced in all populations
tend to be more conserved in the coding region than private induced ones. This indicates selective
constraints at the species level due to functional reasons (Nielsen 2005).
A similar  pattern  is  observed  for  the  Pi(a)/Pi(s)  ratios  suggesting  that  the  same  evolutionary
constraints act at the population level. The extremely low values for the Asian private induced genes
is probably a consequence of the sequencing technique. These sequences show a high number of
masked  positions  due  to  residual  heterozygosity  and  therefore  an  almost  zero  level  of
polymorphisms.  The  analysis  of  more  shared  and private  genes  is  needed  in  order  to  test  the
generality of the observed trends (figure 27).
Figure 27 The box plots shows (a) the distribution of Ka/Ks ratios and (b) Pi(a)/Pi(s) ratios for privately and shared induced genes. “Africa” stands
for African privately induced genes, “America” for American privately induced genes, “Asia” for Asian privately induced genes, “Europe” for the
European privately induced genes, “Shared” for genes induced in all populations.
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4.3  EFFECT  OF  WOLBACHIA AND  PARENTAL  PARASITE  EXPOSURE  ON  D.
MELANOGASTER SURVIVAL TO B. BASSIANA 
4.3.1 Effect of the endosymbiont Wolbachia pipientis
4.3.1.1 Wolbachia assessment by PCR
The absence of  Wolbachia in flies exposed to tetracycline was confirmed by PCR. The Wsp W.
pipientis  gene was amplified in the Eg25 and E20 not exposed flies, while no amplification was
detected in tetracycline exposed flies and in the Eg57 not treated flies. On the other hand, the 28S
D. melanogaster ribosomal gene was amplified in cured and not exposed flies from all inbred lines.
The same result was observed in both repetitions of the PCR analysis.
4.3.1.2 First infection experiment
The mean spore concentration in the oil/spore suspension was 3.0 x 108 spores/ml with a standard
deviation of 0.7 x 108 spores/ml (10 independent measurements were performed). The mean spore
density on the ink-jet transparency film was 8,933 spores/mm2 with a standard deviation of 4,428
spores/mm2  (10  independent  measurements  were  performed).  No  vial  was  discarded  due  to
contamination. 
4.3.1.2.1 Mortality three days after treatment
4.3.1.2.1.1 Line Eg25
There  was no difference  in  mortality  among infected  and control  flies  (figure  28a)  (p-value  =
0.255150). Flies bearing Wolbachia suffered significantly higher mortality than cured ones (figure
28b) (p-value = 0.005870). In total the percentage of dead flies was 4.43 %.
87
Figure 28 (a) Box plot representing the number of dead flies per vial during the first three days after treatment for control and infected flies. (b) Box
plot representing the number of dead flies per vial during the first three days after treatment for flies bearing Wolbachia and cured flies.
4.3.1.2.1.2 Line E20
There  was no difference  in  mortality  among infected  and control  flies  (figure  29a)  (p-value  =
0.20990). Flies bearing Wolbachia suffered a significantly higher mortality than cured ones (figure
29b) (p-value = 0.00190). In total the percentage of dead flies was 17.37% 
Figure 29 (a) Box plot representing the number of dead flies per vial during the first three days after treatment for control and infected flies. (b) Box
plot representing the number of dead flies per vial during the first three days after treatment for flies bearing Wolbachia and cured flies.
88
a b
a b
4.3.1.2.1.3 Line Eg57
There  was  no  significant  difference  in  mortality  among  infected  and control  flies  (figure  30a)
(p-value  =  0.153058),  although  more  control  flies  died.  Flies  treated  with  tetracycline  died
significantly more than untreated ones (figure 30b) (p-value = 0.000102) . In total the percentage of
dead flies was 5.97%
Figure 30 (a) Box plot representing the number of dead flies per vial during the first three days after treatment for control and infected flies. (b) Box
plot representing the number of dead flies per vial during the first three days after treatment for flies bearing Wolbachia and cured flies.
4.3.1.2.1.4 Conclusions about mortality three days after treatment
These results are quite interesting. Treatment does not have a significant effect during the first three
days, meaning that flies died most likely because they got stuck to the oil or to the food. Therefore
mortality does not reflect susceptibility to the parasite, but is an indicator of flies fitness or vigour.
Eg25  and  E20  lines  show reduced  mortality  after  being  cured,  possibly  pointing  to  a  cost  of
Wolbachia in flies under stress. Indeed negative effect of W. pipientis in D. melanogaster exposed to
lead has been reported (Wang et al. 2012). On the other side the Wolbachia free Eg57 line exhibits
increased  mortality  after  being  exposed to  tetracycline.  This  points  to  a  negative  effect  of  the
antibiotic on fly fitness. An intriguing hypothesis is that by using the antibiotic we got rid of a
different symbiont or of some components of Drosophila gut microbiota and so reduced the flies'
fitness and vigour (Ridley et al. 2012).
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4.3.1.2.2 Mortality at six days after treatment and later
4.3.1.2.2.1 Linear models
4.3.1.2.2.1.1 Line Eg25
"Log time" and "Time squared" were retained and significant, “Treatment” was significant (table
47).
Log Time Time squared Treatment
p-value  5.75e-11 9.92e-06  9.75e-14 
Table 47 P-values of the significant covariates.
4.3.1.2.2.1.2 Line E20
All time covariates were retained and all but "Log time" were significant (table 48). “Treatment”
was significant.
Time Time squared Treatment
p-value 0.0276 0.0162 <2e-16
Table 48 P-values of the significant covariates.
4.3.1.2.2.1.3 Line Eg57
All time covariates were retained and all were significant with the exception of "Log time" (table
49). “Treatment” was significant.
Time Time squared Treatment
p-value 0.02141 0.00511 1.86e-15
Table 49 P-values of the significant covariates.
4.3.1.2.2.2 Kaplan-Meier survival curves
4.3.1.2.2.2.1 Line Eg25
The Kaplan-Meier survival curve for each flies group is shown in figure 31. Infected flies suffered
higher mortality than control ones; control flies bearing  Wolbachia performed worse than control
flies cured from the endosymbiont.
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Figure 31 Kaplan-Meier plot representing survival curves for all flies groups. Full lines represent infected flies, while dashed lines represent control
flies; red lines represents flies bearing Wolbachia, while blue lines represent cured flies (see legend). 
4.3.1.2.2.2.2 Line E20
The Kaplan-Meier survival curve for each flies group is shown in figure 32.  Infected flies suffered
higher mortality than control ones; control flies bearing  Wolbachia performed worse than control
flies cured from the endosymbiont.
Figure 32 Kaplan-Meier plot representing survival curves for all flies groups. Full lines represent infected flies, while dashed lines represent control
flies; red lines represents flies bearing Wolbachia, while blue lines represent cured flies (see legend). 
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4.3.1.2.2.2.3 Line Eg57
The Kaplan-Meier survival curve for each flies group is shown in figure 33. Infected flies suffered
higher mortality than control ones; flies treated with tetracycline performed worse than untreated
flies.
Figure 33 Kaplan-Meier plot representing survival curves for all flies groups. Full lines represent infected flies, while dashed lines represent control
flies; the blue lines represent flies treated with tetracycline, while the red lines represent untreated flies (see legend). 
4.3.1.2.2.3 Cox hazard model
4.3.1.2.2.3.1 Line Eg25
“Treatment” was significant (p-value = 2.5e-13).
4.3.1.2.2.3.2 Line E20
“Treatment” was significant (p-value = 1.1e-16).
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4.3.1.2.2.3.3 Line Eg57
“Treatment” was significant (p-value = 3.1e-15).
4.3.1.2.2.4 Conclusions about mortality at six days after treatment and later
Wolbachia does  not  appear  to  have  any protective  effect  against  fungal  infection  in  this  study
system. This is not the first  case in which such a result  is found, for example no effect of  W.
pipientis has been reported in D. melanogaster infected by a pathogenic bacteria (Rottschaefer and
Lazzaro 2012). Indeed our results are at odds with a previous study showing a protective effect of
Wolbachia in one  D. melanogaster inbred line infected by  B. bassiana  (Panteleev et al. 2007). A
possible  explanation is  that  the  Wolbachia strains  used in  the two studies  are  different.  Indeed
variation in the antiviral protection of different  Wolbachia strains has been found in  D. simulans
(Osborne et al. 2009).
4.3.1.3 Second Infection experiment
The mean spore concentration in the oil/spore suspension was 3.0 x 108 spore/ml with a standard
deviation of 2.0 x 108 spores/ml (10 independent measurements were performed). The mean spore
density on the ink-jet transparency film was 20,927 spores/mm2 with a standard deviation of 6,103
spores/mm2 (10 independent measurements were performed). Three vials were discarded due to
contamination. 
4.3.1.3.1 Mortality three days after treatment
4.3.1.3.1.1 Line Eg25
There was no difference in mortality among infected and control flies (figure 34, table 50). 
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Figure 34 (a) Box plot representing the number of dead flies per vial during the first three days after treatment for control and infected flies. (b) Box
plot representing the number of dead flies per vial during the first three days after treatment for flies bearing Wolbachia and cured flies. (c) Box plot
representing the number of dead flies per vial during the first three days after treatment for female and male flies.
No difference in mortality was present among flies bearing Wolbachia and cured flies and among
sexes (table 50). In total the percentage of dead flies was 3.81%.
Treatment Wolbachia Sex
p-value 0.588000 0.490000 0.720000
Table 50 P-values of model covariates.
4.3.1.3.1.2 Line E20
There was no difference in mortality among infected and control flies (figure 35, table 51). Flies
bearing Wolbachia suffered a significantly higher mortality than cured flues (figure 35, table 51). 
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Figure 35 (a) Box plot representing the number of dead flies per vial during the first three days after treatment for control and infected flies. (b) Box
plot representing the number of dead flies per vial during the first three days after treatment for flies bearing Wolbachia and cured flies. (c) Box plot
representing the number of dead flies per vial during the first three days after treatment for female and male flies.
Male flies suffered a significantly higher mortality than female flies (figure 35, table 51). In total
the percentage of dead flies was 9.98%.
Treatment Wolbachia Sex
p-value 0.098763 0.000265 0.003282
Table 51 P-values of model covariates.
4.3.1.3.1.3 Line Eg57
There was no significant difference in mortality among infected and control flies, although control
flies suffered a higher mortality than treated ones (figure 36, table 52). 
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Figure 36 (a) Box plot representing the number of dead flies per vial during the first three days after treatment for control and infected flies. (b) Box
plot representing the number of dead flies per vial during the first three days after treatment for flies bearing Wolbachia and cured flies. (c) Box plot
representing the number of dead flies per vial during the first three days after treatment for female and male flies.
Flies treated with tetracycline died significantly more than untreated flies (figure 36, table 52). In
total the percentage of dead flies was 8.17%. 
Treatment Antibiotic Sex
p-value 0.165000 1.84e-05 0.342000
Table 52 P-values of model covariates.
4.3.1.3.1.4 Conclusions about mortality three days after treatment
Again we do not find a significant effect of treatment. Interestingly E20 flies carrying Wolbachia
show a significantly higher mortality than their cured counterpart and Eg57 flies exposed to the
antibiotic die significantly more then the not treated ones. These results confirm the conclusions
drawn from the previous experiment. 
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Conversely Eg25 flies carrying Wolbachia do not suffer a higher mortality than cured ones, as was
the case in the first experiment. The reason for this difference could be the lower mortality (3.81%
compared to 4.43% in the present study), although the difference is not too big. 
Finally we see that E20 males suffer higher mortality than females from the same line. 
4.3.1.3.2 Mortality at six days after treatment and later
4.3.1.3.2.1 Linear model
4.3.1.3.2.1.1 Line Eg25
All time covariates were retained and all were significant with the exception of "Log time" (table
53).  “Treatment”  was  significant;  “Wolbachia”,  the  interaction  “Treatment”  x “Wolbachia”  and
“Sex” were not significant.
Time Time squared Treatment
p-value 0.01780 0.00192 5.25e-13
Table 53 P-values of significant covariates.
4.3.1.3.2.1.2 Line E20
There were two best models, the first one in which "log time" and "time" were retained and the
second one in which "log time" and "time squared" were retained. As the second model has a higher
likelihood, we report here the result for this model (table 54). They are not qualitatively different
from the  ones  obtained using  the  other  model.  "Treatment",  "Wolbachia",  their  interaction  and
"Sex" are significant.
Log Time Time squared Treatment Wolbachia Sex Wolbachia *Treatment
p-value < 2e-16 3.29e-09 < 2e-16 0.0244 0.0335 0.0250
Table 54 P-values of significant covariates.
4.3.1.3.2.1.3 Eg57
There were two best models, the first one in which "log time" and "time" were retained and the
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second one in which "log time" and "time squared" were retained. As the second model has a higher
likelihood, we report here the result for this model (table 55). They are not qualitatively different
from the ones obtained using the other model. “Treatment” and “Sex” were significant.
Log Time Time squared Treatment Sex
p-value < 2e-16 1.98e-12 < 2e-16  0.00473
Table 55 P-values of significant covariates.
4.3.1.3.2.2 Kaplan-Meier survival curves
4.3.1.3.2.2.1 Line Eg25
The Kaplan-Meier survival curve for each fly group is shown in figure 37. Infected flies suffered a
higher mortality than control ones.
Figure 37 Kaplan-Meier plot representing survival curves for all flies groups. Full lines represent infected flies, while dashed lines represent control
flies; red lines represents flies bearing Wolbachia, while blue lines represent cured flies (see legend). 
4.3.1.3.2.2.2 Line E20
The Kaplan-Meier survival curve for each fly group is shown in figure 38. Infected flies suffered
higher mortality than control ones; control flies bearing  Wolbachia performed worse than control
flies cured from the endosymbiont.
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Figure 38 (a) Kaplan-Meier plot representing survival curves for all antibiotic treatment – experimental treatment combinations, full lines represent
infected flies, while dashed lines represent control flies; blue lines represent flies treated with tetracycline, while red lines represent untreated flies
(see legend). (b) Kaplan-Meier plot representing survival curves for all sex – experimental treatment combinations, full lines represent infected flies,
while dashed lines represent control flies; red lines represents males, while blue lines represent females (see legend). 
4.3.1.3.2.2.3 Line Eg57
The Kaplan-Meier survival curve for each flies group is shown in figure 39. Infected flies suffered
higher mortality rate than control ones; flies that were treated with tetracycline performed worse
than untreated flies. Male infected flies died more than female infected flies.
Figure 39 (a) Kaplan-Meier plot representing survival curves for all antibiotic treatment – experimental treatment combinations, full lines represent
infected flies, while dashed lines represent control flies; blue lines represent flies treated with tetracycline, while red lines represent untreated flies
(see legend). (b) Kaplan-Meier plot representing survival curves for all sex – experimental treatment combinations, full lines represent infected flies ,
while dashed lines represent control flies; red lines represents males, while blue lines represent females (see legend). 
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4.3.1.3.2.3 Cox hazard model
4.3.1.3.2.3.1 Line Eg25
“Treatment” was significant (p-value = 2.6e-15).
4.3.1.3.2.3.2 Line E20
“Treatment”, “Wolbachia” and their interaction were significant, “Sex” was not significant (table
56).
Treatment Wolbachia Treatment x Wolbachia Sex
p-value 0.000 0.023 0.023 0.028
Table 56 P-values of the significant covariates.
4.3.1.3.2.3.3 Line Eg57
“Treatment” was significant (p-value = 0.000). “Sex” was significant (p-value = 0.0069).
4.3.1.3.2.4 Conclusions about mortality at six days after treatment and later
We did not find a protective effect of "Wolbachia" for Eg25 flies. On the other hand "Wolbachia"
and "Wolbachia" x "Treatment" interaction were significant for E20 flies. Rather than indicating a
protective effect of Wolbachia this is likely a consequence of the high mortality rate of control flies
bearing the endosymbiont.  In fact if we look at figure 38a we see that E20 control flies carrying
Wolbachia have the highest mortality rate at the 4th day and the highest cumulative mortality up to
the 8th day. If we repeat the survival analysis starting from day 4 instead than from the day 3 then
"Wolbachia" and "Wolbachia" x "Treatment" are not significant any more (p-value respectively:
0.2600 and 0.2500). Therefore we can conclude that as in the first experiment no protective effect of
Wolbachia is observed.
"Sex" is significant for E20 and Eg57 flies. Interestingly in both cases infected males suffered a
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lower mortality than infected females. A similar pattern was found in Tinsley et al. (2006), although
only in the latest phase of infection. Indeed it has been shown that mated females suffer reduced
infection defence (Short et al. 2012). As the females we used were not virgins, this could possibly
explain our findings.
4.3.2 Effect of trans-generational immune priming
4.3.2.1 First infection experiment
The mean spore concentration in the oil/spores suspension was 1.1  108 spore/ml with a standard
deviation of 0.6 108 spore/ml (10 independent measurements were performed).  For the parental
infection the mean spore density on the ink-jet  transparency film was 5,457 spores/mm2 with a
standard deviation of 2,762 spores/mm2 (8 independent measurements were performed). For the
offspring infection the mean spore density on the ink-jet transparency film was 1,735 spores/mm2
with a standard deviation of 558 spores/mm2 (8 independent measurements were performed). No
vial was discarded due to contamination. 
4.3.2.1.1 Mortality three days after treatment
There was no difference in mortality among infected and control flies (figure 40, table 57). 
Treatment Parents Sex
p-value  0.5318  0.5193 0.0741
Table 57 P-values of model covariates.
In total the percentage of dead flies was 8.02%.
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Figure 40 (a) Box plot representing the number of dead flies per vial during the first three days after treatment for control and infected flies. (b) Box
plot representing the number of dead flies per vial during the first three days after treatment for flies from infected and control parents. (c) Box plot
representing the number of dead flies per vial during the first three days after treatment for male and female flies.
4.3.2.1.1.1 Conclusions 
“Treatment” was not significant at this time point, meaning that flies did not die as a consequence
of the infection. Also “Parents” was not significant, meaning that the infection state of the parents
did not have an effect on fly vigour. Finally, “Sex” was marginally significant with males exhibiting
higher mortality than females. 
4.3.2.1.2 Mortality six days after treatment and later
4.3.2.1.2.1 Linear model
There are two best models. In the first one “log time” and “time” are retained, while in the second
“log time” and “time squared”. As the first model has a slightly higher likelihood, the results from
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this model are shown (table 58). The two models give anyway almost identical p-values for all
covariates.
Time Log Time Treatment
p-value 1.52e-15 < 2e-16  < 2e-16
Table 58 P-values of the significant covariates.
4.3.2.1.2.2 Kaplan-Meier survival curves
The Kaplan-Meier survival curve for each flies group is shown in figure 41. Infected flies suffered a
higher mortality than control ones.
Figure 41 Kaplan-Meier plot representing survival curves for all flies groups. Full lines represent infected flies, while dashed lines represent control
flies; red lines represents flies from infected parents, while blue lines represent flies from control parents (see legend). 
4.3.2.1.2.3 Cox hazard model
“Treatment” was significant (p-value = 0.00).
4.3.2.1.2.4 Conclusions
These results suggest that there is no trans-generational immune priming in the study system. This
is  in agreement with a previous  study that  did not find evidence of trans-generational immune
priming in D. melanogaster exposed to bacteria (Linder and Promislow 2009). No immune priming
was found also in ants exposed to B. bassiana (Reber and Chapuisat 2012).
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4.3.2.2 Second infection experiment
The mean spore concentration in the oil/spore suspension was 1.1  108 spore/ml with a standard
deviation of 0.6 108 spores/ml (10 independent measurements were performed). Mean spore density
on ink-jet paper was not recorded for parents and offspring in this experiment and is assumed to be
similar to the values reported for the first experiment. No vial was discarded due to contamination.
4.3.2.2.1 Mortality three days after treatment
 
Control flies died more than infected ones (figure 42, table 59). 
Figure 42 (a) Box plot representing the number of dead flies per vial during the first three days after treatment for control and infected flies. (b) Box
plot representing the number of dead flies per vial during the first three days after treatment for flies from infected and control parents. (c) Box plot
representing the number of dead flies per vial during the first three days after treatment for male and female flies.
Flies from control parents died more than flies from infected parents and male flies more than
female ones (figure 42, table 59). In total the percentage of dead flies was 5.61%.
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Treatment Parents Sex
p-value 0.01211 0.00666 6.77e-05
Table 59 P-values of the significant covariates.
4.3.2.2.1.1 Conclusions 
Control flies suffered higher mortality than treated ones, possibly due to the effect of the oil (see
above).  More  interestingly,  flies  whose  parents  were  exposed  to  the  parasite  suffered  a  lower
mortality  than  the  others.  The  same pattern  was  visible  at  six  days  after  infection  (p-value  =
0.00454).  This possibly points  to  an effect  of priming on fly  vigour:  flies whose parents were
infected are more able to survive a stress situation, but do not show increased survival against the
same pathogen. This hypothesis is interesting and deserves further investigation. Finally “Sex” was
significant with males showing higher mortality than females, as we have seen above.  
4.3.2.2.2 Mortality from three days after treatment and later
4.3.2.2.2.1 Linear model 
All time covariates were retained and significant (table 60). “Treatment” was significant.
Time Log Time Time squared Treatment
p-value  2.96e-05 3.04e-09 0.00103  < 2e-16
Table 60 P-values of the significant covariates.
4.3.2.2.2.2 Kaplan-Meier survival curves
The Kaplan-Meier survival curve for each flies group is shown in figure 43. Infected flies died more
than control ones.
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Figure 43 Kaplan-Meier plot representing survival curves for all flies groups. Full lines represent infected flies, while dashed lines represent control
flies; red lines represents flies from infected parents, while blue lines represent flies from control parents (see legend). 
4.3.2.2.2.3 Cox hazard model
“Treatment” was significant (p-value = 0.00).
4.3.2.2.2.4 Conclusions 
Again we do not see any evidence of immune priming in the study system. These results do not
support  the  presence  of  trans-generational  immune  priming  in  D. melanogaster exposed  to  B.
bassiana.
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5 DISCUSSION
5.1 ASSESSMENT OF SURVIVAL TO B. BASSIANA IN D. MEALANOGASTER POPULATIONS
Variation  in  susceptibility  to  a  generalist  parasite  can  reflect  difference  in  life-history  strategy
and/or  in  immune  investment  between  host  populations  (McDade  2003;  Cornet et  al.  2009;
Horrocks et al. 2012). There is some evidence for an effect of latitude on host immune competence
so that the higher species richness at tropics selects for increased immune investment  (Schemske
2009). Indeed Tinsley and co-workers found lower susceptibility to the entomopathogenic fungus
Beauveria bassiana in tropical Drosophila melanogaster populations (Tinsley et al. 2006). 
Here we assessed susceptibility to B. bassiana in two tropical and two temperate D. melanogaster
populations.  We performed three  independent  infection  experiments  with  two different  parasite
strains, but were not able to detect a significant difference in susceptibility among host populations.
Furthermore, temperate populations performed better than tropical ones, showing lower mortality
both in infection and control treatments. This is likely due to their higher general vigour. A possible
explanation is that the inbred lines used to build the African and Asian out-crossed populations were
kept  in  the  lab  for  longer  than  the  other  lines  and  have  possibly  adapted  to  lab  conditions.
Alternatively, the difference could be due to the environment. Indeed, although flies were kept at
25° C during the experimental procedure, they were reared at 23° C and in temperate-like climatic
conditions. Therefore European and American flies could be better acclimated and as a consequence
more fit.
The absence of variation in parasite susceptibility among host populations could be due to several
reasons. In a first place we used different populations and parasite strains as in Tinsley et al. (2006).
Furthermore we worked with D. melanogaster out-crossed populations instead of F1 crosses. The
use of out-crossed populations, although a closer approximation of natural conditions, introduces
more variance in our measurements. In fact each individual is in principle genetically different from
the others due to recombination, while in F1 crosses all offspring are virtually identical. However,
despite  the  increased  variance,  we  would  expect  a  trend  of  lower  susceptibility  in  tropical
populations. As this is not the case, we are confident that no variance in susceptibility is present in
our  system.  Another  difference  is  that  in  Tinsley's  experiment  control  flies  were  kept  on  food
containing the antifungal agent Nipagin,  while in our case both infected and control flies were
reared  on  Nipagin-free  food.  The  reason  for  our  choice  was  to  assure  homogeneity  among
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experimental groups (see Materials and Methods). It is possible that the variability in mortality
between host genotypes observed in Tinsley et al. (2006) reflects, at least partially, a difference in
vigour among the D. melanogaster genotypes used. 
We used two fungal strains coming from different geographic regions, Malaysia and France, and
isolated from distinct host orders, Diptera and Coleoptera. Naively we expected the tropical strain to
be more virulent against the tropical host populations and the temperate one against the temperate
populations (i.e. local adaptation). In contrast with these expectations, we could not find evidence of
local adaptation in our experiments. 
A possible explanation is that B. bassiana, as a generalist pathogen, is not likely to co-evolve with
any host species or population (Kawecki 1998). On the other hand, local adaptation was not found
even in the case of D. melanogaster and its specific parasitoid Asobara tabida (Kraaijeveld, 1999)
and, to our knowledge, has not been reported for any D. melanogaster – parasite combination. The
absence of such reports is possibly due to the scarce information available about D. melanogaster
ecology and to the difficulty to detect local adaptation (see Introduction). On the other hand, there is
evidence of co-evolution between D. melanogaster and its parasite the sigma virus (Wilfert, 2013).
This supports the hypothesis that local adaptation is likely to exist between  D. melanogaster  and
some of its specific parasites in nature. Local adaptation to a-biotic environment has been found in
D. melanogaster populations, for example in terms of correlation between local climate and ability
to enter in diapause (Williams 2009) or between altitude and dissecation resistance (Parkash 2008). 
While latitude alone does not appear to be a good predictor of host immune competence in our
study system, other environmental variables, such us temperature, humidity or a direct measure of
parasite species richness, could be more informative. For example, fly populations coming from
locations with a rich bacterial community have been found to be less susceptible to the bacteria
Lactococcus  lactis  (Corby-Harris  and  Promislow  2008). Although  ecology  is  important  to
understand  host-parasite  interaction  (Schulenburg et  al.  2009),  we  know  little  about  D.
melanogaster in  the  field.  Including  more  detailed  ecological  information  would  increase  our
precision in testing the effect of the environment on host immune investment and other life history
traits.  
5.2 D. MELANOGASTER TRANSCRIPTIONAL RESPONSE TO B. BASSIANA
The role of host transcriptional  response in  determining the out-come of an infection has been
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highlighted in several studies (Apidianakis et al. 2005; Lovegrove et al. 2006; Okado et al. 2009;
Polesani  et  al.  2010; Moscou et  al.  2011;  Lockyer  et  al.  2012).  Especially  early transcriptional
response seems to distinguish susceptible from resistant host genotypes (Okado et al. 2009; Lockyer
et al. 2012). Here we characterized transcriptional response to  B. bassiana in four out-cross  D.
melanogaster populations at two time points, 8 and 24 hours after infection, both by micro-array (8
hours) and RNA sequencing (8 and 24 hours).
At  the  earliest  time  point  few  genes  were  induced.  While  we  were  not  really  able  to  find  a
meaningful pattern out of the micro-array data, clearer results emerge from the RNA sequencing.
The difference was possibly due to the higher power and lower noise of RNA sequencing, that
appears to be a more suitable approach to identify small changes in gene expression profile (Wang
et al. 2009). 
Among the few genes that showed up at the earliest time point in the RNA sequencing analysis, we
found several members of the cytochrome P450 (Cyp450) family. These genes code for enzymes
that are important for drugs and toxic compounds detoxification.  Other induced genes code for
enzymes that further metabolise toxic substances and for transporters that could be involved in
excretion.  These results  suggest a central  importance of malpighian tubules, an excretory organ
responsible for detoxification in insects (Yang et al. 2007) and recently proposed to play a role in
immunity (Davies et al. 2012), in early response to fungal infection. 
One  cytochrome  P450  gene,  Cyp6d2,  was  significantly  induced  in  the  Asian  and  European
populations at  8 hours after  infection and in all  populations at  the latest  time point.  Cyp6d2 is
specifically expressed in D. melanogaster tracheal system (Chung et al. 2009), a hot-spot for fungal
penetration (Pekrul and Grula 1979; Sahayaraj et al. 2013). Therefore Cyp6d2 could be involved in
detoxification of fungal toxins produced during cuticle penetration and possibly trigger the later
defence response. 
Indeed  B. bassiana is known to produce toxins upon infection (see Introduction) and it has been
shown that  B.  bassiana  infection  affects  detoxifying  enzyme  activity  in  the  insect  Eurygaster
integriceps (Zibaee et  al.  2009). Cyp450s and other detoxification genes have been reported to
degrade fungal and plant toxins in insects (Serebrov et al. 2006; Niu et al. 2008; Després et al.
2007).
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Twenty four  hours  following infection we identified around 3,000 induced genes,  considerably
more than in  previous  studies (De Gregorio et  al.  2001;  Roxstrom-Lindquist et al. 2004).  This
difference is likely due to the superior power of the RNA sequencing technology and to the higher
number of replicates  especially  in  the “treatment analysis”.  These results  indicate that  a  strong
transcriptional response to  B. bassiana  is mounted between 8 and 24 hours after infection in D.
melanogaster.  In the  following we will  focus  on the  transcriptional  response  at  24  hours  after
infection.
The gene  ontology categories  (GOs)  enriched in  genes  up-regulated  upon infection  are  mainly
connected  with  response  to  stimulus  or  regulation  of  some biological  process,  pointing  to  the
importance of sensing and mounting a defence response to the pathogen. On the other hand the GOs
enriched in genes down-regulated upon infection have to do mainly with translation, metabolism,
biosynthesis  and  reproduction,  most  likely  reflecting  the  decrease  in  gene  expression  of  not
essential functions in order to save resources for the defence response. 
Indeed, metabolism reduction has been observed in D. melanogaster upon viral infection (Arnold et
al. 2013) and it has been shown that the activation of the Toll pathway in the fat body at the same
time  induces  immunity  and  reduces  nutrient  storage  and  growth  rate  by  acting  on  the  insulin
signalling (DiAngelo et al. 2009). On the other hand, it is possible that the parasite itself suppresses
host translation machinery in order to impair the defence response (Mohr and Sonenberg 2012).
Further  research  is  needed in  order  to  evaluate  the  importance  of  these  two factors  in  the D.
melanogaster – B. bassiana system.
Notably, only a small minority of the induced genes were directly connected with immunity, while
metabolism and stress response were more represented. Therefore, considering genes involved in
stress response (Davies et al. 2012) and metabolism (Chambers et al. 2012) besides immunity genes
can help us to better understand host response to parasites. On the other hand, in De Gregorio  et al.
(2001) and Roxstrom-Lindquist et al. (2004) immune GOs were the most enriched categories in
induced genes. 
A possible reason for this difference is that we looked at an earlier time point. In fact, although we
choose 24 hours after infection, similarly to De Gregorio et al. (2001) and Roxstrom-Lindquist et al.
(2004), we used a different infection protocol. While in these studies flies were infected by shaking
them in a Petri dish with a sporulating culture of B. bassiana, we applied the more natural and less
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traumatic approach from Tinsley et al. (2006). As our method allows flies to get in contact with
fungal spores at the contaminated vial walls, it likely requires more time for infection to take place
and introduces a delay in comparison with other studies. However, our results are of great interest,
as they depict the early, and less characterised, transcriptional response to fungal infection in  D.
melanogaster. 
Finally, the discrepancy could be due to the use of out-crossed populations instead of inbred lines.
Indeed it has been shown that inbreeding by environmental interaction can affect gene expression in
D. melanogaster (Kristensen et al. 2006) and this  effect  is  likely to  be stronger in the case of
infection, as inbreeding has been reported to increase susceptibility to parasites (Luong et al. 2007;
Ilmonen et al. 2008). This is the first study, to our knowledge, to assess transcriptional response to
infection in D. melanogaster out-crossed populations. Therefore, studies directly comparing inbred
lines and out-crossed populations are required to estimate the effect of inbreeding on genes induced
following infection in D. melanogaster. 
When we compare response to infection among populations we see that there is quite a big variation
in the number of induced genes: from around 1,300 in the African population to around 200 in the
Asian one. Also the fold change of induced genes varies, with the Asian population showing on
average the highest values and the African one the lowest. 
One possible explanation is the higher level of genetic diversity in the African population (Duchen
et al. 2013). As gene expression level is dependent on genetic variation (Gilad et al. 2008), it is
likely that more variability in gene expression and transcriptional response is present in the African
population. This would explain the higher number of induced genes and the lower fold changes, if
different genes are induced in different genotypes. Indeed, variability in gene expression has been
found to be slightly higher in an African compared to a European D. melanogaster population both
for male (Hutter et al. 2008) and female flies (Müller et al. 2011). 
A crucial  result  is  that  despite  the diversity  of transcriptional  response,  all  populations  showed
similar susceptibility to B. bassiana. As we used flies from different generations of the out-crossed
populations for the survival assays and the RNA sequencing, and additionally we pooled the pairs of
replicate populations few generations before performing the second study, it could be questioned if
the results from the two analyses can actually be compared. 
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Despite  these  issues,  as  in  each of  the  survival  assays  a  distinct  generation of  the out-crossed
populations  was  used  and  we  did  not  find  difference  in  susceptibility  to  B.  bassiana,  we  are
confident in relating transcriptional and survival data. 
Our  results  are  interesting  and  show that  not  always  the  number  of  induced  genes  is  a  good
predictor of the ability to survive infection. Polesani et al. (2010) reported a higher number of genes
induced upon infection in a resistant grapevine species than in a susceptible one. On the other hand,
Langevin  et  al.  (2012)  found  a  stronger  transcriptional  response to  infection in  a  susceptible
rainbow trout  genotype  than  in  a  resistant  one.  Therefore,  no  clear  expectation  exists  on  how
transcriptional  response  strength  correlates  with  susceptibility  level  and  the  time  point  after
infection is likely to play an important role. 
A possible reason why a different transcriptional response and the same susceptibility level to  B.
bassiana are observed is that  D. melanogaster populations rely on distinct defence mechanisms.
One  example  is  resistance  and  tolerance  (see  Introduction).  Genetic  variability  can  affect  the
respective level of resistance and tolerance in host populations (Råberg et al.  2007;  Ayres et al.
2008) and influence transcriptional response (Glass et al. 2012; Tai et al. 2013). Further work is
required  to  assess  variability  in  resistance  and  tolerance  to  fungal  infection  between  D.
melanogaster populations and its effect on transcriptional response to parasites.
5.2.1 Genes induced upon infection
Many genes of the Toll pathway and only few genes of the Imd pathway are induced in our study.
This  was  expected,  as  Toll  is  responsive  to  fungi  and  Gram-positive  bacteria,  while  Imd  to
Gram-negative bacteria (Lemaitre and Hoffmann 2007).
Several serine proteases and serpins genes, most of them not reported in De Gregorio et al. (2001)
nor in Roxstrom-Lindquist et al. (2004), were induced. Serine proteases and serpins have regulatory
functions  and  some of  them are  known to  be  involved in  not  yet  well  characterised  cascades
up-stream the  Toll  signalling  pathway and the  melanization  and coagulation  defence  responses
(Lemaitre  and  Hoffmann  2007;  Tang  2009).  Therefore  the  identification  of  new  putative
immune-related proteins of these families is important. Of special interest appears the gene CG9649
that is induced in all populations and in De Gregorio et al. (2001), although its function in immunity
is not yet known.
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Also genes involved in phagocytosis, melanization and coagulation defence responses were found.
Pdh and  InaC,  which  are  required  for  phagocytosis  (Stroschein-Stevenson et  al.  2006),  were
induced in all  populations.  As their  role in this  process is  not  yet  characterised,  they are good
candidates for further research. 
Many members of the Cyp450 family were induced upon infection. This suggests that metabolism
of  toxic  compounds  is  of  importance  in  the  defence  response  both  at  8  and at  24  hours  after
infection. The gene  Cyp6d2 was induced in all populations and is discussed above. Another gene
that attracted our attention was Cyp6g1. This gene is responsive to DDT (Daborn et al. 2002; Le
Goff et al. 2003; Daborn et al. 2007; Schmidt et al. 2010) and mercury ion (Rand et al. 2012) and
was induced in all populations in the present study and in De Gregorio et al. (2001). The wide
chemical  responsiveness  of  Cyp6g1 and  of  other  Cyp450s  in  D.  melanogaster is  reviewed  in
Giraudo et al. (2010) and could reflect their ability to detoxify a broad range of xenobiotics. 
The  genes  Urate  oxidase,  Obp99b and  pale were induced  in  all  populations  and  in  both  De
Gregorio et al. (2001) and Roxstrom-Lindquist et al. (2004). Pale is the only gene directly involved
in immunity, as it codes for an enzyme required in the first phases of the melanization defence
response (De Gregorio et al. 2001). 
Obp99b is known to take part in autophagic cell death (Gorski et al. 2003). Recent studies have
highlighted the importance of autophagy in Drosophila response to intracellular bacteria and viruses
(Schnabel et al. 1991; Zirin and Perrimon 2010; Levine et al. 2011). However, its role in anti-fungal
immunity is not defined yet. 
Urate oxidase codes for an enzyme active in the malpighian tubules where it converts uric acid into
allantonin and it was found to be strongly induced in D. melanogaster upon Listeria monocytogenes
infection (Chambers et al. 2012). However, the role of Urate oxidase, uric acid and allontonin in D.
melanogaster immunity is not yet clear and deserves further investigation. 
Genes induced in all populations show higher fold change compared to genes induced only in one
population. This pattern suggests that looking at genes induced in multiple populations upon the
same stress allows to identify the strongly responsive ones. An alternative explanation is that, due to
power considerations,  genes  that  have a  higher  fold change are more likely to  be significantly
induced in all populations, while genes that have a lower fold change tend to be significant only in
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one population and border-line significant in the others. We found that genes privately induced in
one population are far from significance in the others (data not shown). Therefore we are confident
that these genes are induced in a population specific manner. 
In conclusion we found a relatively low percentage of induced genes directly involved in immunity
in comparison with De Gregorio et al.  (2001) and Roxstrom-Lindquist et al.  (2004). This likely
depends on the earlier  stage  after  infection we investigated.  Genes  induced only in  this  study,
especially the  Cyp450s at 8 and 24 hours and the serine proteases and serpins at 24 hours after
infection,  could  be  involved  in  triggering  the  later  immune  response  and  deserve  further
investigation.  On the other hand, genes induced in more than one study are probably generally
important in transcriptional response to infection and should also be subject of further research.
This is especially true if their role in immunity is not yet well understood, as in the case of Urate
oxidase and Obp99b (see above).
5.2.2 Population genomics results
Commonly induced genes appear to have higher coding region conservation, as indicated by lower
Ka/Ks ratio, than privately induced ones, with the possible exception of American privately induced
genes.  This  would  suggest  that  the  generality  and  the  level  of  induction  of  a  gene  upon
stress/infection is a measure of its biological importance and therefore correlates with the sequence
conservation of the protein it codes for. Nuzhdin et al. (2004) found that gene expression divergence
and non synonimous substitution rate among D. melanogaster and D. simulans are correlated. This
supports the idea that selection acts in a concerted manner on protein sequence and gene expression
level (Lemos et al. 2005). 
5.3  EFFECT  OF  WOLBACHIA AND  PARENTAL  PARASITE  EXPOSURE  ON  D.
MELANOGASTER SURVIVAL TO B. BASSIANA 
The outcome of host-parasite interaction not only depends on the genotype of the two interacting
partners.  Not  taking  into  account  other  factors,  such  host  endosymbionts  and  gut  microbiome
(Haine 2008; Koch and Schmid-Hempel 2012) and trans-generational transfer of immunity (Sadd
and Schmid-Hempel  2007),  can  obscure  the  origin  of  host  variation  in  susceptibility.  Here we
assessed both of these factors in the D. melanogaster – B. bassiana system.
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We did  not  find  a  protective  effect  of  Wolbachia  pipientis  in  D. melanogaster infected  by  B.
bassiana. Our report adds to similar ones showing the same pattern in other host-parasite systems
(Longdon et al. 2012; Rottschaefer and Lazzaro 2012). However, this is at odds with a previous
study showing the opposite result (Panteleev et al. 2007). As discussed above, the difference could
be due to the variation in protective ability among different  W. pipientis strains (Osborne et al.
2009). The mechanism by which W. pipientis mediates protection is not known, although it has been
shown that  Wolbachia density  in  the  head,  the  gut  and the  malpighian  tubules  correlates  with
antiviral protection in  D. simulans  and that strains present at low density do not defend against
viruses (Osborne et al. 2012). It would be interesting to test if a low Wolbachia density in the D.
melanogaster lines used in our experiments could explain the absence of a protective effect.
Wolbachia presence increased mortality of flies from the E20 line during the first three days in both
experiments. As at this time point the effect of B. bassiana was not yet visible and the major cause
of death was sticking to the vial walls or soaking in the oil, we conclude that the ability to survive
was dependent on flies' general vigour and that Wolbachia reduced it in the E20 line.
Indeed, negative fitness effects of W. pipientis have been reported (Fleury et al. 2000; Wang et al.
2012). A similar pattern is present for the D. melanogaster Eg25 line in the first experiment, but not
in the second one. A possible explanation is the lower mortality of the Eg25 line in comparison with
the other two lines, especially in the second experiment. This could make the Wolbachia effect on
flies' vigour, if present, more difficult to detect. 
On the other hand, the antibiotic treatment had a negative effect on flies from the Eg57 line. This
line was naturally Wolbachia free and was used as a control in our study. In both experiments we
found a significantly higher mortality during the first three days in Eg57 flies that were exposed to
tetracycline. As the discrepancy appeared only at this time point, we conclude that it did not have to
do with susceptibility to the parasite, but that it reflected unequal fly vigour. A possible explanation
is that by antibiotic treatment another symbiont or gut microbiome was removed. A negative effect
of depriving D. melanogaster of its gut microbiome has indeed been reported (Ridley et al. 2012). It
should be noted that we exposed tetracycline treated flies to food from their untreated counterpart
for two days before performing the experiments. However, it is possible that this procedure was not
enough to restore a normal gut microbiome. 
If indeed a negative effect of tetracycline on fly vigour exists, it should affect also flies from the
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E20 and Eg25 lines. The fact that E20 and Eg25 flies supplied with the antibiotic exhibited higher
vigour could be explained if the positive effect of removing Wolbachia outweighed the negative one
of tetracycline exposure. However, given the difference in host genotype, endosymbiont and gut
microbiota among  D. melanogaster lines, it is difficult to draw conclusions and more research is
needed to distinguish the effect of each factor and of their interactions. 
An interesting point in our study is that W. pipientis, and possibly fly gut microbiota, affected, if not
susceptibility to B. bassiana, D. melanogaster vigour. It can be questioned if the measure we used
for vigour, namely the number of flies that died sticking to vial walls or soaking in the oil, makes
sense form a biological perspective.  We should probably speak of “ability to cope with abiotic
stress” instead of “vigour”. In the first three days of the experiments flies had to cope with change
in temperature, oily transparency film and absence of preservatives in the food. This was likely a
stressful condition.
It has been shown that there is a genetic correlation for tolerance to different environmental stress
and that stress tolerance is negatively associated with metabolic rate in D. melanogaster (Hoffmann
and Parsons 1989). As Wolbachia can potentially affect the metabolism of its insect host (Brownlie
et al. 2009; Evans et al. 2009), it would be interesting to investigate if it increases metabolic rate in
the D. melanogaster lines used. It should also be tested if our result could be replicated when a
different type of stress is applied. However, no effect of Wolbachia on heat or nutritional tolerance
in D. melanogaster has been identified so far (Harcombe and Hoffmann 2004). 
Finally, in the second experiment we found that infected males from the E20 and Eg57 lines died
significantly later than infected females from the respective lines. This result could be explained by
a report showing that mated females suffer reduction in immune activity in D. melanogaster due to
male seminal fluid components (Short et al. 2012). 
We did not observe trans-generational immune priming in D. melanogaster infected by B. bassiana.
Similar  results  were  found  in  other  study  systems  (Linder  and  Promislow  2009;  Reber  and
Chapuisat 2012). Interestingly, in the second experiment, flies whose parents were exposed to  B.
bassiana exhibited  a  lower  mortality  during  the  first  six  days.  However,  this  trend  was  not
significant overall. A possible explanation is that flies whose parents were exposed to the parasite
had an  increased  ability  to  cope with  stress.  We did  not  observe  the  same pattern  in  the  first
experiment, possibly because a different D. melanogaster out-crossed population was used. 
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It  is  possible  that  we  were  not  able  to  detect  trans-generational  immune  priming  because  we
exposed the offspring to a too high spore density and that this masked the effect of priming. A
second hypothesis is that we selected eggs laid too early after parasite exposure. It has been shown
that in the mealworm beetle Tenebrio mollitor immune challenged females provide their eggs with
antimicrobial activity starting from the fourth day after immune challenge (Zanchi et al. 2012). As
we collected eggs produced during the first two days after priming, it could have been too early to
see an effect.
A third possibility is that we used a too high spore density when priming the parents. In the first
experiment, for which these value were recorded, parents were exposed to a higher spore density
than offspring. Conversely, in other studies working on the same subject, parents were challenged
with a sub-lethal dose or with heat-killed parasites (Roth et al. 2010; Reber and Chapuisat 2012).
Indeed, it has been shown that D. melanogaster primed with heat-killed B. bassiana spores suffers
reduced mortality if subsequently exposed to the living parasite (Pham et al. 2007). Therefore, it
would be interesting to assess if protection acquired in this way could persist through generations.
5.4 OUTLOOK
We did not find an effect of latitude on D. melanogaster susceptibility to B. bassiana and speculate
that other environmental factors, such as local parasite species richness, could better predict host
immune competence.  To test  this  hypothesis,  D. melanogaster populations for which ecological
information is available should be used in future infection experiments. This will help to understand
how ecology shapes immunity in D. melanogaster (Schulenburg  2009).
A drawback of our infection protocol is the low precision in the number of spores to which flies are
exposed, as the use of an airbrush does not allow an exact quantification.  New techniques that
ensure a better determination of infective dose are now available (Farenhorst and Knols 2010) and
should be used in future experiments. 
During the experiment we reared flies on standard media without the anti-fungal agent Nipagin and
the antimicrobial compound propanoic acid. This was done in order to avoid any possible effect on
the infection procedure. However, in the absence of preservatives contamination from commensal
bacteria and fungi occurred, affecting fly mortality and causing some vials to be discarded (see
Material and Methods). As the effect of Nipagin and propanoic acid on B. bassiana has not been
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tested, it should be assessed if their use has indeed negative consequences on the fungus, justifying
the choice of preservatives-free food. Alternatively, flies could be reared on agar molasses plates, as
we observed no contamination in the absence of preservatives when this media was used. Tests
should be performed in order to define the best and more convenient infection protocol.
We found a different set of genes induced after  B. bassiana infection than in  De Gregorio et al.
(2001)  and  Roxstrom-Lindquist et  al.  (2004).  The  most  likely  reason  is  that  we  assessed
transcriptional response at  an earlier  stage,  when fungal infection is  just  perceived,  xenobiotics
compounds  are  recognised  and detoxified,  and immune response  begins  to  be  mounted.  A big
difference is present also among the two time points examined in our study. While at 8 hours only
few genes, mainly involved in detoxification, were induced, a strong response is observed at 24
hours  after  infection.  As  few hours  can  dramatically  change  the  set  of  induced  genes,  further
experiments  should  assess  transcriptional  response  at  multiple  time  points  in  order  to  better
characterise the timing of defence transcriptional response. The development of RNA sequencing
technology will make this approach feasible in the near future. 
We  identified  genes  induced  in  all  host  populations  and  in  De  Gregorio et  al.  (2001)  and/or
Roxstrom-Lindquist et al. (2004). As the role of most of these genes in defence response is not yet
characterised,  we  propose  to  assess  susceptibility  and  immune  response  to  B.  bassiana n  D.
melanogaster mutation  lines,  as  in  Jin  et  al.  (2008).  Future experiments  should  also determine
change in protein level for some candidate genes following infection.
We found higher protein conservation at common than at private genes. However, this analysis was
performed only on a small subset of genes and should be repeated on the full data. Further analysis
should be performed to determine the level of genetic variability at common and private genes both
for coding and regulatory regions, as there is evidence of regulatory evolution for gene expression
(Fraser et al. 2010, Shibata et al. 2010).
As the B. bassiana genome is now available (Xiao et al. 2012), we could map the reads from the
RNA sequencing to  identify parasite  genes  differently  expressed between 8 and 24 hours  after
infection. This will also allow to assess the relationship among host and parasite expression profiles
in different D. melanogaster populations.
We did  not  find  an  effect  of  Wolbachia  on  D. melanogaster  susceptibility  to  fungal  infection.
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However,  Wolbachia affected  fly  fitness  in  one  D.  melanogaster line.  On  the  other  hand,  we
reported  an  effect  of  the  tetracycline  treatment  on  general  fly  vigour  in  a  Wolbachia-free  D.
melanogaster line. This could be a consequence of the loss  of important microbiome components.
Future experiments should aim to characterise the microbiome composition of  D. melanogaster
lines and its effect on fly fitness and susceptibility to parasites, as with next-generation sequencing
technology this analysis is now feasible and practical (Fink et al. 2013). 
We did not find evidence of trans-generational immune priming in D. melanogaster infected with
B. bassiana.  However, it  would be interesting to expose the parents to heat-killed spores, as in
Pham et al. (2007), or to secreted fungal compounds and to assess if trans-generational priming is
present in these cases. As in the mealworm beetle Tenebrio molitor the level of protection conferred
to offspring has been found to depend on the time after parasite exposure (Zanchi et al.  2012),
future experiments should be performed to test if this is the case also in our system. 
5.5 RELEVANCE OF THE PRESENT WORK AND CONCLUSION 
The  present  work  addresses  several  aspects  of  host-parsite  interactions.  We  first  asked  if
susceptibility to the fungal pathogen B. bassiana varies among D. melanogaster populations and if
tropical populations exhibit lower mortality than temperate ones. This question, prompted from the
work of Tinsley et al.  (2006), is of central interest in ecological immunology, the study of how
immunity  is  shaped by ecological  factors  (Schulenburg  et  al.  2009).  We found no variation  in
susceptibility among host populations and no general effect of latitude on host immune competence.
We discuss other factors that could determine immune investment and that should be investigated in
future work.
We looked for  genotype  x genotype  interaction  and local  adaptation  by assessing  two parasite
strains of different geographic origin. There is no evidence of genotype x genotype interaction and
of parasite adaptation to hosts coming from close geographical regions. We hypothesize that the
geographical scale assessed may not allow to identify local adaptation (Kaltz and Shykoff 1998;
Gandon 2002; Kawecki and Ebert 2004; Vos et al. 2009). Furthermore, we discuss that B. bassiana,
as  a  generalist  pathogen,  is not  likely  to  engage  in  co-evolutionary  arms  race  with  its  hosts
(Kawecki 1998).
As change in gene expression profile following parasite exposure depends on the genotype of the
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interacting partners (Riddel et al. 2009), we assessed transcriptional response to B. bassiana in four
D. melanogaster populations and found different numbers of induced genes. We discuss that, as
variation in  gene expression is  dependent  on genetic  variability  (Gilad et  al.  2008),  the higher
number  of  induced  genes  in  the  African  population  may be  due  to  its  higher  level  of  genetic
diversity (Duchen et al. 2013). 
Time is important when looking at transcriptional response to infection and early response has been
found to be a predictor of parasite susceptibility in D. melanogaster (Okado et al. 2009). We found
that, while D. melanogaster expression profile is almost no affected by B. bassiana after 8 hours, a
strong response is mounted 24 hours following infection. We identified early induced genes, mainly
Cyp450s, and discuss their possible role in triggering later immune response.
Gene ontology categories enriched in genes up-regulated after infection are related to stress and
regulation of biological processes,  while categories enriched in genes down-regulated following
infection  are  connected  with  translation,  biosynthesis  and  reproduction.  We  discuss  that,  as
metabolism reduction  has  been  reported  to  accompany  immune  induction  in  D.  melanogaster
(DiAngelo et  al. 2009),  a  trade-off  between  mounting  a  defence  response  and  executing
biosynthetic/reproduction processes is likely to exist.
The genes Urate oxidase, Obp99b and pale are induced in all populations in our study and in both
De Gregorio et al. (2001) and Roxstrom-Lindquist et al. (2004).  Therefore these genes appear to
play a central role in defence response to fungi. We discuss the importance of better characterising
Urate oxidase and Obp99b, as their function in immune defence is not yet clear.
As  there  is  evidence  that  selection  acts  in  a  concerted  manner  on  protein  sequence  and  gene
expression level (Nuzhdin et al. 2004; Lemos et al. 2005), we investigated protein conservation in
genes commonly induced in all populations and found a pattern of purifying selection. As only a
sub-set of private and common genes was assessed, we discuss the importance of repeating this
analysis with the full data-set.
We found no protective effect of W. pipientis in D. melanogaster infected by B. bassiana. Our result
is in agreement with studies performed in different host-parasite systems  (Longdon et al.  2012;
Rottschaefer and Lazzaro 2012). We report a negative effect of Wolbachia on fly vigour in one D.
melanogaster inbreed line. We discuss this result in relation to other studies reporting detrimental
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fitness effects of Wolbachia (Fleury et al. 2000; Wang et al. 2012) and propose a connection with its
ability to influence host metabolism (Brownlie et al. 2009; Evans et al. 2009). 
Trans-generational immune priming does not appear to play a role in D. melanogaster infected by
B. bassiana. This result is in agreement with previous work in other host-parasite systems (Linder
and  Promislow  2009;  Reber  and  Chapuisat  2012).  We  discuss  the  opportunity  to  investigate
immune competence of offspring produced at different time points after parasite-exposure, as it has
been reported that antimicrobial activity provided by Tenebrio molitor immune challenged females
varies with time after immune challenge (Zanchi et al. 2012).
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6 APPENDIX
6.1 Standard fly media preparation
Dissolve 52 g Kobe Agar in 2500 ml Water (Roth) by autoclaving 5 min. at 110°C. In the meantime
add to 8500 ml of purified water:
500 ml Golden Syrup (Grafschafter),
500 g Bio -Polenta (Neuform),
500 g Dry yeast (Uniferm). 
Boil, let cool down to 60 °C and then add:
60 ml propanoic acid (Roth),
16 g Nipagin (Geyer) in 150 ml Ethanol (Roth),
Finally add the dissolved agar. 
Distribute the food in vials or bottles (VWR or K-TK) and let dry at room temperature over-night.
The next day close the vials/bottles with anti-mites stopper and store at 8°C.
6.2 Lines and crosses to build the out-crossed populations
In table 1 the inbreed lines used in the crosses to build the out-crossed populations are reported.
Reciprocal crosses are performed  (see main text).
AFRICA AMERICA ASIA EUROPA
A 84F * A95 M RAL 303 F * RAL 324 M KL1 F * KL2 F E1 F * E2 M
A 95 F * A84 F RAL 324 F * RAL 303 M KL2 F * KL1 F E2 F * E1 M
A 145 F * A157 M RAL 380 F * RAL 391 M KL6 F * KL7 F E11 F * E12 M
A 157 F * A145 M RAL 391 F * RAL 380 M KL7 F * KL6 F E12 F * E11 M
A 184 F * A191 M RAL 427 F * RAL 437 M KL8 F * KL10 F E13 F * E14 M
A 191 F * A184 M RAL 437 F * RAL 427 M KL10 F * KL8 F E14 F * E13 M
A 229 F * A377 M RAL 555 F * RAL 732 M KL11 F * KL12 F E15 F * E16 M
A 377 F * A229 M RAL 732 F * RAL 555 M KL12 F * KL11 F E16 F * E15 M
A 384 F * A398 M RAL 774 F * RAL 820 M KL19 F * KL20 F E17 F * E18 M
A 398 F * A384 M RAL 820 F * RAL 774 M KL20 F * KL19 F E18 F * E17 M
RAL 852 F * RAL 705 M KL21 F * KL22 F E19 F * E20 M
RAL 705 F * RAL 852 M KL22 F * KL21 F E20 F * E19 M
Table 1 Lines used in the crosses to build the out-crossed populations. “M” stays for male and “F” for females.
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6.3 Microarray protocols 
These protocols come with minor modifications from a previous one written by Prof. Baines in
2007  and  are  based  on  the  ones  provided  by  the  Drosophila  Resource  Centre  (DGRC)
(http://dgrc.cgb.indiana.edu) and Corning/Promega (http://www.corning.com). A list of the kits used
and the composition of the Pre-hybridization and Washing Solutions are reported at the end. 
6.3.1 RNA extraction protocol
This protocol was used for RNA extraction form frozen flies.
1. Collect all  the frozen flies in one Eppendorf tube, add 600  μl Trizol and grind the flies
completely.
2.  Add 400 μl Trizol; mix by inverting and incubate at room temperature for 5 minutes.
3. Centrifuge 12,000 rcf at 4°C for 10 minutes, transfer the supernatant to a clean tube.
4. Add 200 μl chloroform, mix well by shaking the tubes vigorously for 15 seconds by hand,
incubate at room temperature for 3 minutes.
5. Centrifuge 12,000 rcf at 4°C for 10 minutes, transfer the aqueous (upper) phase to a clean
tube. 
6. Add 500  μl isopropanol, mix thoroughly and incubate at room temperature for exactly 10
minutes. 
7. Centrifuge 12,000 rcf at 4° C for 10 minutes, remove supernatant (a clearly-visible white
pellet should remain). 
8. Wash the pellet with 1 ml 75% ethanol prepared with RNAse-free water.
9.  Centrifuge 12,000 rcf at 4° C for 10 minutes. 
10. The sample can now be stored at -20° C overnight (up to 3-4 weeks). 
11. Remove the ethanol completely and dry 5-10 minutes under the hood. Do not over-dry or
samples may be difficult to resuspend. 
12. Resuspend the pellet in 30  μl of RNAse-free water. Dissolving may be aided by several
tapping + brief centrifugation's and/or heating at 37°-55° until dissolved. 
13. Assess RNA concentration with Nanodrop after vortexing and brief centrifugation.
14. (Run 1 μl on a gel, rRna bands should be visible). 
15. You should be left with 29 (or 28)  μl of sample at a concentration of 4-5  μg/μl. This is
enough for two hybridizations. 
16. Proceed directly to First-strand cDNA Synthesis.
6.3.2 First-strand cDNA Synthesis
This protocol was used to synthetise first-strand cDNA from RNA.
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1. Take two tubes and label them: 555 and 647, each will be used for a different dye. Add to the
tubes in this order: 
a) DEPC treated water; volume = 18 μl - X μl – 2μl,
b) Hexomere random primers (2.5 μg/μl); volume = 2 μl,
c) Purified RNA; volume = X μl containing 25-30 μg of RNA. 
2. Incubate at 70°C for 5 minutes, quick chill on ice for 1 minute and briefly centrifuge again. 
3. Add the following to each tube in this order. 
a) 5 x First-Strand Buffer Volume = 6 μl
b) 0.1 DTT Volume = 1.5 μl
c) dNTP mix Volume = 1.5 μl
d) RnaseOUT (40U/uL) Volume = 1 μl
e) SuperScriptTM III RT (400U/μl) Volume = 2 μl
Final Volume = 30 μl
4. Mix gently and collect the contents of each tube by briefly centrifugation. Incubate at 46°C
for 3 hours. 
5. Proceed directly to Hydrolysis and Neutralization. 
6.3.3 Hydrolysis and Neutralization
This protocol was used to degrade the original RNA.
1. Add 15 μl of 1 N NaOH to each reaction tube, mix thoroughly. 
2. Incubate at 70 °C for 10 minutes. 
3. Add 15 μl of 1N HCl immediately after the 10 minutes incubation to neutralize the pH, mix
gently and centrifuge briefly. 
4. Proceed directly to Purifying First-Strand cDNA. 
6.3.4 Purifying First-Strand cDNA 
This protocol was used to remove unincorporated dNTPs by ethanol precipitation.
1. Add 24 μl 3 M Sodium Acetate, pH 5.2 and 2 μl glycogen. 
2. Add 360 μl ice-cold 100% ethanol and mix by vortexing. 
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3. Place at -20° C for at least 1 hour, sample can be incubated over-night.
4. Centrifuge  at  14,000  rcf  at  4°  C  for  20  minutes.  Carefully  remove  and  discard  the
supernatant;  use  pipette,  not  trash the supernatant  because the pellet  is  not  fixed  to  the
bottom.
5. Wash the pellet  with 1 ml 75% ethanol  and centrifuge at  14,000 at  4°C for  2  minutes.
Carefully remove and discard the supernatant; use pipette, not trash the supernatant because
the pellet is not fixed to the bottom.
6. Centrifuge at 14,000 rcm at 4° C for 1 minute more and remove again the supernatant with
the pipette.
7. Dry the sample  in  the  hood for  10-15 minutes,  sample  will  turn  from white  to  viscous
(glass-like) when ready. Avoid over drying, as it will be harder to resuspend the samples.
8. Resuspend the samples in 5 μl of 2 X Coupling Buffer, vortex thoroughly to resuspend and
centrifuge quickly.
9. Proceed directly to Labelling with Fluorescent Dye.
6.3.5 Labelling with fluorescent Dye
This protocol was used to label the amino-modified cDNA with the Alexa Fluor dyes. The dyes or
the already labelled cDNA were not exposed to direct sun or overhead light
1. Remove the Alexa Fluor dye vials from -20°C storage. 
2. Add 2 μl of DMSO and 3 μL DEPC-treated H2O directly in each dye vial (2  μl)  and mix
thoroughly. Add it to the sample tube to get a total volume of 10 μl. 
3. Mix samples by vortexing, centrifuge briefly and incubate at room temperature in the dark
for 1-3 hours. 
4. While waiting prepare a fresh Prehybridization solution and incubate it at 42 °C.
5. Proceed directly to Purification of Labeled cDNA. 
6.3.6 Purifying Labelled cDNA
This protocol was used to purify the labelled cDNA. 
1. Add 700  μl of  Binding Buffer  to  the  reaction  tubes  containing  the  labeled  cDNA from
Coupling. Vortex briefly and centrifuge shortly to mix. 
2. Each Low-Elution Volume Spin Cartridge is pre-inserted into a collection tube. For multiple
reactions, clearly label each collection tube and then load the cDNA/Binding Buffer solution
directly onto the Spin Cartridge.
3. Centrifuge  at  3,300  rcm  for  1  minute.  Remove  the  collection  tube  and  discard  the
flow-through. 
4. Place the Spin Cartridge in the same collection tube and add 600 μl of wash Buffer to the
column. 
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5. Centrifuge at maximum speed for 30 seconds. Remove the collection tube and discard the
flow-through. 
6. Place the Spin Cartridge in the same collection tube and centrifuge at maximum speed for 30
seconds to remove any residual Wash Buffer. Remove the collection tube and discard it. 
7. Place the Spin Cartridge onto a new amber collection tube and label it. 
8. Add 20 μl of DEPC-treated water to the centre of the Spin Cartridge and incubate at room
temperature for 1 minute.
9. Centrifuge  at  maximum  speed  for  1  minute  to  collect  the  purified  cDNA.  The  eluate
contains your purified cDNA.
10.Vacuum centrifuge for 30 minutes. 
6.3.7 Prehybridization
This protocol was used to prepare the arrays for the hybridization.
1. Warm Prehybridization solution to 42° C. 
2. Immerse arrays in Prehybridization Solution and incubate at 42° C for 45-60 minutes.
3. Transfer prehybridized arrays to Wash Solution 3 and incubate at ambient temperature
 (22° C to 25 ° C) for 5 minutes. 
4. Repeat step 3. 
5. Transfer arrays to a centrifuge tube filled with RNAse-free water at ambient temperature for
30 seconds. 
6. Dry  arrays  by  centrifugation  at  2,500  rcf  for  2  minutes.  Keep  arrays  in  a  dust  free
environment while completing the preparation of the hybridization solution. Label array at
the bar code and write down the bar code of each array. 
6.3.8 Hybridization
This protocol was followed to hybridize the labelled cDNAs on the array.
1. Prepare Hybridization solution. The following volumes are enough to resuspend one sample:
Nuclease free water: 8,4 μl 
Blocking agent 100 x : 1,1 μl 
2x Hi-RPM Hybridization Buffer : 55 μl 
2 Resuspend each of the two samples to be competitively hybridized in 40 μl of hybridization
solution; let them 3 minutes at room temperature, then vortex and briefly centrifuge.
3. Incubate the labelled cDNA solution at 95° C for 3 minutes, protecting samples from light
and then let them 1 minute on ice. 
4. Centrifuge the cDNA at 13,500 rcf for 2 minutes to collect condensation. 
5. Transfer the two samples to be competitively hybridized in one tube (one in other, total
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volume around 80 μl ), vortex and briefly centrifuge. 
6. Place array in Corning Hybridization Chamber (make sure to fill the two moisturising wells
with 10 μl H2O each). Pipet the label cDNA gently up and down and then transfer onto the
surface of the printed side of the slide. Carefully place the cover glass on the array. Avoid
trapping air bubbles between the array and the cover glass. Small air bubbles that do form
usually dissipate during hybridisation. Assemble the chamber. Incubate the chamber-array at
42° C for 16-18 hours in a water bath. 
6.3.9 Post-Hybridization Washes
These washes were performed after hybridization to prevent unspecific signal.  Arrays were not
allowed to dry out between washes, as this would have irreversibly increased background levels.
Multiple containers were utilized to perform the washes in the most efficient manner. All containers
and the volumes of washing solutions were prepared before starting the procedure.
Containers required:
-Wash Solution 1: 2
-Wash Solution 2: 2
-Wash Solution 3: 5
-Wash Solution 4: 1
1. Disassemble the hybridization chambers.
2. Immerse arrays in Wash Solution 1 at 42° C (immerse cuvette in the 42° C bath 1 hour before
starting) until the coverslip moves freely away from the slide ( around 3-4 minutes).
3. Transfer arrays to fresh Wash Solution 1 at 42° C for 5 minutes.
4. Transfer arrays to Wash Solution 2 at room temperature for 5 minutes.
5. Repeat step 4.
6. Transfer arrays to Wash Solution 3 at room temperature for 1 minute.
7. Repeat Step 6 four times.
8. Rinse arrays in Wash Solution 4 for 10 seconds.
9. Dry arrays by centrifugation at 1,600 rcf for 2 minutes.
10. Store arrays in light-proof container until ready to scan.
6.3.10 Commercial kits used
The  following  materials  are  supplied  with  the  Core  Module  from  Invitrogen  (Cat.  Number
L1014-02):
1. Random hexamers 
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2. dNTP mix, including amino-modified nucleotides 
3. 5x First-Strand Buffer 
4. RnaseOUT 
5. SuperScriptTM Reverse transcriptase (RT) 
6. 0.1 M DTT 
7. DEPC treated H2O 
8. 2x Coupling Buffer 
9. DMSO 
The following materials are supplied with the Purification Module from Invitrogen (Cat. Nummer
45-0042):
21.S.N.A.P. column(s) and clear collection tube(s) 
22.Amber collection tube(s) 
23.Loading Buffer with isopropanol added 
24.Wash Buffer with ethanol added.
The following materials are supplied with the Alexa Flour 555 and Alexa Fluor 647 Reactiv Dye
DecaPacks from Invitrogen (Cat. Number A-32755):
25.Alexa Fluor 555 
26.Alexa Fluor 647 
2x Hi-RPM Hybridization Buffer is from Agilent (Cat. Number: 5190-0403 )
The following material  is  supplies with  the Pronto! universal microarray hybridisation kit  from
Corning (Cat. Number: 40026):
Blocking agent 100x
6.3.11 Prehybridization and washing solutions
Solutions were prepared following the UltraGAPS Coated slides Instruction Manual, Corning Life
Science (http://www.corning.com). For all solution double-distilled water (ddH2O) was used. 
-Prehybridization Solution: 5 x SSC, 0.1% SDS and 0.1 mg/ml BSA
-Wash Solution 1: 2 x SSC, 0.1% SDS
-Wash Solution 2: 0.1 x SSC, 0.1% SDS
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-Wash Solution 3: 0.1 x SSC
-Wash Solution 4: 0.01 x SSC 
6.4 Micro-array hybridisation scheme
COMPARISON SAMPLE 1 SAMPLE 2 COMPARISON SAMPLE 1 SAMPLE 2
1 Africa 1 I Africa 1 C 13 Africa  2 I Africa 2 C
2 America 1 I America 1 C 14 America 2 I America 2 C
3 Asia 1 I Asia 1 C 15 Asia 2 I Asia 2 C
4 Europe 1 I Europe 1 C 16 Europe 2 I Europe 2 C 
5 Africa 1 I America 1 I 17 Africa 2 I America 2 I
6 America 1 I Asia 1 I 18 America 2 I Asia 2 I
7 Asia 1 I Europe 1 I 19 Asia 2 I Europe 2 I
8 Europe 1 I Africa 1 I 20 Europe 2 I Africa 2 I
9 Africa 1 C America 1 C 21 Africa 2 C America 2 C
10 America 1 C Asia 1 C 22 America 2 C Asia 2 C
11 Asia 1 C Europe 1 C 23 Asia 2 C Europe 2 C
12 Europe 1 C Africa 1 C 24 Europe 2 C Africa 2 C
Table 2 The table reports the comparisons among all population and treatment combinations. “I” stands for infected and “C” for controls. For each
comparison two hybridisations (dye swaps) were performed.
6.5 Fly vials used for RNA sequencing
VIAL POPULATION TREATMENT VIAL POPULATION TREATMENT VIAL POPULATION TREATMENT
1 AF C 25 AM I08 49 AS I24
2 AF C 26 AM I08 50 AS I24
3 AF C 27 AM I08 51 AS I24
4 AF C 28 AM I08 52 AS I24
5 AF C 29 AM I08 53 AS I24
6 AF C 30 AM I08 54 AS I24
7 AF I08 31 AM I24 55 EU C
8 AF I08 32 AM I24 56 EU C
9 AF I08 33 AM I24 57 EU C
10 AF I08 34 AM I24 58 EU C
11 AF I08 35 AM I24 59 EU C
12 AF I08 36 AM I24 60 EU C
13 AF I24 37 AS C 61 EU I08
14 AF I24 38 AS C 62 EU I08
15 AF I24 39 AS C 63 EU I08
16 AF I24 40 AS C 64 EU I08
17 AF I24 41 AS C 65 EU I08
18 AF I24 42 AS C 66 EU I08
19 AM C 43 AS I08 67 EU I24
20 AM C 44 AS I08 68 EU I24
21 AM C 45 AS I08 69 EU I24
22 AM C 46 AS I08 70 EU I24
23 AM C 47 AS I08 71 EU I24
24 AM C 48 AS I08 72 EU I24
Table 3 Scheme indicating the number of vials for each population – treatment combination. "AF" stands for Africa, "AM" for America,"AS" for Asia
and "EU" for Europe. "C" stands for control, "I08" for 8 hours infection and "I24" for 24 hours infection. 
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6.6 PCR conditions
NAME SEQUENCE Tm
28sF3633 TAC CGT GAG GGA AAG TTG AAA 58 °C 
28sR4076 AGA CTC CTT GGT CCG TGT TT 58 °C 
Wsp81F TGG TCC AAT AAG TGA TGA AGA AAC 55 °C 
Wsp691R AAA AAT TAA ACG CTA CTC CA 55 °C 
Table 4 Primers used to amplify the Wsp and the 28S gene.
CYCLES TEMPERATURE TIME
1x 95° C 5 m
30 X 95°C 20 s
X° C 1 m
72° C Y s
1 x 72° C 10 m
Table 5 PCR instructions for PCR reactions; “s” stands for seconds and “m” for minutes, X is 57° C for Wsp and 57° C for 28S; Y is 38 s for Wsp and
45 s for 28S.
COMPONENT VOLUME
H2O 16.12 μl
10x PCR Buffer 2.5 μl
Mg 50 mM 1 μl
dNTPs (12.5 mM) 0.25 μl
Taq 0.13 μl
5’ primer (10 mM) 2 μl
3’ primer (10 mM) 2 μl
Genomic DNA (500ng/μl) 1 μl
Total 25 μl
Table 6 Components of PCR reactions.
6.7 Gene Ontology analysis at 8 hours after infection
8 HOURS INFECTION AMERICA (FUNCTION)
GO Term Description p-value FDR q-value
GO:0016491 oxidoreductase activity 1.40E-04 3.40E-01
CONTROL FLIES AMERICA (PROCESS)
GO Term Description p-value FDR q-value
GO:0045103 intermediate filament-based process 2.77E-04 1.00E+00
GO:0045104 intermediate filament cytoskeleton organization 2.77E-04 7.35E-01
GO:0060052 neurofilament cytoskeleton organization 2.77E-04 4.90E-01
GO:0046684 response to pyrethroid 2.77E-04 3.67E-01
CONTROL FLIES AMERICA (FUNCTION)
GO Term Description p-value FDR q-value
GO:0005248 voltage-gated sodium channel activity 8.31E-04 1.00E+00
CONTROL FLIES AMERICA (COMPONENT)
GO Term Description p-value FDR q-value
GO:0034706 sodium channel complex 5.54E-04 4.86E-01
GO:0001518 voltage-gated sodium channel complex 5.54E-04 2.43E-01
8 HOURS INFECTION ASIA (PROCESS)
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GO Term Description p-value FDR q-value
GO:1901563 response to camptothecin 3.69E-04 1.00E+00
CONTROL EUROPE (FUNCTION)
GO Term Description p-value FDR q-value
GO:0008480 sarcosine dehydrogenase activity 1.85E-04 4.48E-01
GO:0046997 oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor 1.85E-04 2.24E-01
GO:0004047 aminomethyltransferase activity 7.39E-04 5.98E-01
Table 7 Gene ontology categories enriched in induced genes. "PROCESS" stays for ontology categories related to biological process, "FUNCTION"
for ontology categories related to molecular function and "COMPONENT" for ontology categories related to cellular and extra-cellular component.
For each category p-value and false discovery rate corrected q-value are reported. 
6.8 Gene Ontology analysis at 24 hours after infection
RESPONSE TO STIMULUS OR SUBSTANCE
GO Term Description p-value FDR q-value
GO:0050896 response to stimulus 2.40E-22 1.27E-18
GO:0009605 response to external stimulus 2.59E-17 1.96E-14
GO:0042221 response to chemical stimulus 3.33E-17 2.21E-14
GO:0048583 regulation of response to stimulus 1.16E-11 2.55E-09
GO:0048585 negative regulation of response to stimulus 6.16E-009 6.80E-007
GO:0010033 response to organic substance 1.68E-08 1.59E-06
GO:0014070 response to organic cyclic compound 3.92E-07 2.60E-05
GO:0097305 response to alcohol 7.25E-07 4.00E-05
GO:0051716 cellular response to stimulus 1.10E-006 5.94E-005
GO:0009628 response to abiotic stimulus 1.58E-05 6.20E-04
GO:1901700 response to oxygen-containing compound 1.58E-05 6.17E-04
GO:0009719 response to endogenous stimulus 2.74E-004 6.85E-003
GO:0045471 response to ethanol 3.90E-05 1.33E-03
GO:0009607 response to biotic stimulus 2.68E-004 6.77E-003
GO:0017085 response to insecticide 1.39E-004 4.03E-003
GO:0001964 startle response 9.21E-004 1.80E-002
IMMUNITY
GO Term Description p-value FDR q-value
GO:0019730 antimicrobial humoral response 9.17E-05 2.78E-03
GO:0051707 response to other organism 2.11E-04 5.72E-03
GO:0009636 response to toxic substance 4.23E-04 9.43E-03
GO:0008063 Toll signaling pathway 7.15E-04 1.44E-02
GO:0006955 immune response 4.28E-04 9.50E-03
CIRCADIAN 
GO Term Description p-value FDR q-value
GO:0007623 circadian rhythm 1.48E-10 2.71E-08
GO:0048512 circadian behavior 4.35E-09 5.12E-07
GO:0022410 circadian sleep/wake cycle process 1.63E-04 4.58E-03
TRACHEAL SYSTEM
GO Term Description p-value FDR q-value
GO:0007424 open tracheal system development 5.37E-05 1.75E-03
GO:0035152 regulation of tube architecture, open tracheal system 2.19E-04 5.85E-03
Table 8 Subset of gene ontology categories enriched in genes up-regulated after infection in the African population. For each category p-value and
false discovery rate corrected q-value are reported. 
GO Term Description p-value FDR q-value
GO:0022904 respiratory electron transport chain 7.20E-014 3.82E-010
GO:0022900 electron transport chain 2.46E-013 6.52E-010
GO:0044710 single-organism metabolic process 2.51E-012 4.44E-009
GO:0006091 generation of precursor metabolites and energy 5.69E-011 7.55E-008
GO:0032504 multicellular organism reproduction 9.34E-011 9.90E-008
GO:0000003 reproduction 2.49E-010 2.20E-007
GO:0055114 oxidation-reduction process 1.34E-008 1.02E-005
GO:0006123 mitochondrial electron transport, cytochrome c to oxygen 2.44E-008 1.62E-005
GO:0006120 mitochondrial electron transport, NADH to ubiquinone 2.73E-008 1.61E-005
GO:0015985 energy coupled proton transport, down electrochemical gradient 8.28E-007 4.39E-004
GO:0015986 ATP synthesis coupled proton transport 8.28E-007 3.99E-004
GO:0006754 ATP biosynthetic process 3.97E-006 1.75E-003
GO:0009206 purine ribonucleoside triphosphate biosynthetic process 1.37E-005 5.58E-003
GO:0009145 purine nucleoside triphosphate biosynthetic process 1.37E-005 5.18E-003
GO:0009201 ribonucleoside triphosphate biosynthetic process 1.80E-005 6.35E-003
GO:0009142 nucleoside triphosphate biosynthetic process 1.80E-005 5.95E-003
GO:0046034 ATP metabolic process 2.98E-005 9.31E-003
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GO:0035092 sperm chromatin condensation 3.38E-005 9.95E-003
GO:1901566 organonitrogen compound biosynthetic process 3.71E-005 1.03E-002
GO:0044281 small molecule metabolic process 9.60E-005 2.54E-002
GO:0046390 ribose phosphate biosynthetic process 2.03E-004 5.14E-002
GO:0009260 ribonucleotide biosynthetic process 2.03E-004 4.90E-002
GO:1901659 glycosyl compound biosynthetic process 2.79E-004 6.43E-002
GO:0042455 ribonucleoside biosynthetic process 2.79E-004 6.16E-002
GO:0009163 nucleoside biosynthetic process 2.79E-004 5.91E-002
GO:0006818 hydrogen transport 5.89E-004 1.20E-001
GO:0015992 proton transport 5.89E-004 1.16E-001
GO:0009152 purine ribonucleotide biosynthetic process 5.89E-004 1.12E-001
GO:0042451 purine nucleoside biosynthetic process 7.29E-004 1.33E-001
GO:0046129 purine ribonucleoside biosynthetic process 7.29E-004 1.29E-001
GO:0006164 purine nucleotide biosynthetic process 7.39E-004 1.26E-001
GO:0050953 sensory perception of light stimulus 8.39E-004 1.39E-001
GO:0007601 visual perception 8.39E-004 1.35E-001
GO:0009165 nucleotide biosynthetic process 9.07E-004 1.41E-001
Table 9 Gene ontology categories enriched in genes down-regulated after infection in the African population. For each category p-value and false
discovery rate corrected q-value are reported. 
GO Term Description p-value FDR q-value
GO:0044710 single-organism metabolic process 3.46E-16 1.84E-12
GO:0055114 oxidation-reduction process 3.50E-11 9.29E-08
GO:0044281 small molecule metabolic process 3.62E-11 6.39E-08
GO:0043436 oxoacid metabolic process 3.47E-08 4.60E-05
GO:0006082 organic acid metabolic process 3.47E-08 3.68E-05
GO:0019752 carboxylic acid metabolic process 9.33E-08 8.25E-05
GO:0009069 serine family amino acid metabolic process 1.82E-07 1.38E-04
GO:0008152 metabolic process 2.64E-07 1.75E-04
GO:1901605 alpha-amino acid metabolic process 2.27E-06 1.34E-03
GO:1901566 organonitrogen compound biosynthetic process 2.85E-06 1.51E-03
GO:0044712 single-organism catabolic process 3.20E-06 1.54E-03
GO:0044282 small molecule catabolic process 3.20E-06 1.41E-03
GO:0016054 organic acid catabolic process 4.68E-06 1.91E-03
GO:0046395 carboxylic acid catabolic process 4.68E-06 1.77E-03
GO:0015985 energy coupled proton transport, down electrochemical gradient 5.64E-06 2.00E-03
GO:0015986 ATP synthesis coupled proton transport 5.64E-06 1.87E-03
GO:0006544 glycine metabolic process 1.02E-05 3.17E-03
GO:0006754 ATP biosynthetic process 1.65E-05 4.86E-03
GO:0044711 single-organism biosynthetic process 1.66E-05 4.63E-03
GO:0009152 purine ribonucleotide biosynthetic process 2.94E-05 7.81E-03
GO:0006164 purine nucleotide biosynthetic process 3.67E-05 9.27E-03
GO:0009206 purine ribonucleoside triphosphate biosynthetic process 3.93E-05 9.46E-03
GO:0009145 purine nucleoside triphosphate biosynthetic process 3.93E-05 9.05E-03
GO:1901564 organonitrogen compound metabolic process 4.06E-05 8.97E-03
GO:0019395 fatty acid oxidation 4.62E-05 9.80E-03
GO:0009201 ribonucleoside triphosphate biosynthetic process 4.76E-05 9.71E-03
GO:0009142 nucleoside triphosphate biosynthetic process 4.76E-05 9.35E-03
GO:0046390 ribose phosphate biosynthetic process 5.03E-05 9.53E-03
GO:0009260 ribonucleotide biosynthetic process 5.03E-05 9.20E-03
GO:0034440 lipid oxidation 6.23E-05 1.10E-02
GO:0046034 ATP metabolic process 6.83E-05 1.17E-02
GO:1901576 organic substance biosynthetic process 9.45E-05 1.57E-02
GO:0072329 monocarboxylic acid catabolic process 1.06E-04 1.70E-02
GO:0072522 purine-containing compound biosynthetic process 1.18E-04 1.83E-02
GO:1901137 carbohydrate derivative biosynthetic process 1.82E-04 2.76E-02
GO:0006546 glycine catabolic process 1.84E-04 2.71E-02
GO:0006119 oxidative phosphorylation 1.84E-04 2.64E-02
GO:0009071 serine family amino acid catabolic process 1.84E-04 2.57E-02
GO:0001659 temperature homeostasis 2.31E-04 3.14E-02
GO:0060086 circadian temperature homeostasis 2.31E-04 3.06E-02
GO:0009058 biosynthetic process 2.33E-04 3.01E-02
GO:1901607 alpha-amino acid biosynthetic process 2.58E-04 3.26E-02
GO:0006091 generation of precursor metabolites and energy 3.04E-04 3.75E-02
GO:0032787 monocarboxylic acid metabolic process 3.06E-04 3.69E-02
GO:0044283 small molecule biosynthetic process 3.64E-04 4.29E-02
GO:0007618 mating 3.85E-04 4.44E-02
GO:0009416 response to light stimulus 4.09E-04 4.62E-02
GO:0022904 respiratory electron transport chain 4.13E-04 4.56E-02
GO:0009165 nucleotide biosynthetic process 5.66E-04 6.12E-02
GO:0022900 electron transport chain 5.73E-04 6.08E-02
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GO:2000678 negative regulation of transcription regulatory region DNA binding 6.86E-04 7.13E-02
GO:2000677 regulation of transcription regulatory region DNA binding 6.86E-04 6.99E-02
GO:0009066 aspartate family amino acid metabolic process 6.91E-04 6.91E-02
GO:0000096 sulfur amino acid metabolic process 6.91E-04 6.78E-02
GO:0042451 purine nucleoside biosynthetic process 7.07E-04 6.82E-02
GO:0046129 purine ribonucleoside biosynthetic process 7.07E-04 6.70E-02
GO:0090407 organophosphate biosynthetic process 7.20E-04 6.70E-02
GO:0044249 cellular biosynthetic process 7.63E-04 6.97E-02
GO:1901293 nucleoside phosphate biosynthetic process 8.70E-04 7.82E-02
GO:0006635 fatty acid beta-oxidation 8.88E-04 7.85E-02
GO:0044703 multi-organism reproductive process 8.88E-04 7.72E-02
GO:0017085 response to insecticide 8.88E-04 7.60E-02
GO:0008652 cellular amino acid biosynthetic process 9.42E-04 7.93E-02
Table 10 Gene ontology categories enriched in genes down-regulated after infection in the European population.
6.9 Immunity related induced genes
SERINE PEPTIDASE ACTIVITY (GO:0008236) 
GENE SYMBOL NAME T AF AM AS EU ALSO IN
CG31205 CG31205 0.99 1.14 1.16 0.85
CG5909 CG5909 0.87 0.92 1.1 0.8 DeGreg01 & Roxs04
CG6048 CG6048 0.73 0.69 1.04 0.88
CG9649 CG9649 0.61 0.73 0.52 0.62 0.55 DeGreg01
CG6580 Jon65Aii Jonah 65Aii 0.61 0.61 0.69 0.7
CG9372 CG9372 0.51 0.8 0.38 0.43 Roxs04
CG33329 Sp212 Serine-peptidase 212 0.48 0.55 0.57 0.48
CG1304 CG1304 0.46 0.62 0.63
CG9631 CG9631 0.38 0.39 0.54 DeGreg01
CG31326 CG31326 0.35 0.41 0.41
CG10772 Fur1 Furin 1 0.32 0.35
CG2045 Ser7 Ser7 0.32 0.31 DeGreg01 & Roxs04
CG18493 CG18493 0.28 0.4
CG31199 CG31199 0.27 0.43
CG3066 Sp7 Serine protease 7 0.27 DeGreg01 & Roxs04
CG17242 CG17242 0.26 0.52
CG18211 βTry β Trypsin 0.24 0.28
CG2071 Ser6 Serine protease 6 0.24
CG31200 CG31200 0.23 0.44 0.35
CG5896 grass Gram-positive Specific Serine protease 0.23 0.3
CG42280 ome omega 0.23 0.28
CG18734 Fur2 Furin 2 0.22 0.3
CG31267 CG31267 0.22
CG31217 modSP modular serine protease 0.2
CG17475 CG17475 0.19
CG11841 CG11841 0.18 0.27 0.32 DeGreg01 & Roxs04
CG4821 Tequila Tequila 0.18 0.23
CG11066 scaf scarface 0.17 0.31
CG32483 CG32483 0.17
CG6438 amon amontillado 0.15 0.24
CG34043 CG34043 0.15 0.43
CG10586 Sems Seminase -0.13
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CG3734 CG3734 -0.14
CG7532 l(2)34Fc lethal (2) 34Fc -0.15 DeGreg01
CG4477 CG4477 -0.16
CG11037 CG11037 -0.17 -0.24
CG4271 CG4271 -0.2
CG16996 Phae1 Phaedra 1 -0.22 -0.27
CG18030 Jon99Fi Jonah 99Fi -0.23 -0.33 DeGreg01
CG32382 sphinx2 sphinx2 -0.24
CG5390 CG5390 -0.25 -0.25 -0.29
CG9672 CG9672 -0.25 DeGreg01
CG32383 sphinx1 sphinx1 -0.25
CG10477 CG10477 -0.26 -0.36 -0.27
CG12558 CG12558 -0.26
CG12350 λ Try λ Try -0.27 -0.46
CG12386 ηTry η Trypsin -0.27
CG33276 CG33276 -0.31
CG7754 ιTry ι Trypsin -0.33 -0.41 -0.45
CG8579 Jon44E Jonah 44E -0.33 -0.57 DeGreg01
CG10041 CG10041 -0.34 -0.42
CG11664 CG11664 -0.37
CG12385 θTry θTrypsin -0.38 DeGreg01
CG8871 Jon25Biii Jonah 25Biii -0.39 DeGreg01 & Roxs04
CG6298 Jon74E Jonah 74E -0.45 Roxs04
CG10475 Jon65Ai Jonah 65Ai -0.53 -0.45 DeGreg01
CG4812 Ser8 Ser8 -0.72 -0.63 -0.88 DeGreg01
CG9564 Try29F Trypsin 29F -0.78 -1.08 -0.95 -0.79
CG18179 CG18179 -0.87 DeGreg01
CG3739 CG3739 -1.18 -1.15 -1.31 -1.44
CG11842 CG11842 0.45 DeGreg01 & Roxs04
CG18180 CG18180 0.38 DeGreg01
CG12351 δ Try δ Trypsin 0.27 DeGreg01
CG30028 γTry γTrypsin 0.25
CG30025 CG30025 0.24
CG30031 CG30031 0.24
CG18444 αTry α Trypsin 0.24
CG5246 CG5246 -0.56 Roxs04
Table 11 Genes coding for serine proteases induced in one or more populations and/or in the treatment analysis are shown in the table. When a gene is
significant the log2 fold change in expression is shown. All genes are member of the gene ontology "serine peptidase activity" (GO:0008236)  as
reported in Flybase.
SERINE-TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY (GO:0004867) 
GENE SYMBOL NAME T AF AM AS EU ALSO IN
CG1857 nec necrotic 0.3 0.33 0.37 DeGreg01 & Roxs04
CG7219 Spn28Dc Serpin 28Dc 0.26 0.44 DeGreg01 & Roxs04
CG18525 Spn88Ea Serpin 88Ea 0.16 DeGreg01 & Roxs04
CG10913 Spn55B Serpin 55B -0.18
CG8342 Kaz-m1 Kazal-type protease inhibitor m1 -0.21
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CG42472 Sfp33A1 Seminal fluid protein 33A1 -0.22 -0.37
CG10031 CG10031 -0.22
CG16712 CG16712 -0.22 Roxs04
CG42459 Sfp23F Seminal fluid protein 23F -0.22
CG6953 fat-spondin fat-spondin -0.23 -0.29 -0.33 DeGreg01
CG6289 Spn77Bc Serpin 77Bc -0.24 -0.59
CG42461 Sfp24Ba Seminal fluid protein 24Ba -0.27
CG31777 CG31777 -0.28
CG44008 CG44008 -0.32 -0.35
CG3604 CG3604 -0.33 DeGreg01 & Roxs04
CG31704 CG31704 -0.34 -0.37 -0.54
CG6663 Spn77Bb Serpin 77Bb -0.34 -0.7 -0.27 DeGreg01
CG1262 Acp62F Accessory gland protein 62F -0.36 -0.31 -0.5
CG16704 CG16704 -0.41 -0.6 -0.52 Roxs04
CG42467 CG42467 -0.46
CG31515 CG31515 -0.69 -0.6 -0.79 -0.69
Table 12 Genes  coding for Serpins induced in one or more populations and/or in the treatment analysis are shown in the table. When a gene is
significant the log2 fold change in expression is shown. All genes are member of the gene ontology "Serine-type endopeptidase inhibitor activity"
(GO:0004867) as reported in Flybase.
PHAGOCYTOSIS (GO:0006909) 
GENE SYMBOL NAME T AF AM AS EU ALSO IN
CG4899 Pdh Photoreceptor dehydrogenase 0.76 0.96 0.54 0.72 0.77
CG6518 inaC inactivation no afterpotential C 0.62 0.63 0.63 0.56 0.69
CG2993 CG2993 0.32
CG5599 CG5599 0.31 0.47
CG5166 Atx2 Ataxin-2 0.3 0.31
CG16791 CG16791 0.27 0.36
CG7068 Tep3 Thioester-containing protein 3 0.25 0.37
CG4027 Act5C Actin 5C 0.25 0.33
CG2244 MTA1-like MTA1-like 0.25 0.28
CG10539 S6k RPS6-p70-protein kinase 0.23 0.28
CG11527 Tig Tiggrin 0.22 0.25
CG5848 cact cactus 0.21 0.23 DeGreg01 & Roxs04
CG7586 Mcr Macroglobulin complement-related 0.2 0.28
CG7052 Tep2 Thioester-containing protein 2 0.18 DeGreg01 & Roxs04
CG2028 CkIα Casein kinase Iα 0.16 0.21
CG3638 CG3638 0.16
CG10233 rtp retinophilin 0.16
CG9351 flfl falafel 0.15
CG32697 l(1)G0232 lethal (1) G0232 0.15
CG7398 Trn Transportin 0.15
CG4122 svr silver 0.14 0.23
CG7149 CG7149 0.14
CG5215 Zn72D Zinc-finger protein at 72D 0.14
CG11804 ced-6 ced-6 -0.13
CG3843 RpL10Aa Ribosomal protein L10Aa -0.14
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CG5826 Prx3 Peroxiredoxin 3 -0.15
CG4780 membrin membrin -0.16
CG3948 ζ COP ζ COP -0.17
CG5861 CG5861 -0.18 -0.32
CG7610 ATPsyn-γ ATP synthase-γ chain -0.2
CG30427 CG30427 -0.2
CG9527 CG9527 -0.21 DeGreg01
CG8189 ATPsyn-b ATP synthase subunit b -0.22
CG32089 Vha16-2 Vacuolar H+ ATPase 16kD subunit 2 -0.23
CG5853 CG5853 -0.44 -0.48 -0.52
CG5178 Act88F Actin 88F -0.71 -0.68 DeGreg01
CG3494 CG3494 -0.23
Table 13 Genes coding for proteins involved in the phagocytosis defence response that are induced in one or more populations and/or in the treatment
analysis are shown in the table. When a gene is significant the log2 fold change in expression is shown. All genes are member of the gene ontology
"Imd signalling pathway" (GO:0006909)  as reported in Flybase.
IRON ION BINDING (GO:0005506) 
GENE SYMBOL NAME T AF AM AS EU ALSO IN
CG4373 Cyp6d2 Cyp6d2 1.06 0.88 1.09 1.12 1.15
CG10118 ple pale 0.58 0.61 0.59 0.6 0.51 Roxs04 & DeGreg01
CG10247 Cyp6a21 Cyp6a21 0.49 0.62 0.69 0.41
CG9438 Cyp6a2 Cytochrome P450-6a2 0.49 0.52 0.35
CG8859 Cyp6g2 Cyp6g2 0.47 0.46 0.64 0.42
CG10241 Cyp6a17 Cytochrome P450-6a17 0.45 0.43 0.53 0.44
CG8453 Cyp6g1 Cyp6g1 0.43 0.4 0.5 0.47 0.37 DeGreg01
CG10842 Cyp4p1 Cytochrome P450-4p1 0.4 0.46 0.63
CG6910 CG6910 0.3 0.43 DeGreg01
CG2397 Cyp6a13 Cyp6a13 0.29 0.37
CG9674 CG9674 0.29 0.27
CG8733 Cyp305a1 Cyp305a1 0.24
CG10245 Cyp6a20 Cyp6a20 0.22 0.47
CG6342 Irp-1B Iron regulatory protein 1B 0.22 0.26
CG10843 Cyp4p3 Cyp4p3 0.22 Roxs04 & DeGreg01
CG11715 Cyp4g15 Cyp4g15 0.22 0.45
CG10246 Cyp6a9 Cytochrome P450-6a9 0.17 0.4
CG10240 Cyp6a22 Cyp6a22 0.16
CG11466 Cyp9f2 Cyp9f2 0.14
CG6045 CG6045 0.12
CG4349 Fer3HCH Ferritin 3 heavy chain homologue -0.16
CG31022 PH4α EFB prolyl-4-hydroxylase-alpha EFB -0.17
CG3466 Cyp4d2 Cytochrome P450-4d2 -0.17
CG4335 CG4335 -0.17
CG15539 CG15539 -0.18
CG1998 CG1998 -0.18
CG18233 CG18233 -0.18
CG6042 Cyp12a4 Cyp12a4 -0.19 -0.29
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CG10833 Cyp28d1 Cyp28d1 -0.21 DeGreg01
CG5137 Cyp312a1 Cyp312a1 -0.22 -0.31
CG1644 Cyp6t1 Cyp6t1 -0.25
CG9964 Cyp309a1 Cyp309a1 -0.28 -0.53
CG5493 CG5493 -0.28 -0.34 -0.37 DeGreg01
CG17970 Cyp4ac2 Cyp4ac2 -0.3
CG18559 Cyp309a2 Cyp309a2 -0.3 -0.43 -0.4
CG14032 Cyp4ac1 Cyp4ac1 -0.3 -0.38 DeGreg01
CG3050 Cyp6d5 Cyp6d5 -0.35 -0.58 -0.43
CG17903 Cyt-c-p Cytochrome c proximal -0.36 -0.26 -0.53
CG3360 Cyp313a1 Cyp313a1 -0.38 -0.74
CG3540 Cyp4d14 Cyp4d14 -0.38 -0.36 -0.57 -0.65 DeGreg01
CG30489 Cyp12d1-p Cyp12d1-p -0.41 -0.7 -0.68
CG33503 Cyp12d1-d Cyp12d1-d -0.42 -0.76 -0.64
CG6730 Cyp4d21 Cyp4d21 -0.73 -0.43 -1.04 -0.85
CG13263 Cyt-c-d Cytochrome c distal -0.23
CG4769 CG4769 -0.27
CG4105 Cyp4e3 Cytochrome P450-4e3 -0.88
Table 14 Genes coding for iron ion binding proteins that are induced in one or more populations and/or in the treatment analysis are shown in the
table. When a gene is significant the log2 fold change in expression is shown. All genes are member of the gene ontology "iron ion binding"
(GO:0005506) as reported in Flybase.
LIPASE ACTIVITY (GO:0016298) 
GENE SYMBOL NAME T AF AM AS EU ALSO IN
CG31272 CG31272 0.51 0.64 0.43
CG6675 CG6675 0.49 0.35 0.71 0.53 Roxs04&DeGreg01
CG4979 sxe2 sex-specific enzyme 2 0.39 0.48 0.69
CG4267 CG4267 0.35 0.41 0.52 Roxs04&DeGreg01
CG4574 Plc21C Phospholipase C at 21C 0.24 0.3
CG17097 CG17097 0.23 0.33
CG14034 CG14034 -0.16
CG6113 Lip4 Lipase 4 -0.18
CG10116 CG10116 -0.2
CG1583 GIIIspla2 -0.24
CG15533 CG15533 -0.3
CG6295 CG6295 -0.34
CG5966 CG5966 -0.41
CG8093 CG8093 -0.43 -0.47 -0.45
CG34447 CG34447 -0.48 -0.4 -0.61
CG6271 CG6271 -0.5 -0.63 -0.67
CG6277 CG6277 -0.56 -0.54 -0.77
CG5932 mag magro -0.59 -0.63 -0.64 DeGreg01
CG31091 CG31091 -0.65
CG17192 CG17192 -0.81 DeGreg01
CG42237 CG42237 -0.9 -0.88 -0.85 -0.9 -0.97
CG5162 CG5162 0.3
Table 15 Genes coding for proteins with lipase activity that are induced in one or more populations and/or in the treatment analysis are shown in the
table.  When a  gene  is  significant  the  log2  fold change in  expression  is  shown.  All  genes are  member  of  the  gene  ontology  "lipase  activity"
(GO:0016298) as reported in Flybase.
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